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RESUMO 
 
Objetivos: O zolpidem (Zolp) é um fármaco seletivo para a subunidade α1 dos 
receptores GABAA com propriedades hipnóticas. Há relatos que sua 
administração pode induzir efeitos amnésticos. Até o presente momento 
nenhum estudo avaliou os efeitos cognitivos do Zolp em modelos 
experimentais de insônia. O objetivo desta Tese foi verificar os efeitos da 
administração repetida de Zolp (ou de sua retirada) sobre o processo de 
aprendizado/memória em camundongos submetidos à restrição de sono (RS). 
Métodos: Os camundongos foram submetidos à RS pelo método de gentle 
handling. Após a RS, os animais foram tratados com Zolp. Os paradigmas 
comportamentais utilizados foram a esquiva discriminativa em labirinto em cruz 
elevado (ED-LCE), a esquiva passiva (EP), reconhecimento de objetos (RO) e 
discriminação social (DS). O padrão de sono também foi analisado por meio do 
registro eletroencefalográfico. Resultados: A privação aguda de sono por 6 h 
promove amnésia, que é tolerada após a repetição do protocolo por 10 dias. 
Por outro lado, enquanto um curto período de privação de sono (3 h) não 
modificou a memória quando da sua ocorrência aguda, a repetição por 10 dias 
foi efetiva em prejudicar o desempenho na tarefa de ED-LCE. Ainda, todos os 
protocolos de privação de sono aumentaram a expressão de c-fos na amígdala 
basolateral e no giro denteado, estrutura que parece estar relacionada aos 
efeitos cognitivos da RS. Na tarefa de ED-LCE, a RS (3 h por 10 dias) 
promoveu déficits de memória quando realizada anteriormente ao treino ou ao 
teste. O prejuízo pré-treino foi revertido pela administração aguda de Zolp ou 
pela retirada do tratamento. O prejuízo de evocação foi revertido apenas após 
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o tratamento repetido com a droga. Ainda na ED-LCE, o antagonista β-cct 
reverteu o efeito agudo promnéstico do Zolp em animais submetidos à RS, mas 
não foi capaz de mimetizar os efeitos da retirada do tratamento. Na EP, uma 
tarefa de grande conteúdo emocional, a RS não foi capaz de promover déficits 
de retenção independente do momento em que ocorre. Já em paradigmas não-
aversivos (RO e DS), a RS promoveu déficits de memória em ambos os 
modelos. O déficit de memória na tarefa de RO foi abolido pela administração 
de Zolp. Por outro lado, apenas a administração aguda dessa droga reverteu o 
prejuízo de memória induzido pela RS observado na tarefa de DS. Com relação 
ao padrão de sono, o protocolo de RS se mostrou efetivo em aumentar a vigília 
e, consequentemente, em reduzir significativamente o sono de ondas lentas 
(SOL), o sono paradoxal e o tempo total de sono. A administração de Zolp 
aumentou o SOL em ambas as fases do ciclo, mas diminuiu o sono paradoxal. 
Nos animais restritos de sono e tratados com Zolp, houve um aumento de SOL 
e de sono paradoxal e se manteve elevado no rebote. Conclusão: Os achados 
da presente Tese demonstram a importância da validação de modelos 
experimentais de insônia bem como a avaliação dos efeitos do tratamento com 
Zolp em condições de RS, uma vez que os efeitos dessa droga podem ser 
discrepantes dependendo das condições de sono e do método de avaliação 
empregado. 
 
Palavras-chaves: zolpidem; memória; restrição de sono; registro de sono; 
camundongos. 
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ABSTRACT 
 
Purpose: Zolpidem (Zolp) is an imidazopyridine agent, which selectively binds 
to the α1 subunit into the GABAA receptors with mainly hypnotic properties. Zolp-
induced amnestic effects have been reported. Cognitive effects of Zolp in 
animal models of insomnia remain poorly understood. Thus, the present work 
was tailored to examine the effects of the repeated administration of Zolp (or its 
withdrawal) on learning/memory phases in mice subjected to sleep restriction 
(SR). Methods: Mice were sleep restricted by gentle handling. After SR, 
animals were treated with Zolp. The behavioral paradigms employed were the 
plus-maze discriminative avoidance task (PM-DAT), the passive avoidance task 
(PAT), spontaneous object recognition (SOR) and social discrimination (SD). 
Sleep pattern was analyzed by electroencephalographic recording. Results: 
We observed that the deleterious effects of acute SR for 6 h may be tolerated 
when the protocol was repeated for 10 days. Oppositely, a shorter period of 
sleep deprivation (3 h) impaired memory in the PM-DAT when repeated during 
10 days, but not when acutely employed. All of the SR protocols induced an 
increase in c-fos expression in the basolateral amygdala and dentate gyrus. Of 
note, c-fos expression in the dentate gyrus seems to be related to the cognitive 
effects of SR. In the PM-DAT, SR (3 h for 10 days) induced memory deficits 
when it occurred before training or testing. The pre-training impairment was 
abolished by the acute administration of Zolp or its withdrawal. Conversely, the 
retrieval deficit was abolished only after the repeated treatment with Zolp. The 
deleterious effects on memory were partially counteracted by the administration 
of the antagonist β-cct. In the PAT, a paradigm with a higher emotional 
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component, SR per se cannot promote retention deficits. In non-aversive 
paradigms (SOR and SD), SR promoted memory impairments in both tasks. 
The memory deficit in the SOR was abolished by Zolp administration. On the 
other hand, only the acute administration of this hypnotic counteracted the SR-
induced memory impairment in the SD task. Regarding the sleep pattern, the 
SR protocol was effective in increasing wake time and consequently reducing 
slow-wave sleep (SWS), paradoxical sleep and total sleep time (TST). The 
acute administration of Zolp increased SWS in both cycle phases but decreased 
paradoxical sleep in control animals. An increase in SWS and paradoxical sleep 
were detected in sleep-restricted mice treated with Zolp, which persisted during 
rebound. Conclusion: The findings presented herein strengthen the importance 
to validate animal models of insomnia as well as the investigation of the effects 
of Zolp treatment under SR conditions since the effects of this drug may be 
dependable of the sleep conditions and the evaluation methods. 
 
Keywords: zolpidem; memory; sleep restriction; sleep recording; mice. 
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1. INTRODUÇÃO 
 
1.1 Sono 
 
O sono é um processo fisiológico dividido em dois estados 
fundamentais, o sono NREM (do inglês, non-rapid eye movements) e o sono 
paradoxal ou REM (do inglês, rapid eye movements). É uma atividade que 
ocupa cerca de um terço de nossas vidas e é fundamental para uma boa saúde 
mental e emocional, além de ser essencial na manutenção de uma vida 
saudável (Everson et al., 1989; Rechtschaffen, 1998). 
Fisiologicamente, é considerado como um estado funcional, cíclico e 
reversível que está presente em todas as faixas etárias e na maioria das 
espécies animais. Possui algumas características comportamentais, como uma 
imobilidade relativa e o aumento do limiar de resposta aos estímulos externos 
(Hoshino, 2008). O organismo tem grande necessidade de manifestar o sono e 
quando isso não se torna possível podem ocorrer alterações marcantes, 
incluindo a morte em caso de um período prolongado de privação de sono em 
animais (Rechtschaffen et al., 1998). 
A compreensão moderna do sono originou-se dos primeiros registros da 
atividade elétrica cerebral em seres humanos. Esses registros, denominados 
de eletroencefalograma (EEG), permitiram a identificação de diferentes 
padrões durante o sono e ainda proporcionaram uma riqueza de informações 
sobre os potenciais corticais relacionados com mudanças fisiológicas distintas 
em cada fase do sono. Muitas alterações eletroencefalográficas ocorrem no 
decorrer de uma noite de sono, indicando uma sucessão bem ordenada e 
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cíclica de frequências de ondas nas fases de sono. Na primeira fase, ocorre o 
sono NREM, caracterizado pelo alentecimento progressivo da atividade cortical 
com três estágios: estágio S1 (sonolência); estágio S2 (sono “leve”) e estágio 
S3 (sono de ondas lentas propriamente dito). Esses estágios usualmente 
ocorrem em sequência, frequentemente com flutuações ao longo da noite. A 
seguir, ocorre o sono REM que tem como principais características o 
movimento rápido dos olhos e a atonia muscular, além de ser o período em que 
ocorrem os sonhos (Aserinsky e Kleitman, 2003; Dement e Kleitman, 1957). O 
sono REM é também denominado sono paradoxal, uma vez que o padrão 
eletroencefalográfico é semelhante ao da vigília, apesar de ser acompanhado 
pela atonia muscular que sugeriria um sono profundo (Jouvet et al., 1964). Em 
humanos, um ciclo de sono completo consiste de uma sequência de sono 
NREM e REM, e cada ciclo tem duração em média de 90 a 110 minutos. Em 
geral, são observados de quatro a seis ciclos durante uma noite de sono. Os 
episódios de sono REM aumentam do primeiro ao último ciclo de sono e 
podem durar até uma hora no fim da noite (Zisapel, 2007). 
Na década de 70, foi realizada uma detalhada análise das várias fases 
do sono do rato. Esse estudo revelou a existência de semelhanças com o sono 
humano maiores do que se acreditava até então. Os episódios de sono em 
roedores frequentemente se concentram durante o período claro, enquanto que 
a vigília predomina no período escuro. Os roedores, em média, dormem cerca 
de 62% do período claro e 33% do período escuro, sendo que, durante a 
vigília, os animais realizam suas atividades vitais e sociais (alimentação, 
procriação, autolimpeza, interação social e exploração do ambiente). Somando-
se os períodos de sono, verifica-se que os roedores dormem cerca de 50% das 
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24 horas, dividindo-se em sono de ondas lentas e sono paradoxal (Timo-Iaria et 
al., 1970). 
 
1.2 Restrição de sono e insônia 
 
Na sociedade moderna, as pessoas dormem menos do que o 
recomendado seja por estilo de vida, razões profissionais ou, ainda, em 
consequência de distúrbios do sono. De forma marcante, diversos estudos 
demonstram que o sono é essencial para garantir a sobrevivência. 
Consequentemente, a perda de sono promove alterações fisiológicas, como 
diminuição da tolerância à glicose (Spiegel et al., 1999), aumento da pressão 
arterial (Tochikubo et al., 1996), ativação do sistema nervoso simpático (Kato et 
al., 2000), diminuição nos níveis de leptina – hormônio da saciedade – (Spiegel 
et al., 2004) e aumento de marcadores inflamatórios (Meier-Ewert et al., 2004). 
Do ponto de vista epidemiológico, um levantamento demonstrou que o 
número de americanos que relatavam dormir menos de 6 h durante a semana 
aumentou de 12% em 1998 para 15% em 2002 e, em 2009, alcançou 20%. Por 
outro lado, aqueles que relatavam dormir mais de 8 h por noite diminuiu de 
35% em 1998 para 30% em 2002, chegando a 28% em 2009 (Tabela 1). Esses 
dados refletem a mudança no padrão de sono da sociedade moderna, 
revelando que os indivíduos estão cada vez mais submetidos a uma restrição 
crônica de sono. 
A perda parcial de sono pode acontecer em decorrência da 
fragmentação do sono, da privação de estágios específicos do sono ou da 
restrição de sono. Assim, a fragmentação do sono é frequentemente observada 
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em indivíduos com distúrbios do sono como, por exemplo, a apneia obstrutiva 
do sono, nos quais a progressão normal dos estágios do sono é interrompida. 
A privação de estágios específicos parece ser menos comum e pode ocorrer 
quando a fragmentação do sono acontece exclusivamente durante um estágio 
específico (por exemplo, episódios de apneia principalmente durante o sono 
REM ou medicamentos que suprimem uma fase específica do sono). A 
restrição de sono, também chamada de débito de sono, é caracterizada por 
uma redução na duração do sono. Tal diminuição pode ocorrer em 
consequência a distúrbios do sono ou outras condições médicas, trabalhos em 
turno, responsabilidades sociais e domésticas e estilo de vida, sendo a mais 
comum na sociedade atual (Banks e Dinges, 2007). 
Com relação à perda parcial de sono em decorrência de distúrbios do 
sono, um dos distúrbios mais frequentes na sociedade atual é a insônia. Esse 
distúrbio é caracterizado por dificuldade em adormecer, em manter o sono ou 
despertar precoce, associados à insatisfação com o padrão de sono ocorrendo 
no mínimo 3 noites por semana por pelo menos 3 meses, diante de 
oportunidade adequada para o sono (American Psychiatric Association. 
Diagnostic and Statistical Manual of Mental Disorders, 2013). Este distúrbio 
resulta em prejuízo das funções diárias, tornando-se assim um importante 
objeto de saúde pública com graves implicações socioeconômicas (Billiard e 
Bentley, 2004; Revel et al., 2009; Roehrs e Roth, 2004; Roth e Drake, 2004).  
Estudos demonstram que a insônia é o distúrbio do sono mais 
prevalente, afetando 10 a 25% da população adulta em diferentes países 
(Leger et al., 2008; Morin et al., 2006; Ohayon, 2002; Sivertsen et al., 2009; 
Soldatos et al., 2005). Ainda, episódios de insônia ocasional são relatados por 
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cerca de metade dos americanos adultos, enquanto que a insônia crônica afeta 
10 a 14% dessa população nos Estados Unidos (Leger et al., 2008; Roehrs e 
Roth, 2004). No Brasil, um levantamento nacional baseado em questionário 
mostrou que 35% dos entrevistados reclamavam de algum sintoma de insônia 
com frequência acima de 3 vezes por semana (Bittencourt et al., 2009). 
Especificamente no estado de São Paulo, a prevalência de insônia objetiva, ou 
seja, demonstrada por avaliação polissonográfica, é de 32% (Castro et al., 
2013). Nesse contexto, tem-se tornado importante a validação de modelos pré-
clínicos para avaliação de potenciais tratamentos farmacológicos da insônia. 
 
Tabela 1 – Relato do número de horas de sono nas últimas 2 semanas na 
população americana entre 1998 e 2009 
 Dias úteis Finais de semana 
 1998 2001 2002 2005 2009 1998 2001 2002 2005 2009 
Menos de 6 h 12% 13% 15% 16% 20% 8% 7% 10% 10% 14% 
Entre 6 e 7 h 23% 18% 24% 24% 23% 14% 10% 12% 15% 16% 
Entre 7 e 8 h 28% 31% 29% 31% 27% 23% 21% 22% 24% 24% 
Mais de 8 h 35% 38% 30% 26% 28% 53% 61% 52% 49% 44% 
Média das horas de sono - 7,0 6,9 6,8 6,7 - 7,8 7,5 7,4 7,1 
Adaptado de National Sleep Foundation, 2009 
 
Conforme revisado por Revel e colaboradores (2009), idealmente um 
modelo animal de insônia deve mimetizar as principais características da 
insônia em humanos, ou seja, deve exibir qualidade ou quantidade de sono 
diminuída no período em que o animal estaria fisiologicamente dormindo. 
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Nessa revisão, os autores avaliaram criticamente os potenciais modelos 
animais de insônia, tais como aqueles relacionados ao estresse, os 
farmacológicos, as perturbações do ritmo circadiano e modelos baseados em 
doenças, bem como situações experimentais capazes de interromper o sono 
(modelos relacionados à restrição de sono). 
Entre os modelos relacionados à privação de sono, destaca-se a 
privação total de sono pelo método de gentle handling (Tobler et al., 1990). De 
fato, sugere-se que a privação total de sono causaria prejuízos maiores do que 
aqueles causados pela privação de um estágio específico do sono, como é o 
caso da privação de sono paradoxal. Em concordância, a privação de sono 
total por meio do método de gentle handling mostrou-se mais efetiva em 
promover amnésia do que a privação de sono paradoxal (Patti et al., 2010). 
Dessa maneira, a perturbação não seletiva de sono por algumas horas/dia 
durante períodos prolongados poderia ser um possível modelo de restrição de 
sono e, assim, de insônia experimental. 
De importância para a presente Tese, no que diz respeito à cognição, o 
sono tem um papel crucial no aprendizado e formação de memórias. De fato, 
diversos estudos têm demonstrado que tanto a privação de sono paradoxal 
como a privação de sono total promovem prejuízos de memória em diversos 
modelos animais, como as tarefas de esquiva (Bueno et al., 1994), o labirinto 
aquático de Morris (Youngblood et al., 1997, 1999), o labirinto radial (Smith et 
al., 1998), reconhecimento de objetos (Palchykova et al., 2006) e a esquiva 
discriminativa em labirinto em cruz elevado (Alvarenga et al., 2008; Fernandes-
Santos et al., 2012; Patti et al., 2010; Silva et al., 2004). Em protocolos de 
restrição de sono, os indivíduos são submetidos a curtos períodos de perda 
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total de sono (Banks e Dinges, 2007). Nesse aspecto, apesar de alguns 
modelos de restrição de sono em animais terem sido desenvolvidos 
recentemente (Everson e Szabo, 2009; Kim et al., 2007, 2012; Leemburg et al., 
2010; McCoy et al., 2013; Yang et al., 2012; Zielinski et al., 2013), o emprego 
desse método ainda é menos frequente quando comparado ao emprego da 
privação de sono paradoxal ou total em trabalhos avaliando os possíveis 
efeitos neurocomportamentais da privação de sono. O pequeno número de 
estudos utilizando modelos animais de restrição de sono somado aos dados 
epidemiológicos – que refletem a mudança no padrão de sono da sociedade 
moderna – demonstram a importância do desenvolvimento de novos métodos 
de restrição de sono, um modelo com características translacionais. 
Com relação a estudos em humanos, foi demonstrado que a restrição de 
sono prejudica o alerta, medido pelo teste de vigilância psicomotora, sendo que 
quanto menor o tempo permitido de sono maior a magnitude de redução no 
alerta. Além disso, os efeitos neurocomportamentais da restrição de sono 
parecem semelhantes àqueles da privação de sono total (Belenky et al., 2003; 
Van Dongen et al., 2003). No que diz respeito a modelos animais, a restrição 
de sono por meio do método da locomoção forçada promove déficits de 
memória espacial (McCoy et al., 2013; Zielinski et al., 2013). Contudo, os 
modelos de privação de sono por locomoção forçada induzem um estresse 
excessivo nos animais, o qual poderia influenciar os resultados 
comportamentais. De nosso conhecimento, apenas o estudo conduzido por 
Yang e colaboradores (2012) avaliou os efeitos da restrição de sono sobre a 
memória utilizando o gentle handling, um modelo de privação menos 
estressante (Palchykova et al., 2006). Nesse estudo, o protocolo de restrição 
Karina Agustini Zanin  Introdução 
 
8 
 
de sono impediu a consolidação de uma memória espacial em ratos 
adolescentes, mas não em adultos. 
Os possíveis efeitos do sono sobre a memória de longo-prazo foram 
primeiramente considerados com base na hipótese restauradora do sono. Essa 
hipótese propõe que a síntese proteica é facilitada durante o sono (Idzikowski, 
1984), o que poderia resultar numa potencialização dos mecanismos celulares 
que levam à consolidação da memória. Em animais, há indicações de que, 
após a aquisição de uma tarefa, ocorrem pequenas e vulneráveis “janelas de 
sono paradoxal”, caracterizadas por um aumento na duração normal desse tipo 
de sono, proporcionais à quantidade de informações apresentadas durante a 
aquisição. Durante essas “janelas” ocorreria uma plasticidade neuronal 
acelerada, que seria sensível à interrupção do sono paradoxal (Smith, 1996). 
Contudo, embora a grande maioria dos estudos procure esclarecer o papel do 
sono paradoxal na formação da memória, um importante papel do sono de 
ondas lentas também tem sido relatado (Power, 2004; Gais e Born, 2004). 
Além disso, estudos sugerem que as fases de ondas lentas e paradoxal seriam 
complementares para os processos de memória que ocorreriam durante o sono 
(Diekelmann e Born, 2010; Ficca e Salzarulo, 2004). 
A privação de sono pode promover alterações significativas em diversos 
sistemas de neurotransmissão central, dentre eles o dopaminérgico, o qual tem 
uma participação importante nos processos relacionados à formação da 
memória. Assim, a privação de sono parece estar relacionada com alterações 
na plasticidade da transmissão dopaminérgica. De fato, um aumento de 
diversos comportamentos relacionados à ação da dopamina, induzidos pela 
administração de agonistas diretos ou indiretos, tem sido observado após a 
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privação de sono (Arriaga et al., 1988; Ferguson e Dement, 1969; Frussa-Filho 
et al., 2004; Troncone et al., 1988; Tufik et al., 1978; Tufik, 1981a,b). 
 
1.3 Zolpidem 
 
Até a década de 1980, todos os hipnóticos não barbitúricos 
apresentavam estruturas químicas e farmacológicas semelhantes: os clássicos 
benzodiazepínicos (BZDs). Apesar da considerável eficácia, os BZDs causam 
efeitos adversos importantes como sedação persistente, ataxia, amnésia e 
tolerância, além de um considerável potencial de induzir dependência e abuso 
(Akhondzaded et al., 2002; Allison e Pratt, 2003). Nesse cenário, na tentativa 
de evitar tais efeitos, novos ligantes foram desenvolvidos. Assim, em 1988 foi 
lançado na França o zolpidem (Markowitz e Brewerton, 1996). Com a sua 
liberação pelo US Food and Drug Administration em 1992, o zolpidem se 
tornou o hipnótico mais vendido nos Estados Unidos e no continente europeu 
(Besnard et al., 1996). 
O zolpidem é um derivado imidazopiridínico (Figura 1) e, assim como os 
BDZs, aumenta o efeito inibitório do ácido gama-aminobutírico (GABA) ao se 
ligar aos receptores GABAA. Esses receptores são canais de íons cloreto com 
estrutura pentamérica formada pela combinação de pelo menos 19 
subunidades diferentes pertencentes a 7 famílias principais: α, β, γ, δ, ε, π e θ 
(Fitzgerald et al., 2014; Tan et al., 2011). A função específica de cada 
subunidade do receptor GABAΑ tem sido estuda por métodos farmacológicos e 
comportamentais com a utilização de animais transgênicos, nos quais 
diferentes subunidades são excluídas ou modificadas (Tabela 2). Em sua 
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maioria, os receptores GABAA são compostos pelas subunidades 2α, 2β e 1γ 
(Nutt, 2006). Especificamente, os receptores que contêm as subunidades α1, 
α2, α3 ou α5 em combinação com quaisquer subunidades β e a subunidade γ2 
são sensíveis aos BZDs clássicos como o diazepam (Hadingham et al. 1996; 
Wafford et al. 1996; Wisden et al. 1991). Por outro lado, o zolpidem apresenta 
maior afinidade pelos receptores GABAA que contem a subunidade α1. Já a 
afinidade pelas subunidades α2 e α3 é 10 a 20 vezes menor, enquanto que 
para a subunidade α5 é ainda menor (Fitzgerald et al., 2014). Essa seletividade 
confere ao zolpidem propriedades predominantemente hipnóticas e ausência 
relativa de efeitos anticonvulsivante e relaxante muscular que são associados 
aos BDZs (Depoortere et al., 1986; Lloyd e Zivkovic, 1988; Salvà e Costa, 
1995; Zivkovic et al., 1988). 
 
 
 
 
 
 
Figura 1 – Estrutura molecular do zolpidem. 
 
Sob o aspecto farmacocinético, após a administração oral, o zolpidem é 
absorvido de maneira rápida, tendo uma biodisponibilidade de 70% (Langtry e 
Benfield, 1990). Sua meia-vida em humanos é de 1,5 a 2,5 horas (American 
Sleep Disorders Association, 1990), não possuindo nenhum metabólito ativo 
(Langtry e Benfield, 1990), características que evitam efeitos residuais pela 
manhã (American Sleep Disorders Association, 1990). A dose comumente 
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empregada na clínica é de 10 mg na hora de dormir. Essa dose parece 
promover problemas de memória, confusão, e sintomas psicóticos em 2% dos 
pacientes (American Sleep Disorders Association, 1990; Langtry e Benfield, 
1990; Salvà e Costa, 1995). Com relação à arquitetura do sono, o zolpidem 
diminui a latência de sono e aumenta o tempo total de sono (American Sleep 
Disorders Association, 1990), podendo aumentar o sono de ondas lentas, 
geralmente reduzido em pacientes com insônia (Besset et al., 1995), sem, 
entretanto, alterar o sono REM (do inglês, rapid eye movements) ou estágio S2 
do sono não-REM (Colle et al., 1991; Poyares et al., 2005). 
 
Tabela 2 – Participação das diferentes subunidades do receptor GABAA 
nos efeitos comportamentais 
 α1 α2 α3 α5 β2 β3 γ2 δ 
Efeito dos benzodiazepínicos         
Sedação + - - - +    
Ansiólise - + -/+ -     
Amnésia +   +     
Miorrelaxante -  +      
Prejuízo motor - - -      
Anticonvulsivante + - - -     
Potencialização do etanol    +     
Efeito anestésico +    + +  + 
Ansiedade       +  
Aprendizado e memória    +    + 
Adaptado de Nutt, 2006 
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Tendo em vista a semelhança entre o zolpidem e os clássicos BZDs, 
poder-se-ia argumentar que assim como ocorre com BZDs, o zolpidem poderia 
ter potencial de induzir abuso e dependência. Entretanto, devido a sua 
seletividade, sugeriu-se que esse risco seria diminuído (Evans et al., 1990; 
Perrault et al., 1990). Por outro lado, estudos e relatos recentes têm 
demonstrado que, opostamente ao esperado, o zolpidem apresenta potencial 
para abuso e dependência. Nesse sentido, Hajak e colaboradores (2003) 
realizaram um levantamento bibliográfico dos relatos de caso sobre abuso e 
dependência ao zolpidem entre 1966 e 2002. Nesse estudo, esses autores 
verificaram o total de 36 casos de dependência, com incidência semelhante 
entre homens e mulheres e com uma média de ingestão de 400 mg/dia. 
Entretanto, apesar desses relatos, os autores concluem que o zolpidem é uma 
droga relativamente segura, embora pacientes com histórico de dependência 
ou doenças psiquiátricas representem um grupo de risco. Em consequência, a 
prescrição de zolpidem deve ser cautelosa. Com efeito, Svitek e colaboradores 
(2008) relataram um caso de dependência em um homem jovem e insone sem 
histórico de abuso a outras substâncias, o qual consumia até 800 mg/dia de 
zolpidem e que desenvolveu síndrome de abstinência quando da retirada da 
droga. Com relação à tolerância, alguns estudos relatam o desenvolvimento de 
tolerância aos efeitos de ataxia e de indução do sono (Griffiths et al., 1992; 
Stoops e Rush, 2003; Ware et al., 1997). 
Do ponto de vista neuroquímico, apesar de os BZDs e de o zolpidem 
atuarem no sistema GABAérgico, conhecidamente depressor do sistema 
nervoso central, sugere-se que haja um aumento compensatório nas sinapses 
excitatórias glutamatérgicas após a estimulação crônica de sinapses 
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GABAérgicas por meio do uso de BZDs (Stephens, 1995). Assim, o aumento 
da estimulação glutamatérgica poderia contribuir para tolerância e síndrome de 
abstinência relacionadas aos BZDs (Heikkinen et al., 2009). Nesse contexto, 
Heikkinen e colaboradores (2009) observaram que uma única administração de 
5 mg/Kg de zolpidem é capaz de induzir um aumento na transmissão 
glutamatérgica dos neurônios dopaminérgicos da área tegmentar ventral (VTA), 
região de grande importância nos processos de reforço e recompensa 
associados às drogas de abuso (Di Chiara e Imperato, 1988; Schultz, 1998; 
Wise, 1996). Ainda, foi demonstrado que drogas moduladoras do sistema 
GABAérgico como os BZDs, podem inibir os interneurônios da VTA e da 
substância negra (Grace et al, 1980; Tan et al, 2010). Em consequência, os 
neurônios GABAérgicos deixam de inibir as células dopaminérgicas, 
aumentando a liberação de dopamina. Especificamente, foi demonstrando que 
esses interneurônios inibitórios expressam principalmente a subunidade α1, 
sítio de ação do zolpidem (Gao et al., 1993; Gao e Fritschy, 1994). Nada se 
sabe até o momento, entretanto, sobre o possível desenvolvimento de 
tolerância aos efeitos do zolpidem sobre o desempenho cognitivo. 
 
1.4 Memória 
 
A memória é geralmente definida como a capacidade de reter e 
manipular informações adquiridas anteriormente por meio da plasticidade 
neuronal. Ela pode ser classificada como implícita ou explícita, dependendo de 
como a informação é retida e evocada; ou memória de curto e longo prazo, 
dependendo de sua duração. A memória implícita ou não-declarativa inclui o 
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condicionamento clássico, habilidades e hábitos, e é em grande parte ou, com 
frequência, completamente inconsciente. A memória explícita ou declarativa, 
por outro lado, envolve a recuperação consciente de eventos ou fatos que 
tenham ocorrido. Esses tipos de memória são processados de formas 
diferentes e em partes diferentes do cérebro, embora estejam relacionados por 
meio de inúmeras conexões neurais (Thompson et al., 2002). 
Assim, o hipocampo é considerado o responsável pela conversão de 
memória de curto prazo em memória de longo prazo e pela informação 
espacial, enquanto o neocórtex, pelo armazenamento da memória de longo-
prazo declarativa (Jerusalinsky et al., 1997). Já o corpo estriado está envolvido 
com a memória de procedimento (Mishkin et al., 1984) e a amígdala parece ser 
especializada no processo de alerta e informação aversiva e participaria da 
memória para eventos com significado emocional (Cahill et al., 1990; Davis, 
1992; Sarter et al., 1985). O septo medial também participa do processo de 
informação aversiva, por um mecanismo distinto daquele da amígdala 
(Izquierdo, 1991) e o córtex entorrinal, que apresenta conexões mono e 
polissinápticas com a amígdala, hipocampo e septo medial, processa 
informação espacial, aversiva, além de outras, estando particularmente 
envolvido com a memória associativa (Ferreira et al., 1992; Witter et al., 1989; 
Zola-Morgan et al., 1989). 
Investigações farmacológicas também fornecem base para o possível 
papel exercido pela acetilcolina no processo de formação da memória, uma vez 
que um efeito amnéstico geralmente é verificado após a administração de 
antagonistas colinérgicos como a escopolamina (Givens e Olton, 1990; Glick e 
Zimmerberg, 1971; Weissman, 1967; Wiener e Messer, 1973). Além disso, o 
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tratamento com inibidores de colinesterase como a fisostigmina (Deutsch et al., 
1979; Straton e Petrinovich, 1963) é sabiamente estimulador da memória, 
assim como o tratamento com agonistas colinérgicos como a nicotina (Battig, 
1970; Erickson, 1971; Evangelista et al., 1970; Garg, 1969) ou a oxotremonina 
(Baratti et al., 1979). Apesar de a relação entre a acetilcolina e a função 
cognitiva, outros neurotransmissores como a serotonina (Steckler e Sahgal, 
1995) e as catecolaminas (Dismukes e Rake, 1972; Randt et al., 1971) 
parecem também participar do processo de formação da memória. 
Dentre os mecanismos celulares e moleculares envolvidos na memória e 
aprendizado, destacam-se a sensibilização e a potenciação de longa duração 
(LTP – Long Term Potentiation). A sensibilização consiste num processo de 
facilitação pré-sináptica da transmissão neuronal que ocorre nas memórias de 
curto e longo prazo. É um processo heterossináptico, no qual o aumento da 
força sináptica é induzido por interneurônios moduladores ativados pela 
estimulação. Estes liberam serotonina e outros neurotransmissores, que se 
acoplam a receptores transmembrânicos específicos ligados à proteína Gs, 
ativando a adenilil ciclase, que catalisa a conversão de ATP (adenosina 
trifosfato) em AMPc (adenosina 3',5'-monofosfato cíclico), o qual ativa a 
proteína cinase A (PKA), causando, aliada à proteína cinase C (PKC), o 
aumento da liberação de neurotransmissores nos terminais sinápticos. A LTP é 
uma facilitação que consiste num aumento da amplitude dos potenciais pós-
sinápticos excitatórios devido a um “trem” de estímulos em alta frequência. Ela 
possui uma fase precoce transitória (duração de aproximadamente 1 a 3 horas, 
não requer síntese de novas proteínas e é induzida por apenas uma série de 
estimulações) e uma fase tardia de consolidação (ocorre devido a 4 ou mais 
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séries de estimulações; com duração de no mínimo 24 horas e síntese de 
novas proteínas) (Kandel, 2003). 
 
1.5 Zolpidem e memória 
 
Conforme previamente comentado, o perfil farmacológico do zolpidem, 
embora qualitativamente diferente daquele apresentado pelos BZDs clássicos, 
possui intersecções farmacológicas com essas drogas (Evans et al., 1990). 
Nesse sentido, os efeitos amnésticos dos BZDs são amplamente conhecidos 
tanto em humanos (Lister, 1985) quanto em animais (Stackman e Walsh, 1992; 
1995a,b). Ainda, apesar de aparentemente apresentar menos efeitos deletérios 
sobre os processos cognitivos em comparação aos BZDs, efeitos amnésticos 
do zolpidem não deixam de ser relatados tanto em investigações com modelos 
animais como em estudos clínicos. 
No que concerne a animais de laboratório, a administração aguda de 
zolpidem atenuou a aquisição da tarefa de medo condicionado em 
camundongos (Sanger et al., 1986) e em ratos (Chodera et al., 1994). Ainda, a 
administração aguda de 1 – 10 mg/Kg dessa droga promoveu efeitos 
amnésticos em camundongos avaliados na esquiva passiva (Edgar et al., 1997; 
Tang et al., 1995) e prejudicou a memória de trabalho avaliada no modelo do 
labirinto radial (Herzog et al., 2000). Mais recentemente, verificamos que a 
administração aguda de 5 ou 10 mg/Kg de zolpidem (mas não de 2 mg/Kg) 
promove uma completa amnésia em camundongos avaliados na esquiva 
discriminativa em labirinto em cruz elevado. De fato, tal efeito amnéstico 
ocorreu somente quando o zolpidem foi administrado agudamente antes do 
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treino (efeitos sobre o aprendizado e a consolidação), mas não quando foi 
administrado imediatamente após o treino (efeito sobre a consolidação) ou 
antes do teste (efeito sobre a evocação). Conjuntamente, tais resultados 
sugerem que o zolpidem promove um déficit de memória anterógrada. Além 
disso, também foi verificado um atraso no aprendizado da tarefa após a 
administração aguda de 10 mg/Kg de zolpidem (Zanin et al., 2013). Ainda no 
que concerne aos efeitos cognitivos, a administração aguda dessa mesma 
dose também promove déficits de habituação em campo aberto, um modelo 
animal de memória implícita (Zanin et al., 2011). De relevância, a administração 
aguda desse hipnótico – em todas as doses (2, 5 ou 10 mg/Kg) – promoveu um 
marcante efeito hipolocomotor dose-dependente, refletindo o efeito sedativo 
dessa droga (Zanin et al., 2013). 
Sob o aspecto clínico, estudos revelaram que a administração aguda de 
zolpidem produziu déficits de memória tais quais aqueles induzidos pela 
administração aguda de triazolam, um BZD clássico. Além disso, o zolpidem 
também promoveu uma distorção na avaliação subjetiva do desempenho em 
tarefas de aprendizado e memória, como tempo de reação e o reconhecimento 
de figuras (Evans et al., 1990). Cashman e colaboradores (1987) 
demonstraram que o zolpidem produziu amnésia anterógrada quando da 
administração aguda em mulheres, e que tal amnésia se mostrou dependente 
de dose. Por fim, a administração aguda de zolpidem, 2 ou 3 horas antes do 
horário de acordar, promoveu efeitos residuais no desempenho psicomotor e 
prejuízos tanto na memória de trabalho quanto na memória de curta duração 
(Danjou et al., 1999). Tomados em conjunto, os achados descritos acima 
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sugerem que a administração aguda de zolpidem promove um efeito inibitório 
sobre os processos de aprendizado e memória. 
Apesar de haver poucos estudos que tenham avaliado os efeitos 
prejudiciais do tratamento repetido com zolpidem por um período clinicamente 
relevante sobre o desempenho cognitivo, Stoops e Rush (2003) demonstraram 
que houve prejuízo no desempenho de humanos tratados agudamente com 
zolpidem em 3 diferentes tarefas. Contudo, não houve diferença no 
desempenho quando comparado ao 1º dia após 4 dias de tratamento, 
sugerindo que não houve desenvolvimento de tolerância aos efeitos 
prejudiciais induzidos por essa droga. Ainda nesse sentido, Kleykamp e 
colaboradores (2012) também não observaram tolerância aos efeitos deletérios 
cognitivos do zolpidem mesmo após 22 a 30 dias de tratamento por todas as 
noites. Esses mesmos autores observaram que após a descontinuação do 
tratamento, apesar de haver uma tendência, não houve efeito significativo da 
abstinência sobre o desempenho cognitivo dos indivíduos. Entretanto, esses 
mesmos autores sugerem que a magnitude desses efeitos poderia aumentar 
com o uso de doses maiores da droga ou um prolongamento de seu uso por 
vários meses ou anos. Por outro lado, ao que sabemos, nenhum estudo avaliou 
os efeitos decorrentes da administração repetida dessa droga sobre o a 
aprendizado/memória em condições experimentais que mimetizem a insônia. 
 
1.6 Genes de expressão imediata e família Fos 
 
A estimulação neuronal ativa mecanismos distintos para processar e 
transmitir a informação. Essa ativação pode envolver alterações da atividade 
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eletrofisiológica neuronal ou na cascata de segundos mensageiros que evoca a 
produção de fatores que induzem ou inibem a transcrição de genes (Herdegen 
e Leah, 1998). Os genes ativados por fatores de transcrição podem produzir 
proteínas como as que constituem receptores, canais iônicos e as requeridas 
para síntese e regeneração de neurotransmissores. Entre os fatores de 
transcrição conhecidos, um dos mais estudados é o c-Fos, o qual é induzido 
rapidamente após a ativação sináptica, atingindo o pico entre 90 e 120 minutos 
após a estimulação (Nestler et al., 2001). 
Mais especificamente, c-Fos é um proto-oncogene pertencente à família 
dos genes de expressão imediata, immediate early genes – IEGs. Esses genes 
são fatores de transcrição, ativados rápida e transientemente na cascata inicial 
da expressão gênica, responsável por iniciar o processo de mudanças 
adaptativas induzidas por estímulos extracelulares e atividade sináptica 
excitatória (Davis et al., 2003). A proteína c-Fos, produto do gene c-Fos, é uma 
proteína regulatória que, em conjunto com outros membros das famílias Fos e 
JUN, formam um complexo heterodimérico AP1, que por sua vez, se liga ao 
DNA para controlar a expressão gênica. 
Na maioria das células, os níveis de expressão basal de c-Fos são 
relativamente baixos. Todavia, o seu RNAm e os níveis proteicos aumentam 
rapidamente após a aplicação de uma variedade de estímulos extracelulares, 
como por exemplo estresse (Del-Bel et al., 1993; Titze-de-Almeida et al., 1994), 
epilepsia (Herrera e Robertson, 1996), estímulos nociceptivos (Harris et al., 
1996; Hunt et al., 1987) e drogas de abuso (Aston-Jones e Harris, 2004; 
Nestler, 2004). Essa ausência de expressão basal seguida de um aumento de 
expressão de c-Fos contribuem para a sensibilidade da técnica, onde a 
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presença da proteína c-Fos pode ser usada como um marcador de ativação 
celular gerada por estímulo. No sistema nervoso central, esse aumento pode 
ser detectado rapidamente (15-30 minutos para a ativação de RNAm e 30-60 
minutos para a ativação da proteína c-Fos) pela técnica de imuno-histoquímica. 
A incubação do tecido em solução contendo o anticorpo anti-c-Fos, após a 
revelação, produz um precipitado escuro marcando o núcleo das células c-Fos 
positivas. A extensão e intensidade da expressão de c-Fos determinam as 
áreas cerebrais ativadas em uma determinada tarefa (Grzanna e Brown, 1993). 
Os genes que codificam as proteínas da família Fos são classificados 
como IEGs devido ao seu rápido e transitório padrão de indução. Entretanto, 
uma subclasse de antígenos estáveis relacionados à proteína Fos (Fos-related 
antigens – FRAs) foram posteriormente identificados (Chen et al., 1995; Hope 
et al., 1994). Alguns desses antígenos crônicos são isoformas estabilizadas de 
delta-FosB (Hiroi et al., 1997, 1998). Resumidamente, como representado na 
figura 2, um estímulo agudo induz a síntese de c-Fos. O c-fos e a maioria 
dessas proteínas são instáveis e, portanto, dissipadas rapidamente após a 
estimulação. Após a repetição do estímulo, as isoformas de delta-FosB 
gradualmente acumulam em níveis elevados e fisiologicamente ativos, ao 
passo que a indução de c-Fos e outras proteínas da família Fos, é 
dessensibilizada após um estímulo repetido. Em consequência, as isoformas 
de delta-FosB tornam-se as proteínas da família Fos predominantes após um 
tratamento crônico e medeiam as modificações na expressão gênica. 
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Figura 2 – padrão de expressão das proteínas Fos (adaptado de Nestler et al., 2001) 
 
Com relação aos processos mnemônicos, a expressão pós-treino de 
RNA para c-Fos tem sido descrita em diversas tarefas, incluindo a esquiva 
ativa (Nikolaev et al., 1992), tarefas de discriminação de luminosidade (Grimm 
et al., 1997; Tischmeyer et al., 1990) e odor (Hess et al., 1995a,b), além da 
tarefa de alternância (Nagahara e Handa, 1995). De importância, diversos 
estudos têm demonstrado que a expressão da proteína c-Fos é aumentada no 
hipocampo após o aprendizado (Cammarota et al., 2000; Papa et al., 1995; 
Vann et al., 2000; Wan et al., 1999; Zhu et al., 1997). Com relação à evocação 
de tarefas, foi demonstrado que camundongos que aprenderam uma tarefa de 
discriminação espacial apresentaram uma maior expressão de proteínas c-Fos 
no hipocampo e no córtex entorrinal ao recordar uma memória recente, mas 
não uma memória de longa duração. Entretanto, diversas regiões corticais, 
como os córtices pré-frontal, temporal e cingulado anterior, foram mais ativadas 
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após a recordação de uma memória de longa duração (Bontempi et al, 1999; 
Maviel et al., 2004). Ainda, as regiões corticais que são recrutadas para dar 
suporte à memória de longa duração dependem da tarefa. Dessa forma, em 
uma tarefa olfativa, o teste da memória de longa duração foi associado com a 
atividade aumentada nos córtex piriforme, entorrinal e órbito-frontal, mas não o 
córtex cingulado anterior (Ross e Eichenbaum, 2006). 
No que diz respeito ao sono, diversos estudos realizados em ratos 
(Cirelli et al., 1993, 1995; Garcia-Garcia et al., 1998; Grassi-Zucconi et al., 
1993, 1994a,b; Novak e Nunez, 1998; O’Hara et al., 1993; Pompeiano et al., 
1992, 1994, 1997; Sherin et al., 1996) e em camundongos (Basheer et al., 
1997) demonstram que a expressão de c-Fos no cérebro é baixa, ou mesmo 
ausente, após algumas horas de sono, enquanto que essa atividade está 
aumentada em animais mantidos acordados por algumas horas. Nesse sentido, 
o padrão de expressão de c-Fos após algumas horas de privação de sono total 
é similar ao padrão observado após a vigília espontânea (Cirelli, 2002), 
sugerindo que a expressão de c-Fos está relacionada à vigília per se. Ainda, 
apesar de diferentes protocolos de privação de sono promoverem um aumento 
nos níveis de c-Fos, essa expressão não é necessariamente proporcional à 
“quantidade” de vigília. Nesse sentido, o aumento de c-Fos é mais acentuado 
após 3 horas de privação do que após 24 horas na maior parte das regiões 
cerebrais (Cirelli et al., 1995). Ainda, a expressão de c-Fos é induzida de 
maneira mais eficiente por estímulos novos do que por estímulos familiares 
(Anokhin et al., 1995; Hess et al., 1995b; Radulovic et al., 1998; Zhu et al., 
1995), bem como por curtos períodos de privação ao invés de períodos 
prolongados (Cirelli et al., 1995, 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objetivos 
 
Karina Agustini Zanin  Objetivos 
 
23 
 
2. OBJETIVOS 
 
2.1 Objetivo geral 
Considerando a crescente utilização do zolpidem no tratamento da 
insônia, as evidências prévias observadas por nosso grupo de pesquisa que 
sugerem alterações cognitivas induzidas pela administração aguda dessa 
droga, e a falta de estudos que abordem sistematicamente os efeitos do 
tratamento repetido com zolpidem sobre os processos mnemônicos, a presente 
Tese tem por objetivo analisar os efeitos do tratamento repetido com zolpidem 
ou de sua retirada abrupta sobre as diversas fases da formação da memória 
por meio dos paradigmas da esquiva discriminativa em labirinto em cruz 
elevado, esquiva passiva, reconhecimento de objetos e reconhecimento social. 
Ainda, visto que clinicamente o tratamento com zolpidem é iniciado após 
períodos variáveis de privação de sono, compararemos os resultados obtidos 
em camundongos mantidos em condições controle de sono ou submetidos à 
restrição de sono. 
 
2.2 Objetivos específicos 
 
Avaliar: 
1. efeitos da privação de sono total por 3 ou 6 h agudamente ou durante 
10 dias consecutivos no paradigma da esquiva discriminativa em 
labirinto em cruz elevado (Manuscrito 1); 
2. efeitos da administração repetida de zolpidem (ou de sua retirada 
abrupta) sobre o aprendizado, consolidação e evocação no paradigma 
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da esquiva discriminativa em labirinto em cruz elevado em animais 
restritos de sono 3 h por dia durante 10 dias (Manuscrito 2); 
3. efeitos da administração repetida de zolpidem (ou de sua retirada 
abrupta) sobre o aprendizado, consolidação e evocação no paradigma 
da esquiva passiva em animais restritos de sono 3 h por dia durante 
10 dias (Manuscrito 3); 
4. efeitos da administração repetida de zolpidem (ou de sua retirada 
abrupta) sobre o aprendizado/consolidação nos paradigmas de 
reconhecimento de objetos ou social em animais restritos de sono 3 h 
por dia durante 10 dias (Manuscrito 4); 
5. efeitos do tratamento repetido com zolpidem no padrão de sono de 
camundongos restritos ou não de sono 3 h por dia durante 10 dias por 
meio de registro eletroencefalográfico (Manuscrito 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manuscrito 1 
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ABSTRACT 
Purpose: It has been extensively demonstrated that paradoxical sleep 
deprivation impairs learning and memory. Although the total sleep deprivation 
(TSD) is more common in modern societies, its effects of on cognition remained 
overlooked. In agreement, we have already shown that acute TSD for 6 h 
induced memory impairments in mice subjected to the plus-maze discriminative 
avoidance task (PM-DAT). The present study was tailored to investigate 
whether 3 h or 6 h of acute or repeated TSD for 10 days could induce memory 
deficits in mice tested in the PM-DAT. Still, we examined the pattern of c-fos 
protein expression in the hippocampus and basolateral amygdala after TSD. 
Design: Male mice were kept in home cage (CTRL – control condition) or 
subjected to acute TSD by the gentle handling method for 3 h (TSD3h) or 6 h 
(TSD6h). The same condition of TSD was repeated for 10 consecutive days. At 
the ending of TSD period, animals were trained in the PM-DAT and 12 days 
after, animals were tested. Results: Acute TSD for 6h induced memory deficits, 
which were tolerated when the sleep deprivation was repeated for 10 
consecutive days. Acute TSD for 3 h did affect memory. However, when the 
duration of the SR was prolonged, it induced amnesia. There was an increase 
in c-fos expression in the dentate gyrus, which was of higher magnitude after 
acute TSD for 3 h. All of SR groups also displayed increase in c-fos expression 
in the basolateral amygdala. Conclusions: TSD-induced memory deficits are 
critically influenced by duration and frequency of the sleep deprivation. 
Collectively, these data suggest that the amount of sleep loss is an important 
factor affecting performance. 
Keywords: sleep restriction, memory, c-fos. 
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INTRODUCTION 
 
It is well-established that sleep plays a critical role in learning and 
memory formation. Indeed, a myriad of studies have demonstrated that both 
paradoxical sleep deprivation and total sleep deprivation (TSD) methods leads 
to memory deficits in several animal models such as avoidance tasks (Bueno et 
al., 1994; Harris et al., 1982; Skinner et al., 1976), the Morris water maze 
(Youngblood et al., 1997, 1999), the radial maze (Smith et al., 1998), object 
recognition (Palchykova et al., 2006) and the plus-maze discriminative 
avoidance task (PM-DAT) (Alvarenga et al., 2008; Fernandes-Santos et al., 
2012; Patti et al., 2010; Silva et al., 2004a). 
Although the consequences of paradoxical sleep deprivation have been 
studied for many years, the effects of TSD on learning/memory as well as on 
anxiety and locomotor activity in animal models remained overlooked. 
Notwithstanding, Patti and colleagues (2010) have demonstrated that acute 
TSD for 6 h in adult mice promoted memory deficits in the PM-DAT when 
applied both before training and/or test and that these memory impairments are 
not related to state-dependency. Still, Fernandes-Santos and colleagues (2012) 
demonstrated that the TSD-induced retrieval deficits depends on the task 
involved and is influenced by sex. Indeed, Guan and colleagues (2004) reported 
that 6 h of TSD impaired spatial memory, but not spatial learning, and did not 
influence non-spatial learning or memory in rats evaluated in the Morris water 
maze. On the other hand, it was shown that 6 h of TSD did not affect 
spontaneous alternation behavior in the Y maze (Ramanathan et al., 2010). 
Similarly, Pierard and colleagues (2007) reported that TSD for 3 h had no 
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effects on the same model. Conversely, when the period of TSD was prolonged 
it impaired the ability of mice to run the alternation task. Still, mice subjected to 
10 h of TSD decreased the spontaneous alternation behavior compared to non-
deprived mice. Collectively, these data suggest that the amount of sleep loss is 
an important factor affecting performance. 
It is known that neuronal stimulation activates several mechanisms to 
process information. This activation involves stimulation or inhibition of gene 
transcription (Herdegen and Leah, 1998). Among the transcriptional factors, one 
of the most studied is the c-fos, a proto-oncogene classified as an immediate 
early gene (IEGs). IEGs are responsible for initiating adaptive changes induced 
by extracellular stimuli or excitatory synapses (Davis et al., 2003). After 
activation, c-fos is rapidly induced reaching its peak after 90-120 min (Nestler et 
al., 2001). 
The aim of the present study was to investigate whether different 
regimens of TSD (3 or 6 h acute or repeated during 10 consecutive days) would 
be able to induce memory impairments or other behavioral alterations in mice in 
the PM-DAT – an animal model which concomitantly evaluates 
learning/memory, anxiety-like behavior and locomotor activity. In addition, we 
analyzed the expression of c-fos in the dentate gyrus and basolateral amygdala. 
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MATERIAL AND METHODS 
 
Subjects 
Three-month-old Swiss male mice (outbred, raised, and maintained in 
the Centre for Development of Experimental Models in Medicine and Biology of 
Universidade Federal de São Paulo) were used. Animals weighing 35-40 g 
were housed under conditions of controlled temperature (22-23°C) and lighting 
(12h light, 12h dark; lights on at 6:45 a.m.). Food and water were available ad 
libitum throughout the experiments. Animals used in this study were maintained 
in accordance with the National Institute of Health Guide for the Care and Use 
of Laboratory Animals (NIH Publications Nº 8023, revised 2011) and with the 
Brazilian Law for Procedures for Animal Scientific Use (#11794/2008). The 
experimental procedures were approved by the Institutional Animal Care and 
Use Committee under the protocol #1741/10. 
 
Total Sleep Deprivation (TSD)  
Mice were submitted to TSD through the gentle handling method, 
described elsewhere (Tobler et al., 1990). This method consists of keeping the 
animal awake by tapping on the cage and, if necessary, by gently touching 
them with a soft brush if behavioral signs of sleep are observed. The animals 
were sleep deprived for 3 (10 AM to 1 PM) or 6 h (7 AM to 1 PM) during 1 or 10 
consecutive days and immediately after the ending of sleep deprivation were 
submitted to behavioral session. 
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Plus-maze discriminative avoidance task (PM-DAT) 
The apparatus employed was a modified elevated plus-maze, made of 
wood, containing two enclosed arms with sidewalls, and no top (28.5 x 7 x 18.5 
cm), opposite to two open arms (28.5 x 7 cm). A non-illuminated, 100-W lamp 
and a hair dryer were placed over the exact center of one of the enclosed arms 
(aversive enclosed arm). In the training session, each mouse was placed at the 
center of the apparatus and, during a 10-min period, an aversive stimulus was 
administered every time the animal entered the enclosed arm containing the 
lamp and was continued until the animal left the arm. The aversive stimuli were 
the 100-watt light and an air blow produced by the hairdryer over the aversive 
enclosed arm. In the test session, mice were again placed in the center of the 
apparatus and were observed for 3 min; however, the mice did not receive an 
aversive stimulus when they entered the aversive enclosed arm (although the 
non-illuminated lamp and the hair dryer were still placed on the middle of this 
arm to help distinguish between the aversive and non-aversive arm). In all 
experiments, the animals were observed in a blind manner, and the apparatus 
was cleaned with a 5% alcohol solution after each behavioral session. Learning 
and memory were evaluated by the time spent in the aversive versus non-
aversive enclosed arms in the training and testing session, respectively. 
Anxiety-like behavior was evaluated by the percent time spent in the open arms 
of the apparatus (time spent in open arms/time spent in both open and enclosed 
arms). The total number of entries into any of the arms was used to evaluate 
locomotion. 
 
Perfusion procedure 
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The animals were deeply anesthetized with ketamine/xilazine. The chest 
cavity was opened, and the mice were perfused via the left ventricle with 100 ml 
phosphate-buffered saline (PBS, pH 7.2), followed by 100 ml of buffered 4% 
paraformaldehyde solution in PBS (pH 7.2), each one during approximately 10 
min. The skulls were maintained in 4% paraformaldehyde solution for 24 h. 
After that, the fixed brains were removed from the skulls and kept in 4% 
paraformaldehyde solution at 4ºC until use. Then, the brains were transferred to 
30% sucrose buffer solution and kept overnight at 4ºC. Brains were then frozen 
and coronal sections (50 µm thick) were cut in cryostat. 
 
Immunohistochemistry 
The tissue was rinsed in 0.1 M PBS (3 times for 5 min each) and 
incubated in 0.1 M PBS containing 5% normal goat serum and 0.2% Triton X-
100 (Sigma®) for 30 min. Sections were then incubated overnight in 0.1 M PBS 
containing anti-C-Fos rabbit polyclonal antibody (1:3000) and 0.1% Triton X-100 
at room temperature. After exposure to the primary antibody, the sections were 
then rinsed in 0.1 M PBS (5 times for 5 min each) and incubated in 0.1 M PBS 
containing biotinylated goat anti-rabbit IgG (1:200) and 0.1% Triton X-100 for 2 
h. The sections were rinsed again using 0.1 M PBS (5 times for 5 min each) and 
incubated in avidin-biotin complex (Vectastain® ABC Kit) for 1h30min. The 
reaction was terminated by rinsing the tissue in 0.1 M PBS (5 times for 5 min 
each) and then in sodium acetate solution (5 times for 5 min each). Sections 
were mounted on gelatin-coated slides, dehydrated and coverslipped prior to 
viewing with a stereological microscope. 
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Stereology analysis 
The stereological analysis was performed using the software Stereo 
Investigator (version 11.01, MicroBrightField, USA). An optical fractionator 
method was used to estimate the total number of nuclei positive c-fos of 
neurons in each region analyzed at high magnification with a 100x oil objective. 
The optical fractionator method (West et al., 1991) is a 3D probe placed through 
the reference space, which was used to estimate the number of nuclei of 
neurons in each region analyzed. After cutting the brain, the sampling of tissue 
sections followed a systematic, uniform, random sampling scheme to ensure 
that all parts of the structure had an equal probability of being sampled. Thus, 
the analysis of the sections started from a random position at the origin of the 
brain structures. Every 3 sections were included. A total of 11-14 (dentate 
gyrus) and 4-6 (basolateral amygdala) sections were obtained for stereological 
examination. The contour delineations (left and right) of the structures were 
made according to the atlas of Paxinos and Franklin (2001) and were drawn 
using a 4x objective. 
Counts for the dentate gyrus were obtained from sections corresponding 
to planes ranging from -0.94 to -3.88 mm from bregma. For the basolateral 
amygdala, counts were obtained from sections corresponding to planes ranging 
from -0.58 to -2.06 mm from bregma. After the pilot stereological test, each 
counting frame, 75 x 60 µm for the dentate gyrus and 50 x 50 µm for the 
basolateral amygdala, was placed at an intersection of the lines forming a 
virtual grid (250 x 125 µm for the dentate gyrus and 200 x 200 µm for the 
basolateral amygdala) which was randomly generated and placed by the 
software within each structure of interest. The optical dissector height 
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(thickness) was 20 µm with a 2 µm top and bottom guard zones. The mean 
section thickness measured at every other counting frame site was used for 
final calculation of nuclei of neuron number for each region analyzed. The 
precision of the individual estimations is expressed by the coefficient of error 
(CE) and was calculated as described by Gundersen and colleagues (1999) 
and should not be over 0.10. Counting was made by a person blind to the 
condition using a 100x oil immersion objective. Still, it was previously defined 
that a cell should be counted when presenting a spherical or oval shape with 
color ranging from brown to black and well-defined margins. 
 
Experimental design 
 
Experiment I: Effects of acute total sleep deprivation for 3 or 6 h 
Animals were assigned to one of the following groups: control (CTRL, 
n=12); total sleep deprived for 3 h (TSD 3 h, n=12) or total sleep deprived for 6 
h (TSD 6 h, n=12). Mice allocated in CTRL groups were kept in their home 
cages throughout the experiment. On the other hand, mice allocated in the TSD 
groups were gently handled for 3 or 6 h before the training session. Immediately 
after the end of the TSD period animals were submitted to training in the PM-
DAT. Twelve days after training, they were submitted to testing. 
 
Experiment II: Effects of repeated total sleep deprivation for 3 or 6 h during 10 
consecutive days 
The same protocol of Experiment I was employed, but the sleep 
deprivation condition was repeated for 10 consecutive days. 
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Experiment III: Effects of different regimens of total sleep deprivation on c-Fos 
protein expression 
Animals were assigned to one of the following groups: control (CTRL, 
n=5); total sleep deprived for 3 h (TSD 3 h/1 day, n=5); total sleep deprived for 
6 h (TSD 6 h/1 day, n=5); total sleep deprived for 3 h during 10 days (TSD 3 
h/10 days, n=5) or total sleep deprived for 6 h during 10 days (TSD 6 h/10 days, 
n=5). Mice allocated in CTRL groups were kept in their home cages throughout 
the experiment. On the other hand, mice allocated in the TSD groups were 
gently handled for 3 or 6 h daily for 1 or 10 days. On the 10th day, mice 
allocated in the groups acutely sleep deprived were submitted to TSD on their 
respective period. Immediately after the end of the TSD period, animals were 
anesthetized and perfused, as described before. 
 
Statistical analysis 
 
Two-way ANOVA and Duncan’s test were used to analyse time spent in 
the aversive versus non-aversive enclosed arms. Total number of entries in any 
of the arms, percent time spent in the open arms and the estimated total 
numbers of nuclei of neurons in the stereological counting method were 
compared using one-way ANOVA followed by Duncan’s test. A probability of 
p<0.05 was considered significant for all comparisons made. 
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RESULTS 
 
Experiment I: Effects of acute total sleep deprivation for 3 or 6 h 
In the training session, analyzing time spent in the enclosed arms, two-
way ANOVA showed significant effects of arm type (aversive vs. non-aversive) 
[F(1,66)=241.77; p<0.001], group (CTRL, TSD 3 h or TSD 6 h) [F(2,66)=4.75; 
p=0.01] and arm type x group interaction [F(2,66)=4.50; p=0.01]. Duncan’s post 
hoc revealed that all groups discriminated the enclosed arms, spending 
significantly less time in the aversive enclosed arm then in the non-aversive one 
(Figure 1A). Regarding anxiety, ANOVA for the percent time spent in the open 
arms showed significant effects of group [F(2,33)=9.34; p<0.001]. The post hoc 
analyses showed that the sleep deprived for 3 h group (TSD 3 h) presented a 
higher exploration of the open arms compared to the other groups (Figure 1B). 
Analyzing motor activity, ANOVA for the total number of entries showed 
significant effects of group [F(2,33)=5.82; p=0.007]. In fact, mice in the TSD 3 h 
group presented an increased motor activity compared to the other groups 
(Figure 1C). 
In the testing, two-way ANOVA for the time spent in the enclosed arms 
showed significant effects of arm type [F(1,66)=71.72; p<0.001] and arm type x 
group interaction [F(2,66)=12.94; p<0.001]. Duncan’s post hoc revealed that 
only mice under control condition or sleep deprived for 3 h (CTRL and TSD 3 h 
groups) spent significantly less time in the aversive then in the non-aversive 
enclosed arm, remembering the task (Figure 1D). Still in this session, ANOVA 
did not show significant differences concerning the percent time in the open 
arms or the total number of entries (Figures 1E and 1F, respectively). 
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Experiment II: Effects of repeated total sleep deprivation for 3 or 6 h during 10 
consecutive days 
Two-way ANOVA for the time spent in the enclosed arms during training 
revealed significant effects only for arm type [F(1,42)=316.19; p<0.001]. Indeed, 
as demonstrated by Duncan’s test, all of the groups spent less time in the 
aversive then in the non-aversive enclosed arm (Figure 2A). In relation to 
anxiety-like behavior, ANOVA for the percent time spent in the open arms did 
not show differences among groups (Figure 2B). In the same way, there were 
no differences in motor activity (Figure 2C). 
During testing, two-way ANOVA demonstrated significant effects of arm 
type [F(1,42)=14.93; p<0.001] and arm type x group interaction [F(2,42)=3.25; 
p<0.05]. The post hoc analyses showed that only the group sleep deprived 3 h 
per day (TSD 3 h) did not discriminate the enclosed arm, while the CTRL and 
TSD 6 h groups spent significantly less time in the aversive enclosed arm then 
the non-aversive one (Figure 2D). Still in this session, ANOVA did not show 
differences neither for the exploration of the open arms nor for total number of 
entries (Figures 2E and 2F, respectively). 
 
Experiment III: Effects of different regimens of total sleep deprivation on c-Fos 
protein expression 
Analyzing the estimated number of c-fos positive cell in the dentate 
gyrus, one-way ANOVA showed significant effects of group F(4,20)=9.33; 
p<0,001]. Duncan’s post hoc demonstrated that animals submitted to TSD 
presented an increase in expression of c-fos compared to CTRL group. 
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Additionally, those animals total sleep-deprived for 3 h during 1 day displayed 
an even greater expression of c-fos positive cells compared to the other groups 
(Figure 3A). 
Regarding the expression of c-fos in the basolateral amygdala, one-way 
ANOVA showed significant effects of group [F(4,20)=4.08; p<0,01]. The post 
hoc analyzes by Duncan’s test demonstrated that animals sleep-deprived 
presented an increase in the expression of c-fos compared to CTRL group 
(Figure 3B). 
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Figure 1: Effects of acute total sleep deprivation (TSD) on learning and consolidation 
of a discriminative task in mice. Animals were subjected to control condition (CTRL) or 
TSD for 3 or 6 h. After TSD period, mice were trained and 12 later tested. Results are 
presented as the mean ± S.E. of time spent in the non-aversive enclosed arm x time 
spent in the aversive enclosed arm in the training (A) and testing (D), percent time 
spent in the open arms in the training (B) and testing (E), and number of entries in the 
training (C) and testing (F). *p<0.05 compared to time spent in the non-aversive arm; 
ºp<0.05 compared to the other groups (one- or two-way ANOVA and Duncan’s test).  
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Figure 2: Effects of repeated total sleep deprivation (TSD) on learning and 
consolidation of a discriminative task in mice. Animals were subjected to control 
condition (CTRL) or TSD for 3 or 6 h during 10 consecutive days. In the 10 th day, after 
TSD period, mice were trained and 12 later tested. Results are presented as the mean 
± S.E. of time spent in the non-aversive enclosed arm x time spent in the aversive 
enclosed arm in the training (A) and testing (D), percent time spent in the open arms in 
the training (B) and testing (E), and number of entries in the training (C) and testing (F). 
*p<0.05 compared to time spent in the non-aversive arm (one- or two-way ANOVA and 
Duncan’s test). 
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Figure 3: Effects of repeated total sleep deprivation (TSD) on c-fos protein expression. 
Animals were subjected to control condition (CTRL) or TSD for 3 or 6 h during 1 or 10 
consecutive days. In the 10th day, after TSD period, mice were euthanized and the 
brains were collected. Results are presented as the mean ± S.E. of c-fos positive cells 
in the dentate gyrus (A) and basolateral amygdala (B). ªp<0.05 compared to CTRL 
group; #p<0.005 compared to the other groups (ANOVA and Duncan’s test). 
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DISCUSSION 
 
In the present study, our findings showed that the memory deficits 
induced by acute TSD for 6 h are tolerated when the sleep deprivation was 
repeated for 10 consecutive days. Conversely, while the acute TSD for only 3h 
did not affect memory, this procedure induced amnesia when an increase of 
TSD frequency occurred. Thus, TSD-induced memory deficits are critically 
influenced by duration and frequency of the sleep loss. The c-fos quantification 
suggests that the higher activation of the dentate gyrus after TSD may have 
prevented the cognitive impairment. In the basolateral amygdala, the stressing 
component of the TSD may have increased c-fos expression. 
It is well-stablished that sleep plays a critical role on learning and 
memory processes. Thus, several studies have shown that paradoxical sleep 
deprivation promotes memory impairments in a variety of animal models 
(Alvarenga et al., 2008; Bueno et al., 1994; Patti et al., 2010; Silva et al., 
2004a,b; Youngblood et al., 1999, 1997). In parallel, TSD models seem to 
mimic what occurs in humans, although its effects in animal models remains 
overlooked. In humans, sleep loss is frequently associated with TSD, chronic 
sleep restriction or sleep fragmentation. TSD involves the completely sleep loss 
over a period significantly prolonging wake time. Sleep restriction refers to a 
reduction of sleep time under the necessary to maintain optimal performance 
levels, being frequent in modern society (Banks and Dinges, 2007). On the 
other hand, sleep fragmentation is usually observed in patients with sleep 
disorders, such as sleep apnea (Reynolds and Banks, 2010). 
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In the experiment I, we evaluated the effects of acute TSD during 3 or 6 h 
prior to training. We observed that TSD for 3 h increased the exploration of the 
open arms, suggesting an anxiolytic effect. Still, this same group also presented 
an increased motor activity. On the other hand, extending the sleep deprivation 
period to 6 h, these modifications on emotionality or locomotion were no longer 
observed. In this concern, it has already been reported that acute TSD for 6 h 
did not modify anxiety-like behavior (Patti et al., 2010). This discrepancy could 
be due to the sleep deprivation period. In this vein, while 3 h of TSD led to 
alterations in the emotional levels (e.g., impulsivity and inquietude) of mice, the 
fatigue and exhaustion that could have been induced by being gentle handled 
for 6 h abolished emotional alterations. One could argue that the increased 
exploration of the open arms would be due to an artifactual effect of the 
hyperlocomotion presented by these animals. However, the percent time spent 
in the open arms of the apparatus during the training session has been 
validated as a measure of anxiety because classical anxiolytic agents 
(Calzavara et al., 2004; Gulick and Gould 2009a,b, 2011; Kameda et al., 2007) 
increase this parameter, and classical anxiogenic decrease it (Gulick and Gould 
2009a; Silva and Frussa-Filho, 2000). In fact, the PM-DAT can dissociate the 
effects of pharmacological (such as ethanol administration) or procedure (such 
as sleep deprivation) manipulations on anxiety-like behavior and motor activity 
separately (Frussa-Filho et al., 2010). 
When memory was analyzed, only acute TSD for 6 h promoted memory 
deficits in the test session. This result corroborates previous studies of our 
group showing that this sleep deprivation regimen induces amnesia when 
applied before training (Patti et al., 2010) or testing (Fernandes-Santos et al., 
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2012) both in the PM-DAT and the passive avoidance task. Of note, other 
groups have also shown memory impairments induced by TSD when it occurred 
immediately (Palchykova et al., 2006) or 1 h (Prince et al., 2014) after training of 
object recognition tasks. These results seem to be in line with a molecular 
perspective, since Guan and colleagues (2004) reported that 6 h, but not 3 h of 
TSD, was able to induce alterations on the extracellular signal-regulated kinase 
2 (ERK2) phosphorylation in the hippocampus, which is activated in response to 
many neurotransmitters and growth factors and by learning (Atkins et al., 1998; 
Cammarota et al., 2000; Swank and Sweatt, 2001) and long-term potentiation 
(LTP) (English and Sweatt, 1996; Wu et al., 1999). This protein kinase is 
involved in long-term synaptic plasticity (Angenstein et al., 1998; Impey et al., 
1999; Mazzucchelli and Brambilla, 2000) and synaptic plasticity-related gene 
expression (Adams et al., 2000; Davis et al., 2000). Thus, these results could 
explain the memory impairments observed after 6 h of TSD but not after 3 h. 
Insomnia is characterized by difficulties in falling asleep or maintaining 
sleep, low sleep quality or non-repairing sleep, leading to impairments on daily 
function and cognition (Billiard and Bentley, 2004). Thus, in the 2nd experiment 
we aimed to mimic the insomnia-induced cognitive deficits by a sleep restriction 
protocol. Thus, animals were subjected to TSD for 10 consecutive days. Our 
data showed that the repetition of TSD for 3 h abolished the observed anxiolytic 
and hiperlocomotor effects of the acute TSD for the same period, suggesting a 
tolerance development. In the same way, while the acute TSD for 6 h induced 
memory deficits, when it was repeated for 10 days, the impairment was no 
longer observed. Oppositely, the repeated TSD for 3 h promoted amnesia, 
which did not occur after the acute procedure. Our results suggest that 
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tolerance seems to occur for the behavioral modifications induced by the acute 
TSD for 3 h (anxiolytic and hiperlocomotor effects) as well as for the deleterious 
effects of acute TSD for 6 h on cognition. 
Studies have shown that TSD in humans promote cognitive deficits 
especially with regard to vigilance (Doran et al., 2001; Van Dogen et al., 2004), 
constructive thinking (Killgore et al., 2008), spatial working memory (Heuer et 
al., 2005) and verbal memory (Harrison and Horne, 1998). Additionally, 
subjective measures such as fatigue, sleepiness and humor are strongly 
affected by acute periods of TSD (Pilcher and Huffcutt, 1996). Regarding sleep 
restriction, Van Dongen and colleagues (2003) demonstrated that restricting 
sleep to 2 or 4 h per night during 14 days induced cognitive deficits in the same 
magnitude of those promoted by TSD for 1 or 2 days, suggesting that even 
shorter periods of sleep restriction when lasting for days may impair behavioral 
function. These authors have also observed that subjective sleepiness was 
diminished in subjects chronically sleep-restricted compared to those totally 
sleep-deprived, suggesting tolerance to the subjective alterations induced by 
TSD. 
As an attempt to find a possible mechanism for the behavioral findings of 
the different sleep deprivation protocol, we investigated the expression of c-fos 
protein in the dentate gyrus and in the basolateral amygdala. In the central 
nervous system, the c-fos protein expression may be induced by several stimuli, 
such as harmful, auditory, thermal, visual and somatosensory. In exception of 
GABA and glycine, the most important neurotransmitters such as dopamine are 
able to enhance c-fos expression (Cirelli and Tononi, 2000). 
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Our results demonstrated that TSD induced an increase in the number of 
c-fos positive cells in dentate gyrus. Of note, this proto-oncogene is sensitive to 
acute modifications, being rapidly induce and reaching its peak 90-120 min after 
stimulation. Corroborating our findings, several studies conducted in rats (Cirelli 
et al., 1993, 1995; Garcia-Garcia et al., 1998; Novak and Nunez, 1998; Sherin 
et al., 1996) and mice (Basheer et al., 1997) have shown that the cerebral 
expression of c-fos is usually low or even absent after normal sleep. Oppositely, 
such activity is enhanced in animals sleep-deprived for some hours. In this way, 
the pattern of c-fos expression after TSD is similar to that observed after 
spontaneous awakening (Cirelli et al., 1995), suggesting that c-fos expression is 
related to wake per se. 
Acute TSD for 3 h induced a higher increment of c-fos expression than 6 
h-TSD for 1 day or 3 h-TSD repeated for 10 days in the dentate gyrus. This 
pattern of activation seems to be in agreement with our behavioral findings. 
Specifically, animals subjected to acute 3 h-TSD retrieved the task. When the 
sleep condition was prolonged, animals displayed amnesia, which was 
accompanied by a reduction in the c-fos expression. Similarly, animals 
submitted to acute 6 h-TSD presented amnesia followed by a reduction in the c-
fos. Interestingly, animals subjected to repeatedly 6 h-TSD displayed a trend 
towards increment of c-fos expression when TSD was applied for 10 days. 
Together, these findings, suggest that the better cognitive performance may be 
associated to the increased c-fos expression in the dentate gyrus, i.e. to a 
higher activation of this region. In fact, it was shown that the dentate gyrus 
granular neurons project to CA3 pyramidal neurons via mossy fiber projections, 
which seems to be essential during learning (Kesner et al., 2004). 
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Specifically concerning the c-fos expression pattern of animals subjected 
to TSD for 6 h during 10 days –which had memory preserved  – higher levels of 
c-fos expression would be expected. This could be explained by the temporal 
pattern of c-fos expression since higher protein concentrations are found a few 
hours after the stimulus and then progressively decrease (Melia et al., 1994; 
Chauduri, 1997). Although several sleep deprivation protocols promote an 
increase of c-fos protein it does not seem to be related to the amount of time 
spent awake. In this regard, the enhancement in the number of c-fos positive 
cells is of higher magnitude after 3 h of sleep deprivation then after 24 h (Cirelli 
et al., 1995). Moreover, the c-fos expression is induced more efficiently by new 
stimuli than familiar one (Anokhin et al., 1995; Hess et al., 1995; Radulovic et 
al., 1998; Zhu et al., 1995), as well as shorter periods of sleep deprivation than 
prolonged periods (Cirelli et al., 1995, 2000). 
It is well-known that the amygdaloid complex (mainly the basolateral 
portion) play a key role in the neurobiological mechanisms involved in aversive 
memory formation. In fact, it was shown that the inactivation of the basolateral 
amygdala impairs memory formation and consolidation of the PM-DAT in rats 
(Ribeiro et al., 2011). Herein, we observed an increase in c-fos expression in 
the basolateral amygdala, regardless of the sleep deprivation regimen 
employed. This result may be due to wake per se, as pointed before. 
Additionally, this finding could reflect the stressing component of the TSD 
procedure. Indeed, the activation of the hypothalamic-pituitary-adrenocortical 
axis has been reported after both acute (Campbell et al., 2002; Sgoifo et al., 
2006) and repeated sleep restriction (Roman et al., 2006) by forced locomotion. 
Thus, once stress and glucocorticoids may influence memory formation (de 
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Kloet et al., 1999; McEwen and Sapolsky, 1995; McGaugh and Roozendaal, 
2009), one could argue that the observed memory deficits could be a 
consequence of stress and not of TSD. However, this does not seem to be the 
case because although all groups presented an increase in c-fos expression, 
only those repeatedly sleep-deprived for 3 h or acutely deprived for 6 h showed 
amnesia. Notably, it was demonstrated a differentiation between the outcomes 
of stress and sleep loss on memory since metyrapone treatment did not prevent 
paradoxical sleep deprivation-induced memory impairment (Tiba et al., 2008). 
Ideally, an insomnia animal model should exhibit decreased sleep quality 
or quantity during the period that the animal is supposed to be physiologically 
sleeping. Thus, there are potential models such as: electrical stimulation, drug-
induced methods and those related to the interruption of sleep as water platform 
techniques and forced locomotion (Revel et al., 2009). However, these sleep 
deprivation methods may cause excessive stress or result in incomplete sleep 
loss, having unfavorable effects on experimental results. Oppositely, the gentle 
handling method seems to be less stressful. Thus, considering that the applied 
protocol of TSD for 3 h during 10 days animals were sleep-restricted during the 
light phase, as well as it promoted memory deficits, it brings the perspective of 
an efficient sleep restriction protocol to mimic insomnia characteristics. 
Collectively, our results show that both the duration and frequency of 
TSD may critically influence the subsequent cognitive impairing-effect. Notably, 
not only the cognitive effects but also the behavioral alterations (anxiety and 
locomotion) may be tolerated or sensitized. These findings strengthen the 
importance of future studies evaluating the effects of short periods of sleep 
restriction.
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FIGURE LEGENDS 
 
Figure 1: Effects of acute total sleep deprivation (TSD) on learning and 
consolidation of a discriminative task in mice. Animals were subjected to control 
condition (CTRL) or TSD for 3 or 6 h. After TSD period, mice were trained and 
12 later tested. Results are presented as the mean ± S.E. of time spent in the 
non-aversive enclosed arm x time spent in the aversive enclosed arm in the 
training (A) and testing (D), percent time spent in the open arms in the training 
(B) and testing (E), and number of entries in the training (C) and testing (F). 
*p<0.05 compared to time spent in the non-aversive arm; ºp<0.05 compared to 
the other groups (two- or one-way ANOVA and Duncan’s test). 
 
Figure 2: Effects of repeated total sleep deprivation (TSD) on learning and 
consolidation of a discriminative task in mice. Animals were subjected to control 
condition (CTRL) or TSD for 3 or 6 h during 10 consecutive days. In the 10th 
day, after TSD period, mice were trained and 12 later tested. Results are 
presented as the mean ± S.E. of time spent in the non-aversive enclosed arm x 
time spent in the aversive enclosed arm in the training (A) and testing (D), 
percent time spent in the open arms in the training (B) and testing (E), and 
number of entries in the training (C) and testing (F). *p<0.05 compared to time 
spent in the non-aversive arm (two- or one-way ANOVA and Duncan’s test). 
 
Figure 3: Effects of repeated total sleep deprivation (TSD) on c-fos protein 
expression. Animals were subjected to control condition (CTRL) or TSD for 3 or 
6 h during 1 or 10 consecutive days. In the 10th day, after TSD period, mice 
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were euthanized and the brains were collected. Results are presented as the 
mean ± S.E. of c-fos positive cells in the dentate gyrus (A) and basolateral 
amygdala (B). ªp<0.05 compared to CTRL group; #p<0.005 compared to the 
other groups (ANOVA and Duncan’s test). 
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3.1.1 Conclusões parciais – manuscrito 1 
 
No presente manuscrito buscamos caracterizar um período de privação 
de sono total que pudesse mimetizar os efeitos da insônia em humanos no que 
diz respeito aos aspectos cognitivos. Em outras palavras, um período de 
restrição de sono diário que fosse capaz de prejudicar a memória, assim como 
é observado na condição clínica. Em conjunto, os resultados apresentados no 
1º manuscrito da presente Tese demonstraram que tanto a duração quanto a 
frequência da privação de sono parecem influenciar criticamente na indução de 
prejuízos cognitivos, levando à tolerância ou à sensibilização das alterações 
comportamentais e cognitivas. Especificamente, a privação de sono total aguda 
por 3 h induziu efeitos ansiolítico e hiperlocomotor sem prejudicar a memória. 
Por ouro lado, após a repetição durante 10 dias houve tolerância aos efeitos 
comportamentais e observamos um prejuízo cognitivo. A privação de sono total 
aguda por 6 h prejudicou o desempenho da tarefa. Contudo, após a sua 
repetição, tal prejuízo foi tolerado. 
Para investigarmos um possível mecanismo para os achados 
comportamentais dos diferentes períodos de privação de sono, avaliamos a 
expressão da proteína c-fos no giro denteado e na amígdala basolateral. Todos 
os protocolos de privação de sono aumentaram a expressão de c-fos em 
ambas as regiões analisadas. Contudo, no giro denteado, a privação de sono 
aguda por 3 h promoveu um aumento de maior magnitude em relação aos 
demais grupos. Esses resultados sugerem que o melhor desempenho cognitivo 
estaria relacionado à maior ativação do giro denteado. Ainda, os resultados 
sugerem que os achados comportamentais estão relacionados à perda de sono 
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per se e não ao estresse inerente ao protocolo de privação, uma vez que a 
ativação da amígdala basolateral foi de mesma magnitude em todos os grupos. 
Coletivamente, esses dados sugerem que a privação de sono total 
desencadeia fenômenos plásticos de adaptação no sistema nervoso central. 
Conforme revisado por Revel e colaboradores (2009), idealmente um 
modelo animal de insônia deve mimetizar as principais características da 
insônia em humanos, ou seja, deve exibir qualidade ou quantidade de sono 
diminuídas no período em que o animal estaria fisiologicamente dormindo. 
Nesse cenário, tendo em vista que a privação de sono total repetida por 3 h 
restringiu o sono dos animais no período diurno e, além disso, também 
promoveu déficits de memória no modelo da ED-LCE, escolhemos utilizar esse 
protocolo de insônia experimental nos experimentos subsequentes. 
Considerando a crescente utilização do Zolp no tratamento da insônia e 
que clinicamente o tratamento com esse hipnótico se inicia após períodos 
variáveis de privação de sono, no 2º manuscrito avaliamos os efeitos do 
tratamento repetido com Zolp ou de sua retirada abrupta sobre o desempenho 
em camundongos mantidos sob o regime de restrição de sono avaliados na 
ED-LCE. 
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ABSTRACT 
The cognitive effects of the repeated administration of Zolpidem (Zolp) in animal 
models of sleep restriction (SR) remain poorly understood. We evaluated the 
effects of the repeated administration of Zolp (or its withdrawal) on the memory 
phases of mice subjected to SR in the plus-maze discriminative avoidance task. 
Additionally, we investigated the possible reversion of effects by the antagonist 
β-cct. Mice were subjected to SR for 3 h per day during 10 days or left 
undisturbed and were then treated with saline (Sal) or Zolp. In the 10th day, half 
of the animals treated with Sal received Zolp and the others received Sal. The 
same occurred for mice treated daily with Zolp. No modifications were found 
during the learning phase. Both the acute and repeated pre-training 
administration of Zolp promoted amnesia. SR induced memory deficits, which 
were counteracted by the acute administration of Zolp, or its withdrawal. No 
effects were found on memory consolidation after concomitant Zolp treatment 
and SR. When the drug was post-training administered in sleep-restricted mice, 
Zolp blocked the SR-induced memory impairment. For retrieval, only the 
repeated administration prevented amnesia. β-cct counteracted only the acute 
effects of Zolp. The interaction between SR and Zolp can positively or 
negatively modulate memory, depending on the phase. The α1-subunit 
activation explains the acute effects but not the long-term administration, which 
suggests the participation of other mechanisms. These data strengthen the 
importance of conducting future studies that evaluate the interaction between 
different SR periods and Zolp administration. 
Keywords: hypnotics, zolpidem, sleep restriction, cognition, plus-maze 
discriminative avoidance task, rodents. 
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INTRODUCTION 
 
It is well established that sleep plays a critical role in learning and 
memory formation. Indeed, many studies have demonstrated that both 
paradoxical sleep deprivation and total sleep deprivation for 6 h leads to 
memory deficits in several animal models (Fernandes-Santos et al., 2012; 
Palchykova et al., 2006). It has been suggested that total sleep deprivation 
could promote cognitive impairment of a higher magnitude than the impairments 
induced by the exclusive deprivation of paradoxical sleep (Patti et al., 2010). 
Experimentally, sleep restriction (SR) models, in which animals are repeatedly 
subjected to shorter periods of sleep, has been increasingly used as a strategy 
to mimic the sleep loss found in modern society. This represents an important 
translational model because SR is most prevalent because of medical 
conditions and lifestyle (Banks and Dinges, 2007). 
In humans, studies have found that SR impairs behavioral alertness, with 
deterioration increasing in magnitude as the time allowed for sleep is reduced. 
Moreover, the neurobehavioral effects of SR appear to be similar to those of 
total sleep deprivation (Belenky et al., 2003; Van Dongen et al., 2003). In animal 
models, it has been demonstrated that SR using forced locomotion models 
impaired spatial memory (McCoy et al., 2013; Zielinski et al., 2013). Of note, 
Yang and colleagues (2012) evaluated the effects of SR on memory using the 
less stressing sleep deprivation method of gentle handling. In their study, the 
SR protocol hindered the consolidation of spatial memory in adolescent (but not 
in adult) rats. 
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Zolpidem (Zolp) is a hypnotic drug that is prescribed to treat insomnia. It 
is an imidazopyridine agent that selectively binds to the α1 subunit-containing 
GABAA receptor subtype (Sancar et al., 2007). Though Zolp appears to exhibit 
fewer deleterious psychomotor and cognitive effects, amnestic effects have 
been repeatedly reported both in humans (Fitzgerald et al., 2014) and in 
laboratory animals (Huang et al., 2010; Savić et al., 2005a,b). Specifically, we 
have recently demonstrated that the acute administration of 5 or 10 mg/kg Zolp 
(but not 2 mg/kg) induced amnesia in mice that were submitted to the plus-
maze discriminative avoidance task (PM-DAT). Such impairment occurred when 
Zolp was administered either before or 2–3 h after training and was not related 
to state dependency, sedation or anxiolysis (Zanin et al., 2013). Additionally, the 
acute administration of 10 mg/kg Zolp promoted habituation deficits in the open 
field arena (Zanin et al., 2011). 
From a clinical perspective, Zolp is typically prescribed as a repeated 
treatment for insomnia. To the best of our knowledge, no studies have 
characterized the effects of the repeated administration of Zolp on memory in 
animal models of SR. Thus, considering the increasing frequency of Zolp 
prescription, the previous evidence supporting the impairing effects induced by 
acute administration of this drug, and the absence of studies that systematically 
evaluated the effects of repeated treatment with Zolp in sleep-restricted 
animals, the aim of the present study was to evaluate the effects of repeated 
administration of Zolp (or its withdrawal) on the different memory phases 
(learning, consolidation and retrieval) of mice submitted to SR for 10 days and 
evaluated in the PM-DAT. Therefore, we performed the following order of 
experiments. First, we evaluated learning by a pre-training treatment and then 
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examined consolidation in 3 steps: 1- SR and treatment immediately after PM-
DAT training; 2- Zolp administration at different time points after PM-DAT 
training; and 3- SR before training and Zolp injection 2 h after. Subsequently, 
we evaluated retrieval by repeating the protocol of experiment 1 before testing. 
Finally, to specifically evaluate a possible reversal of the amnestic effects of 
pre-training Zolp administration, we tested the antagonistic effects of β-
carboline-3-carboxylate t-butyl-ester (β-cct). 
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MATERIAL AND METHODS 
 
Subjects 
Three-month-old Swiss male mice (outbred, raised, and maintained in 
the Centre for Development of Experimental Models in Medicine and Biology of 
Universidade Federal de São Paulo) were used. Animals weighing 35-40 g 
were housed under controlled temperature (22-23°C) and lighting (12 h light, 12 
h dark; lights on at 6:45 a.m.) conditions. Food and water were available ad 
libitum throughout the experiments. The animals used in the present study were 
maintained in accordance with the National Institute of Health Guide for the 
Care and Use of Laboratory Animals (NIH Publications Nº 8023, revised 2011) 
and with the Brazilian Law for Procedures for Animal Scientific Use 
(#11794/2008). The experimental procedures were approved by the Institutional 
Animal Care and Use Committee under the protocol #1741/10. 
 
Drugs 
Zolp (Sanofi-Aventis®) was diluted in 0.9% saline solution (Sal), which 
was also the control solution, and was administered at a dose of 5 mg/kg. The 
dose of Zolp was chosen based on previous experiments conducted by our 
group that demonstrated memory deficits and relatively weak sedative effects in 
mice (Zanin et al., 2013). 
To specifically evaluate a possible reversal of the effects, we used β-
carboline-3-carboxylate t-butyl-ester (β-cct; Sigma®) in Experiment V. Although 
several β-carbolines appear to be inverse agonists, β-cct is an antagonist that 
does not potentiate pentylenetetrazol-induced convulsions or facilitate the 
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suppression of lever-pressing behavior by shock (Shannon et al., 1988). We 
chose the dose of 30 mg/kg, which was diluted with the aid of sonication in a 
solvent containing 85% distilled water, 14% propylene glycol, and 1% Tween-
80, which was the vehicle control solution (Veh). The dose of β-cct was based 
on previous reports (Belzung et al., 2000; Savić et al., 2005a,b). All solutions 
were administered intraperitoneally in a volume of 10 ml/kg 
 
Sleep Restriction (SR)  
Mice were submitted to SR through the gentle handling method, as 
described previously (Tobler and Borbély, 1990). It consists of keeping the 
animal awake by tapping on the cage and, if necessary, gently touching them 
with a soft brush if behavioral signs of sleep are observed. The animals were 
sleep restricted for 3 h (from 10 AM to 1 PM) for 10 consecutive days. This time 
interval was chosen because this is when paradoxical sleep reaches its highest 
expression and slow wave sleep homeostatic pressure is generated (Franken et 
al., 1991). 
 
Plus-maze discriminative avoidance task (PM-DAT) 
The PM-DAT was used to concomitantly evaluate learning, memory, 
anxiety-like behavior, and motor activity, as described previously (Frussa-Filho 
et al., 2010). The aversive stimuli consisted of a 100-W light and an air blow 
produced by a 110-V hairdryer positioned over the aversive enclosed arm. The 
aversive stimuli were present during the 10-min training session. Tests sessions 
lasted 3 min, performed in the absence of the aversive stimuli. In all 
experiments, observations were recorded by an observer blinded to the 
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experimental conditions, and the apparatus was cleaned with a 5% alcohol 
solution after each behavioral session. 
Specifically, learning was evaluated as a progressive decrease in percent 
time spent in the aversive enclosed arm (time spent in aversive enclosed 
arm/time spent in both enclosed arms) throughout the training. Learning and 
memory were evaluated by the time spent in the aversive versus the non-
aversive enclosed arms in the testing. Anxiety-like behavior was evaluated by 
the percent time spent in the open arms of the apparatus (time spent in open 
arms/time spent in both open and enclosed arms). The total number of entries 
into any of the arms was used to evaluate locomotion. 
 
Experimental design 
 
Experiment I: effects of the repeated administration of Zolp or its withdrawal on 
learning and consolidation in sleep-restricted mice  
Animals were kept in their home cages (control condition – CTRL) or 
subjected to SR by gentle handling for 3 h per day during 10 days. Every day, 
after the SR period, mice were treated with Sal (CTRL-Sal and SR-Sal) or Zolp 
(CTRL-Zolp and SR-Zolp). On the 10th day, half of the animals treated with Sal 
received an acute Zolp injection, and the others received Sal. The same 
procedure was applied for mice that were treated daily with Zolp. The following 
groups were formed: CTRL-Sal/Sal (n=12), CTRL-Sal/Zolp (n=12), CTRL-
Zolp/Sal (n=12), CTRL-Zolp/Zolp (n=12), SR-Sal/Sal (n=12), SR-Sal/Zolp 
(n=12), SR-Zolp/Sal (n=12) and SR-Zolp/Zolp (n=12). Thirty min after the last 
injection, mice were subjected to training in the PM-DAT. In this experiment, to 
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specifically evaluate learning, in addition to quantifying the total amount of time 
spent in the aversive enclosed arm in the training during the 10-min session, the 
progressive decrease in the exploration of the aversive enclosed arm was 
quantified min-by-min throughout the session, and the percent of time spent in 
the aversive enclosed arm in each min was calculated. Twelve days later, the 
animals were tested. 
 
Experiment II: effects of the repeated administration of Zolp exclusively on 
memory consolidation in sleep-restricted mice 
Initially, mice were trained in the PM-DAT. Immediately after training 
animals were subjected to CTRL or SR condition. Every day, after the SR 
period, mice were treated with Sal or Zolp, with the following groups formed: 
CTRL-Sal (n=10), CTRL-Zolp (n=10), SR-Sal (n=10), and SR-Zolp (n=10). 
Forty-eight hours after the last injection (12 days after training), mice were 
tested. 
 
Experiment III: effects of the acute administration of Zolp immediately or 2 h 
after training on consolidation in sleep-restricted mice 
Animals were maintained under CTRL or SR condition. On the 10th day, 
after SR period, mice were trained. After training, mice received an acute 
injection of Sal or Zolp immediately after it or 2 h later. This time-point was 
chosen based on an additional experiment detailed in the Supplementary file. 
The Sal group received 2 Sal injections while the other groups received a single 
dose of Zolp and another Sal injection, forming the groups: CTRL-Sal (n=12); 
Karina Agustini Zanin  Manuscrito 2 
 
 
 68 
CTRL-Zolp 0h (n=12); CTRL-Zolp 2h (n=12); SR-Sal (n=12); SR-Zolp 0h 
(n=12); SR-Zolp 2h (n=12). Twelve days after training, testing was performed. 
 
Experiment IV: effects of the repeated administration of Zolp or its withdrawal 
on memory retrieval in sleep-restricted mice 
Mice were trained in the PM-DAT. Forty-eight hours later, animals 
received the same treatment as described for the experiment I, forming the 
following groups: CTRL-Sal/Sal (n=12), CTRL-Sal/Zolp (n=12), CTRL-Zolp/Sal 
(n=12), CTRL-Zolp/Zolp (n=12), SR-Sal/Sal (n=12), SR-Sal/Zolp (n=12), SR-
Zolp/Sal (n=12) and SR-Zolp/Zolp (n=12). Thirty min after the last injection, 
mice were subjected to testing. 
 
Experiment V: effects of the acute administration of β-cct on memory in sleep-
restricted mice treated with Zolp 
Animals were kept under CTRL or SR condition. Every day, after the SR 
period, CTRL mice were treated with Sal (CTRL-Sal, n=10). Sleep-restricted 
mice received a Sal injection (SR-Sal, n=20) or Zolp (SR-Zolp, n=10). On the 
10th day, after the SR period, each animal received 2 injections at a 5-min 
interval. The 1st injection was Veh or β-cct, and the 2nd injection was Sal or Zolp, 
with the following groups formed: CTRL-Sal/Veh+Sal (n=10), SR-Sal/Veh+Sal 
(n=10), SR-Sal/β-cct+Zolp (n=10), and SR-Zolp/β-cct+Zolp (n=10). Thirty min 
after the 2nd injection, mice were subjected to training and were tested 12 days 
later. 
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Statistical analysis 
The decrease in the percent time spent in the aversive enclosed arm 
throughout the training was compared using ANOVA with repeated measures. 
MANOVA and Duncan’s test were used to analyze the other parameters. A 
value of p<0.05 was considered significant for all comparisons. 
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RESULTS 
 
Experiment I: effects of the repeated administration of Zolp or its withdrawal on 
learning and consolidation in sleep-restricted mice 
During training, the percent time spent in the aversive enclosed arm min 
by min was analyzed using ANOVA with repeated measures, with time (min of 
observation) representing the within-subject variance and sleep condition 
(CTRL or SR), treatment (Sal or Zolp) and challenge injection (Sal or Zolp) all 
representing the between-subject variance. These analyses revealed significant 
effects of time [F(9,792)=3.75; p<0.001], treatment x challenge injection 
[F(1,88)=7.22; p=0.009] and sleep condition x treatment x challenge injection 
interactions [F(1,88)=6.16; p<0.05]. Thus, all animals progressively avoided the 
aversive arm (Figure S1). In accordance, MANOVA revealed significant effects 
of arm type (aversive x non-aversive) [F(1,176)=750.38; p<0.001], challenge 
injection [F(1,176)=5.66; p<0.05] and arm type x challenge injection interaction 
[F(1,176)=11.08; p=0.001]. Duncan’s test revealed that all groups spent 
significantly less time in the aversive enclosed arm than in the non-aversive arm 
(Figure 1A). 
Concerning anxiety-like behavior, MANOVA for the percent time spent in 
the open arms revealed no significant differences among groups (Figure 1B). 
Regarding locomotion, MANOVA for total number of entries revealed significant 
effects of sleep condition [F(1,88)=5.79; p<0.05] and challenge injection 
[F(1,88)=60.08; p<0.001]. Duncan’s test showed that all of the animals that 
received Zolp before training displayed decreased motor activity compared to 
their respective control. Although sleep-restricted mice that were acutely treated 
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with Zolp (SR-Sal/Zolp) presented hypolocomotion, it was of a lesser magnitude 
compared to the respective control for the sleep condition (CTRL-Sal/Zolp) 
(Figure 1C). 
In the testing, MANOVA revealed significant effects of arm type 
[F(1,176)=10.39; p=0.002], arm type x challenge injection [F(1,176)=11.43; 
p=0.001], arm type x sleep condition x challenge injection [F(1,176)=8.65; 
p=0.004] and arm type x sleep condition x treatment x challenge injection 
interactions [F(1,176)=10.88; p=0.001]. The post hoc test showed that for CTRL 
animals, only the group that was treated and challenged with Sal (CTRL-
Sal/Sal) and the group that was subjected to Zolp withdrawal (CTRL-Zolp/Sal) 
discriminated the enclosed arms and spent less time in the aversive one. 
Regarding sleep-restricted mice, only the group that was acutely treated with 
Zolp (SR-Sal/Zolp) and the group that did not undergo treatment (SR-Zolp/Sal) 
discriminated the enclosed arms (Figure 1D). No differences were found either 
in the time spent in the open arms or in locomotion (Figures 1E and 1F, 
respectively). 
 
Experiment II: effects of the repeated administration of Zolp exclusively on 
memory consolidation in sleep-restricted mice  
During training, MANOVA revealed only significant arm type effects 
[F(1,72)=387.84; p<0.001]. As expected, because there was no pre-training 
manipulation, Duncan’s post hoc test revealed that all of the groups spent 
significantly less time in the aversive enclosed arm than in the non-aversive 
arm. No differences were found concerning basal anxiety-like behavior or motor 
activity (Table S1). 
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During testing, MANOVA revealed significant effects of arm type 
[F(1,72)=136.98; p<0.001] and arm type x treatment interaction [F(1,72)=4.75; 
p<0.05]. Duncan’s test revealed that all of the groups spent significantly less 
time in the aversive enclosed arm than in the non-aversive one (Figure 2A). 
MANOVA did not show significant effects of time spent in the open arms (Figure 
2B). Regarding the total number of entries, there was a significant effect of 
sleep condition [F(1,36)=6.95; p<0.05]. The post hoc test demonstrated that 
both sleep-restricted groups presented increased motor activity compared to 
their respective controls (Figure 2C). 
 
Experiment III: effects of the acute administration of Zolp immediately or 2 h 
after training on consolidation in sleep-restricted mice 
MANOVA only revealed significant effects of arm type [F(1,132)=532.95; 
p<0.001] during the training. Duncan’s post hoc test revealed that all of the 
groups spent significantly less time in the aversive enclosed arm than in the 
non-aversive arm. No differences were found regarding anxiety-like behavior or 
motor activity (Table S3). 
In the testing, MANOVA followed by Duncan’s test revealed significant 
effects of arm type [F(1,132)=16.24; p<0.001] and arm type x treatment 
interaction [F(5,132)=4.72; p=0.001]. Thus, for those animals in the CTRL 
condition, only those treated with Sal or Zolp immediately after training (CTRL-
Sal and CTRL-Zolp 0h) retrieved the task. Those animals that were sleep-
restricted and treated with Zolp immediately after training (SR-Zolp 0h) spent 
significantly less time in the aversive arm than in the non-aversive enclosed 
arm. The other groups did not discriminate between the enclosed arms (Figure 
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3A). One-way ANOVA did not reveal significant effects for the percent time 
spent in the open arms (Figure 3B) or for the total number of entries (Figure 
3C). 
 
Experiment IV: effects of the repeated administration of Zolp or its withdrawal 
on memory retrieval in sleep-restricted mice 
During training, MANOVA revealed significant effects of arm type 
[F(1,176)=1381.26; p<0.001]. As expected, Duncan’s test revealed that all of 
the groups spent significantly less time in the aversive enclosed arm than in the 
non-aversive one. No differences were found concerning basal emotionality or 
motor activity (Table S4). 
MANOVA revealed significant effects of arm type [F(1,176)=64.06; 
p<0.001], arm type x sleep condition [F(1,176)=6.85; p<0.05], arm type x 
treatment [F(1,176)=11.33; p=0.001], arm type x challenge injection 
[F(1,176)=9.20; p=0.003] and arm type x treatment x challenge injection 
[F(1,176)=6.93; p=0.009] interactions in the testing. Duncan’s post hoc test 
revealed that among the CTRL animals, only the mice subjected to Zolp 
withdrawal (CTRL-Zolp/Sal) did not discriminate the enclosed arms. Concerning 
the sleep-restricted animals, only mice that were repeatedly treated with Zolp 
(SR-Zolp/Zolp) spent significantly less time in the aversive than in the non-
aversive enclosed arm (Figure 4A). 
Further, MANOVA did not reveal significant effects for the percent time 
spent in the open arms (Figure 4B). For the total number of entries, MANOVA 
showed significant sleep condition [F(1,88)=14.55; p<0.001] and challenge 
injection [F(1,88)=70.68; p<0.001] effects. The post hoc analyses demonstrated 
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that the mice challenged with Zolp displayed decreased motor activity 
compared to their respective control groups, which were challenged with Sal. 
For sleep-restricted mice, those treated and challenged with Sal (SR-Sal/Sal) 
presented hyperlocomotion compared to their respective CTRL mice (CTRL-
Sal/Sal). Similarly, those mice acutely treated with Zolp (SR-Sal/Zolp) also 
showed increased motor activity compared to those in the CTRL condition that 
were treated in the same manner (CTRL-Sal/Zolp) (Figure 4C). 
 
Experiment V: effects of the acute administration β-cct on memory in sleep-
restricted mice and treated with Zolp 
During training, MANOVA showed a significant effect of arm type 
[F(1,72)=261.06; p<0.001]. Duncan’s test demonstrated that all animals spent 
significantly less time in the aversive enclosed arm than in the non-aversive arm 
(Figure 5A). Regarding anxiety-like behavior, no significant effects were 
detected (Figure 5B). Similarly, no effects were found for the total number of 
entries (Figure 5C). 
In the testing, MANOVA revealed significant effects of arm type x 
treatment interaction [F(3,72)=11.54; p<0.001]. Duncan’s test showed that only 
mice in the CTRL group discriminated the enclosed arms (Figure 5D). When the 
percent time spent in the open arms was analyzed, no differences were 
observed (Figure 5E). Regarding the total number of entries, there were 
significant treatment effects [F(3,36)=3.47; p<0.05]. In fact, Duncan’s test 
revealed that mice subjected to SR and treated with Sal (SR-Sal/Veh+Sal) or 
mice treated with Zolp and challenged with β-cct and Zolp (SR-Zolp/β-cct+Zolp) 
displayed higher motor activity compared to the control group (Figure 5F). 
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Figure 1: Effects of the repeated administration of zolpidem (Zolp), or its withdrawal, 
on learning and consolidation of memory for a discriminative task in mice submitted to 
sleep restriction (SR). Animals were subjected to a control condition (CTRL) or SR for 
10 days and were treated daily with Sal or 5 mg/kg Zolp. On the 10th day, after the last 
injection, mice were trained and then tested 12 days later. The results are presented as 
the mean ± S.E. of time spent in the non-aversive enclosed arm x time spent in the 
aversive enclosed arm in the training (A) and testing (D), percent time spent in the 
open arms in the training (B) and testing (E), and number of entries in the training (C) 
and testing (F). *p<0.05 compared to the time spent in the non-aversive arm; +p<0.05 
compared to the group of same sleep condition and treatment but different challenge 
injection; p<0.05 compared to the group of same treatment and challenge injection but 
different sleep condition (MANOVA and Duncan’s test). 
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Figure 2: Effects of the repeated administration of zolpidem (Zolp) exclusively on 
memory consolidation of a discriminative task in mice submitted to sleep restriction 
(SR). First, mice were trained, followed by being subjected to control condition (CTRL) 
or SR for 10 days, and treated daily with Sal or 5 mg/kg Zolp. Forty-eight hours after 
the last injection, mice were tested. The results are presented as the mean ± S.E. of 
time spent in the non-aversive enclosed arm x time spent in the aversive enclosed arm 
(A), percent time spent in the open arms (B) and number of entries (C) during testing. 
*p<0.05 compared to the time spent in the non-aversive arm; p<0.05 compared to the 
group of same treatment and challenge injection but different sleep condition 
(MANOVA and Duncan’s test). 
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Figure 3: Effects of the acute administration of zolpidem (Zolp) immediately or 2 h after 
training on consolidation of a discriminative task in mice submitted to sleep restriction 
(SR). Animals were subjected to control condition (CTRL) or SR during 10 days. On the 
10th day, after the SR period, mice were trained in the PM-DAT and were treated with 
Sal or 5 mg/kg Zolp immediately (0 h) or 2 h (2 h) after training. Testing was performed 
12 days later. The results are presented as the mean ± S.E. of time spent in the non-
aversive enclosed arm x time spent in the aversive enclosed arm (A), percent time 
spent in the open arms (B) and number of entries (C) during testing. *p<0.05 compared 
to the time spent in the non-aversive arm (MANOVA and Duncan’s test). 
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Figure 4: Effects of the repeated administration of zolpidem (Zolp) or its withdrawal on 
retrieval of a discriminative task in mice submitted to sleep restriction (SR). First, mice 
were trained. Forty-eight hours later, animals were subjected to control conditions 
(CTRL) or to SR for 10 days and were daily treated with Sal or 5 mg/kg Zolp. After the 
last injection, mice were tested. The results are presented as the mean ± S.E. of time 
spent in the non-aversive enclosed arm x time spent in the aversive enclosed arm (A), 
percent time spent in the open arms (B) and number of entries (C) during testing. 
*p<0.05 compared to the time spent in the non-aversive arm; +p<0.05 compared to the 
group of same sleep condition and treatment but different challenge injection; p<0.05 
compared to the group of same treatment and challenge injection but different sleep 
condition (MANOVA and Duncan’s test). 
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Figure 5: Effects of the acute administration of β-cct on discriminative memory in mice 
submitted to sleep restriction (SR) and treated with zolpidem (Zolp). Animals were 
subjected to control condition (CTRL) or SR for 10 days and were daily treated with Sal 
or 5 mg/kg Zolp. On the 10th day, after the SR period, each mouse received 2 injections 
at a 5-min interval. Thus, they received vehicle (Veh) followed by Sal or β-cct followed 
by Zolp injection. After the injection, mice were trained and then tested 12 days later. 
The results are presented as the mean ± S.E. of time spent in the non-aversive 
enclosed arm x time spent in the aversive enclosed arm in the training (A) and testing 
(D), percent time spent in the open arms in the training (B) and testing (E), and number 
of entries in the training (C) and testing (F). *p<0.05 compared to the time spent in the 
non-aversive arm; ªp<0.05 compared to the CTRL-Sal/Veh+Sal group (ANOVA and 
Duncan’s test). 
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Supplementary information 
 
Supplementary material and Methods 
 
Additional experiment: effects of Zolp administered at specific intervals after 
training 
Mice were trained in the PM-DAT and were then assigned to one of the 
following groups: CTRL (n=15), Sal (n=15), Zolp 1 h (n=15), Zolp 2 h (n=15), 
Zolp 3 h (n=15) or Zolp 6 h (n=15). Thus, mice received Zolp at different time 
points (1, 2, 3, or 6 h) after training. The CTRL group was handled at each time 
point, while the Sal group received Sal injections at all following time points. The 
Zolp groups received the drug at a single time point after training and received 
Sal injections at all of the remaining time points. The test session occurred 12 
days later. 
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Supplementary results 
 
Baseline performance of mice exposed to the training session in the PM-DAT in 
experiment II 
 
Groups TNAv TAv PTO NE 
CTRL-Sal 342.80 ± 37.30 30.10 ± 6.56 * 18.49 ± 4.00 30.90 ± 2.26 
CTRL-Zolp 306.60 ± 28.15 34.00 ± 8.80 * 19.28 ± 2.90 36.90 ± 3.47 
SR-Sal 319.70 ± 19.52 33.30 ± 10.06 * 22.60 ± 4.80 37.40 ± 3.78 
SR-Zolp 324.10 ± 22.23 36.40 ± 5.27 * 20.63 ± 3.15 36.60 ± 3.44 
 
Table S1 – Effects of the repeated administration of zolpidem (Zolp) exclusively 
on memory consolidation. The results are presented as the mean ± SE of time 
spent in the non-aversive enclosed arm (TNAv), time spent in the aversive 
enclosed arm (TAv), percent time spent in the open arms (PTO) and total 
number of entries (NE) during the training session in the plus-maze 
discriminative avoidance task (PM-DAT). *p<0.05 compared to the time spent in 
the non-aversive arm (MANOVA followed by Duncan’s test). 
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Additional experiment: effects of Zolp administered at specific intervals after 
training 
In the training, MANOVA only revealed significant effects of arm type 
[F(1,168)=891.30; p<0.001]. Duncan’s test revealed that all of the groups spent 
significantly less time in the aversive enclosed arm than in the non-aversive 
one, as expected. There were no differences concerning anxiety-like behavior 
or motor activity (Table S2). 
During testing, MANOVA followed by Duncan’s test showed a significant 
effect only for arm type [F(1,168)=71.42; p<0.001]. Thus, the groups treated 
with Zolp 2 or 6 h after training did not discriminate the enclosed arms (Figure 
S2A). Concerning the exploration of open arms, there were no significant 
differences among groups (Figure S2B), and there were no effects on motor 
activity (Figure S2C). 
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Baseline performance of mice exposed to the training session in the PM-DAT in 
experiment SI 
 
Groups TNAv TAv PTO NE 
Ctrl 338.60 ± 18.80 23.67 ± 4.84 * 23.75 ± 6.13 35.80 ± 2.83 
Sal 352.40 ± 89.23 28.8 ± 5.99 * 30.17 ± 7.75 34.33 ± 2.94 
Zolp 1h 269.67 ± 23.49 27.47 ± 5.16 * 32.84 ± 5.91 43.40 ± 3.58 
Zolp 2h 332.07 ± 28.55 18.20 ± 3.97 * 31.12 ± 6.77 32.33 ± 2.88 
Zolp 3h 323.47 ± 18.18 26.20 ± 5.95 * 23.28 ± 5.75 36.73 ± 3.13 
Zolp 6h 358.00 ± 31.06 24.40 ± 4.10 * 27.56 ± 6.95 40.27 ± 2.91 
 
Table S2 – Effects of zolpidem (Zolp) administered in specific intervals after 
training in mice. The results are presented as the mean ± SE of time spent in 
the non-aversive enclosed arm (TNAv), time spent in the aversive enclosed arm 
(TAv), percent time spent in the open arms (PTO) and total number of entries 
(NE) during the training session in the plus-maze discriminative avoidance task 
(PM-DAT). *p<0.05 compared to the time spent in the non-aversive arm 
(MANOVA followed by Duncan’s test). 
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Performance of mice that were sleep restricted and exposed to the training 
session in the PM-DAT in experiment III 
 
Groups TNAv TAv PTO NE 
CTRL-Sal 277.08 ± 37.30 32.50 ± 6.56 * 30.76 ± 7.19 43.75 ± 5.39 
CTRL-Zolp 0h 287.75 ± 28.15 42.17 ± 8.80 * 21.66 ± 3.07 44.25 ± 3.84 
CTRL-Zolp 2h 309.17 ± 19.52 41.75 ± 10.06 * 23.02 ± 3.26 42.75 ± 3.49 
SR-Sal 328.50 ± 22.23 31.75 ± 5.27 * 18.95 ± 3.38 41.58 ± 3.10 
SR-Zolp 0h 303.83 ± 25.37 37.08 ± 6.49 * 21.12 ± 3.95 45.33 ± 4.23 
SR-Zolp 2h 304.00 ± 23.63 45.50 ± 11.37 * 20.52 ± 3.13 45.42 ± 3.39 
 
Table S3 – Effects of the acute administration of zolpidem (Zolp) immediately or 
2 h after training on consolidation in mice subjected to SR. The results are 
presented as the mean ± SE of time spent in the non-aversive enclosed arm 
(TNAv), time spent in the aversive enclosed arm (TAv), percent time spent in 
the open arms (PTO) and total number of entries (NE) during the training 
session in the plus-maze discriminative avoidance task (PM-DAT). *p<0.05 
compared to the time spent in the non-aversive arm (MANOVA followed by 
Duncan’s test). 
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Baseline performance of mice exposed to the training session in the PM-DAT in 
experiment IV 
 
Groups TNAv TAv PTO NE 
CTRL-Sal/Sal 317.33 ± 19.51 14.92 ± 2.87 * 25.11 ± 2.96 30.67 ± 2.44 
CTRL-Sal/Zolp 375.58 ± 23.61 12.33 ± 2.07 * 19.68 ± 3.58 28.83 ± 3.11 
CTRL-Zolp/Sal 374.42 ± 28.22 8.58 ± 1.59 * 20.59 ± 4.45 29.25 ± 4.31 
CTRL-Zolp/Zolp 329.83 ± 30.47 12.75 ± 2.39 * 26.16 ± 6.04 29.00 ± 2.27 
SR-Sal/Sal 340.00 ± 27.91 11.83 ± 2.14 * 24.05 ± 4.62 26.25 ± 2.12 
SR-Sal/Zolp 359.50 ± 29.65 13.83 ± 2.31 * 19.79 ± 4.19 27.83 ± 3.29 
SR-Zolp/Sal 324.08 ± 21.20 22.08 ± 2.78 * 21.69 ± 3.13 34.33 ± 2.39 
SR-Zolp/Zolp 370.33 ± 19.64 13.67 ± 3.09 * 17.71 ± 2.74 26.83 ± 2.81 
 
Table S4 – Effects of the repeated administration of zolpidem (Zolp), or its 
withdrawal, on retrieval in mice subjected to SR. The results are presented as 
the mean ± SE of time spent in the non-aversive enclosed arm (TNAv), time 
spent in the aversive enclosed arm (TAv), percent time spent in the open arms 
(PTO) and total number of entries (NE) during training session in the plus-maze 
discriminative avoidance task (PM-DAT). *p<0.05 compared to the time spent in 
the non-aversive arm (MANOVA followed by Duncan’s test). 
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Supplementary figures 
 
 
 
Figure S1: Effects of the repeated administration of zolpidem (Zolp), or its withdrawal, 
on learning of a discriminative task in mice subjected to SR. The results are presented 
as the mean ± SE of percent time spent in the aversive enclosed arm each min 
throughout the training in the plus-maze discriminative avoidance task (PM-DAT). 
ANOVA with repeated measures revealed significant effects of time factor and 
treatment x challenge injection and sleep condition x treatment x challenge injection 
interactions. 
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Figure S2: Effects of zolpidem (Zolp) administered in specific intervals after training in 
mice. The results are presented as the mean ± S.E. of time spent in the non-aversive 
enclosed arm x time spent in the aversive enclosed arm (A), percent time spent in the 
open arms (B) and the number of entries (C) during testing in the plus-maze 
discriminative avoidance task (PM-DAT). *p<0.05 compared to the time spent in the 
non-aversive arm (MANOVA and Duncan’s test). 
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DISCUSSION 
 
In the current study, we found that acute pre-training treatment with Zolp 
or its withdrawal were able to abolish the adverse cognitive effects induced by 
SR, despite the previously reported amnestic effects induced by the acute 
administration of this hypnotic (Zanin et al., 2013). Regarding consolidation, 
when Zolp was administered immediately after training (but not 2 h after it) in 
sleep-restricted mice, it counteracted the deleterious effects of SR. Interestingly, 
only the repeated treatment with Zolp was able to reverse the amnestic effects 
of SR on retrieval. In addition, the administration of the selective antagonist β-
cct hindered the promnestic effects of the acute administration of Zolp in sleep-
restricted mice, without mimicking the effects of the Zolp treatment withdrawal. 
These results suggest that the acute effects of Zolp are mediated, at least in 
part, by GABAergic receptors but that the effects of the repeated treatment are 
not exclusively related to this system. 
To the best of our knowledge, this is the first study to systematically 
evaluate the effects of repeated treatment with Zolp, or its withdrawal, on 
memory phases in mice subjected to a repeated SR protocol. Thus, in 
experiment I, we assessed the effects of this treatment on learning of a 
discriminative task. Importantly, neither the repeated treatment with Zolp nor the 
SR protocol altered learning levels. These results corroborate our previous 
findings (Zanin et al., 2013) that the acute administration of Zolp in CTRL 
animals did not hamper learning in the same paradigm. Additionally, no effects 
on learning were detected after SR was combined or not with Zolp. 
Karina Agustini Zanin  Manuscrito 2 
 
 
 89 
In the PM-DAT model, the percent time spent in the open arms of the 
apparatus during the training session has been validated as a measure of 
anxiety because classical anxiolytic agents increase this parameter (Gulick and 
Gould, 2011; Kameda et al., 2007), and classical anxiogenic drugs decrease it 
(Gulick and Gould 2009; Silva and Frussa-Filho 2000). We observed no effects 
of SR, Zolp treatment or its interactions on anxiety-like behavior. It has already 
been reported that acute total sleep deprivation does not modify anxiety-like 
behavior (Patti et al., 2010). Herein, we showed that a SR protocol is also not 
able to modify this behavior. Concerning Zolp treatment, we did not find any 
effects on anxiety-like behavior after the repeated administration of Zolp, as 
previously observed for acute administration (Zanin et al., 2013). Notably, the 
majority of studies reported a lack of effects of this drug on anxiety (Huang et 
al., 2010; Savić et al., 2004, 2005a,b). 
Regarding motor activity, mice that were challenged with Zolp before 
training presented decreased locomotion compared to their respective controls, 
thereby corroborating the expected sedative effect of this drug (Zanin et al., 
2011, 2013). In contrast, Zolp-induced hypolocomotion was of a lesser 
magnitude in sleep-restricted mice. Although it was not statistically significant, 
there was a trend towards tolerance to the Zolp-induced hypolocomotor effects 
in CTRL mice. Studies have reported the development of tolerance to the ataxic 
and sleep-inducing effects of Zolp in humans who were repeatedly treated with 
this drug (Stoops and Rush, 2003). 
When memory was assessed, both the acute and repeated pre-training 
administration of Zolp induced memory impairment in CTRL mice. Regarding 
the acute amnestic effects of Zolp, this result is in line with our previous data 
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that showed that this hypnotic drug hindered memory in the discriminative 
avoidance task after acute administration (Zanin et al., 2013). Few studies have 
evaluated the effects of the repeated treatment with Zolp on cognition. Stoops 
and Rush (2003) demonstrated that the acute administration of Zolp promoted 
memory deficits in humans without the development of tolerance after repeated 
treatment. Similarly, Kleykamp and colleagues (2012) did not observe tolerance 
to the amnestic effect of Zolp. However, it could be suggested that the 
magnitude of these effects would increase if higher doses were administered or 
if treatment was prolonged. Indeed, the amnestic effects of Zolp occur after 
higher receptor occupation relative to its sedative effect (Savić et al., 2010). 
Concerning the effects of withdrawal, we did not find any effects on memory in 
mice kept under the CTRL condition. This finding is in agreement with a 
previous report that indicated no significant effects on cognitive performance of 
individuals after discontinuation of treatment (Kleykamp et al., 2012). 
Repeated pre-training SR alone induced memory impairment. Similarly, 
sleep-restricted mice that were concomitantly treated with Zolp also displayed 
memory deficits. Although there are no reports evaluating the effects of Zolp in 
an animal model of SR, previous studies have reported that this drug may 
promote anterograde amnesia, i.e., forgetfulness of events that occurred shortly 
after drug intake (Tsai et al., 2007), thus corroborating the observed deficits in 
the present study. In contrast, the acute pre-training administration of Zolp, or 
treatment withdrawal, counteracted the SR-induced amnestic effects.  
The interaction between Zolp and SR effects is intriguing. We speculate 
that a complex interaction among neurotransmission systems such as GABA 
and dopamine may play a role in the Zolp-induced reversal of the amnesia 
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promoted by SR. For example, it is well-known that paradoxical sleep 
deprivation increases several behaviors related to the dopaminergic system 
(Frussa-Filho et al., 2004; Troncone et al., 1988; Tufik, 1981), which is also 
important for memory persistence (Rossato et al., 2009). The occurrence of 
dopaminergic supersensitivity after paradoxical sleep deprivation is well 
documented. However, the employment of the multiple platform method for the 
deprivation of the paradoxical phase of sleep also markedly decreases the time 
spent in slow wave sleep (Silva et al., 2004). Thus, it could be hypothesized that 
total sleep deprivation could also induce dopaminergic supersensitivity, which 
could, in turn, lead to memory impairment (Xu et al., 2012). In parallel, it has 
already been demonstrated that GABA-modulating drugs such as 
benzodiazepines inhibits the GABAergic interneurons in relevant areas for 
dopaminergic transmission, such as the ventral tegmental area and substantia 
nigra (Tan et al., 2010; Grace et al., 1980). As a result, GABA neurons would no 
longer inhibit dopaminergic cells, thereby increasing dopamine release. Notably, 
it has been shown that these inhibitory interneurons primarily express the α1 
subunit of the GABAergic receptor (Gao and Fritschy, 1994). In agreement with 
this assumption, the SR protocol employed herein may have induced 
dopaminergic supersensitivity, which is associated with the indirect Zolp-
induced increase in dopaminergic activity leading to a lower hypolocomotor 
effect, as observed. Hence, it is tempting to speculate that Zolp administration 
increased dopamine release, which counteracted the SR-induced dopaminergic 
supersensitivity, thus blocking its deleterious effects on memory as occurred for 
motor behavior. This is an initial hypothesis that invites further investigations. 
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In experiment II, we evaluated the interactions between SR and Zolp 
exclusively on memory consolidation. Thus, neither the repeated post-training 
treatment with Zolp nor post-training SR hindered the consolidation of the task. 
Similarly, it has been reported that a similar protocol of post-training SR did not 
promote deficits in a spatial task in adult rats (Yang et al., 2012). Post-training 
SR increased motor activity, which could be due to the dopaminergic 
supersensitivity phenomenon. This hyperlocomotion effect strengthens the 
possible involvement of the dopaminergic system in the cognitive effects found 
in Experiment I. Notably, motor activity is closely related to dopamine 
neurotransmission (Kelly and Iversen, 1976), and sleep deprivation can 
potentiate spontaneous motor activity or amphetamine-induced 
hyperlocomotion in the open-field (Frussa-Filho et al., 2004). Notably, there was 
a trend towards SR-induced hyperlocomotion in the previous experiment. We 
acknowledge that the training environment may have impaired this effect 
because the behavioral sessions of the PM-DAT are qualitatively different: 
whereas the animal is exposed to a new and aversive environment during 
training, in the test session, the apparatus is no longer unknown and the 
aversive stimuli are absent, which makes the environment less anxiogenic. This 
difference between the sessions could have facilitated the expression of 
hyperlocomotion during testing in experiment II. 
Previous studies have shown that consolidation processes have critical 
time points after training in which the memory trace can again become labile 
(Bekinschtein et al., 2010). We have demonstrated that memory persistence is 
impaired when acute 10 mg/kg Zolp is administered 2 or 3 h after (but not 
immediately, 1, or 6 h) the training (Zanin et al., 2013). Thus, to further 
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investigate the interactions between the post-training administration of Zolp and 
SR, we first determined an interval that was capable of promoting consolidation 
deficits after the administration of 5 mg/kg Zolp. Accordingly, mice treated with 
Zolp 2 or 6 h after training presented amnesia during testing, which suggests 
that the effects of this drug on memory consolidation are dose-dependent. 
Considering the interactions between the time of drug administration and 
memory consolidation, in the experiment III, we investigated the effects of post-
training administration of Zolp in mice submitted to SR for 10 days prior to 
training. In the present experiment, the drug administration occurred in distinct 
time points: immediately after training (ineffective in altering memory 
consolidation) or 2 h after it (an interval that is able to induce consolidation 
deficits). Importantly, SR-induced memory deficits were only abolished by Zolp 
when administered immediately after training. Specifically, this finding 
constitutes a retrograde facilitatory effect, i.e., an increased recall of information 
acquired before the drug administration, which has been previously 
demonstrated for Zolp (Fillmore et al., 2001; Kleykamp et al., 2012). 
Comparing these findings with those obtained in experiment I, in which 
the acute pre-training administration of Zolp reversed SR-induced impairments, 
it could be suggested that such promnestic effects could be specifically related 
to consolidation processes. Importantly, even when it is administered before 
training, this hypnotic would still be available during the initial steps of 
consolidation because its half-life is approximately 0.3–1.5 h in rats (Garrigou-
Gadenne et al., 1989). Conversely, when the administration occurred 2 h after 
training, the reversal effect was no longer observed, which suggests that the 
SR-induced cognitive impairments were established after this period. However, 
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the consolidation deficits promoted by the 2 h time point administration could 
have contributed to the deleterious effects of SR. 
Though numerous studies have demonstrated that sleep loss impairs the 
acquisition and consolidation phases of memory (Stickgold et al., 2001), its 
effect on memory retrieval has been overlooked. Notably, some recent studies 
have reported an inhibitory effect of sleep deprivation on this stage of memory 
formation (Alvarenga et al., 2008; Fernandes-Santos et al., 2012; Patti et al., 
2010; Takatsu-Coleman et al., 2013; Talhati et al., 2014). Thus, the SR protocol 
was applied immediately before testing in experiment IV. Neither Zolp treatment 
nor its withdrawal impaired memory retrieval. Again, these findings are in line 
with our previous results from the acute administration of the drug (Zanin et al., 
2013). Regarding SR, it induced amnesia when applied immediately before 
testing. Indeed, previous studies from our group have shown that acute total 
sleep deprivation for 6 h promoted retrieval impairments in the PM-DAT both in 
male (Patti et al., 2010) and female (Fernandes-Santos et al., 2012) mice. Of 
note, the repeated pre-test Zolp treatment (but not its acute administration) 
abolished the retrieval deficits. These results suggest that this recovery phase 
of memory could be more sensitive to the deleterious effects of SR. In line with 
this assumption, the withdrawal of treatment specifically hindered memory 
retrieval. 
To further investigate the involvement of the GABAergic receptors in the 
interaction between SR and Zolp, we designed experiment V using the α1-
selective antagonist β-cct. This antagonist was able to reverse the Zolp-induced 
hypolocomotor effect. Previous studies have reported that β-cct counteracted 
the sedative effects of Zolp (Milić et al., 2012; Savić et al., 2005a). When 
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memory was evaluated, the administration of β-cct in mice that were subjected 
to SR and treated with Zolp promoted memory deficits. In this regard, we 
demonstrated that β-cct administration abolished the promnestic effect of the 
acute Zolp injection. Thus, mice challenged with β-cct and Zolp showed the 
same behavior as did those only subjected to SR: forgetting the task. 
Furthermore, the animals that were repeatedly treated with Zolp also displayed 
amnesia. However, in this case, the administration of β-cct did not counteract 
the cognitive effects of repeated Zolp treatment. A possible explanation that 
could be raised for the lack of effects of β-cct in mice repeatedly treated with 
Zolp is that the use of an antagonist (or the dose employed) was not sufficient 
to mimic the effects of a complete substance withdrawal. Thus, the deleterious 
effects of Zolp would remain. Finally, we observed increased locomotion in the 
group that was only sleep-restricted or subjected to SR and repeatedly treated 
with Zolp, which could reflect a habituation deficit. 
These results suggest that the cognitive effects of the acute administration 
of Zolp are, at least in part, mediated by GABAergic receptors, whereas the 
effects promoted by the repeated treatment with this drug cannot be exclusively 
related to this mechanism. Studies have suggested that β-cct can reverse the 
sedative, anxiolytic and myorelaxant effects of classical benzodiazepines but 
that it is not able to abolish the amnestic effects of these drugs (Belzung et al., 
2000; Milić et al., 2012; Savić et al., 2005a,b). Conversely, Makaron and 
colleagues (2013) reported that the cognitive impairments induced by both 
triazolam and Zolp were blocked by the administration of β-cct. These 
discrepant findings could be explained by the differences in the animal species 
(monkeys vs. mice) and the memory task employed. In that study, the memory 
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task used was associated with executive functions, which appears to be 
strongly influenced by α1 subunit-containing GABAA receptor subtypes (Jentsch 
et al., 1999). 
Taken together, our results suggest that the interaction between SR and 
Zolp can positively or negatively modulate memory formation, depending on the 
phase analyzed. Specifically, the acute administration of Zolp prior to training or 
immediately after it (but not before testing) abolished the cognitive impairments 
induced by SR. Moreover, SR and the concomitant treatment with Zolp did not 
modify the consolidation of associative memory. Notably, the acute effects of 
Zolp administration (but not its withdrawal) can be explained by the GABAergic 
activation because β-cct counteracted the promnestic effect of acute Zolp 
administration. Therefore, the present findings strengthen the importance of 
conducting future studies to evaluate the interaction between sleep restriction 
periods and Zolp on memory, specifically addressing the consolidation phase. 
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3.2.1 Conclusões parciais – manuscrito 2 
 
Os resultados do presente manuscrito sugerem que a interação entre a 
restrição de sono e o tratamento com zolpidem afetam os processos de 
formação da memória de forma dependente da fase desse processo 
(aprendizado consolidação e evocação). Especificamente, há uma interação 
modulatória positiva entre a restrição de sono e o tratamento agudo com Zolp, 
uma vez que quando administrado prévia ou imediatamente após o treino, esse 
hipnótico foi capaz de reverter os déficits de memória induzidos pela RS. Por 
outro lado, quando esse hipnótico foi administrado imediatamente antes do 
teste, esse efeito não foi observado. No houve efeitos significativos sobre a 
fase de consolidação da memória associativa. De importância, não observamos 
tolerância após o tratamento repetido com a droga. 
Para investigar a participação dos receptores GABAérgicos na interação 
entre a RS e o tratamento com Zolp, avaliamos os efeitos da administração 
prévia de β-cct, um antagonista GABAérgico seletivo para o sítio BZ1 dos 
receptores GABAA. Os resultados sugerem que o efeito agudo do Zolp é 
mediado, ao menos em parte, por receptores GABAérgicos, uma vez que a 
administração de β-cct reverteu o efeito promnéstico da administração aguda 
de Zolp. Por outro lado, após o tratamento repetido, o efeito cognitivo não pode 
ser explicado exclusivamente por meio do sistema GABAérgico, sugerindo a 
interação com outros sistemas de neurotransmissão. 
Nossos achados reforçam a importância de mais estudos que avaliem as 
interações entre períodos de RS e os efeitos do Zolp sobre a memória. Nesse 
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sentido, no 3º manuscrito investigamos os efeitos da interação entre a RS e o 
tratamento com Zolp em um modelo clássico de memória, a esquiva passiva. 
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ABSTRACT 
 
Purpose: Zolpidem (Zolp), a hypnotic drug prescribed to treat insomnia, may 
have negative effects on memory. As far as we know, no studies have 
characterized the cognitive effects of Zolp in animal models of sleep restriction 
(SR). Unpublished data of our group found that the interaction between SR and 
Zolp can positively or negatively modulate memory of a discriminative 
avoidance task. Thus, the aim of this study was to evaluate the effects of the 
repeated administration of Zolp (or its withdrawal) on the memory phases of 
mice submitted to SR and tested in a classic memory task (passive avoidance 
task – PAT). Design: Mice were subjected to SR for 3 h per day during 10 days 
or left undisturbed (CTRL) and then were treated with saline (Sal) or Zolp. On 
the 10th day, half of the animals treated with Sal received Zolp while the others 
received Sal. The same occurred for mice daily treated with Zolp. This protocol 
was applied before training, immediately after it or before testing. Results: In 
the PAT, the SR protocol did not induce memory deficits irrespective of the 
phase analyzed. The acute administration of Zolp induced amnesia both in 
CTRL and sleep-restricted mice while the repeated administration promoted 
deficits only in CTRL groups when administered before training. No effects were 
found on consolidation or retrieval. Conclusions: We demonstrated that only 
the acute (but not the repeated or drug withdrawal) Zolp-treatment modify 
memory retention irrespective of sleep condition. 
 
Keywords: zolpidem, sleep restriction, memory, passive avoidance task.
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INTRODUCTION 
 
It is well established that sleep deprivation impairs cognitive function. 
Nonetheless, most studies have involved paradoxical or total sleep deprivation 
procedures. Indeed, it has been demonstrated that both paradoxical and total 
sleep deprivation methods leads to memory deficits in several animal models 
such as avoidance tasks (Bueno et al., 1994), the Morris water maze 
(Youngblood et al., 1997, 1999), the radial maze (Smith et al., 1998), object 
recognition (Palchykova et al., 2006) and in the plus-maze discriminative 
avoidance task (Alvarenga et al., 2008; Fernandes-Santos et al., 2012; Patti et 
al., 2010; Silva et al., 2004a). It remains unclear whether such effects would be 
observed after repeated sleep restriction (SR), which is more common in 
humans, thus representing a better translational model. 
In SR models, the subjects are repeatedly submitted to shorter periods of 
sleep loss (Banks and Dinges, 2007). In humans, studies have found that SR 
impairs behavioral alertness, measured by psychomotor vigilance testing, with 
deterioration being of higher magnitude as time allowed for sleep was reduced. 
Moreover, the neurobehavioral effects of SR appear similar to those of total 
sleep deprivation (Belenky et al., 2003; Van Dongen et al., 2003). Regarding 
animal models, it was demonstrated that SR using forced locomotion models 
impaired spatial memory (McCoy et al., 2013; Zielinski et al., 2013). However, 
the forced locomotion models cause excessive stress in animals, which, in turn, 
can influence the behavioral results. From our knowledge, only Yang and 
colleagues (2012) evaluated the effects of SR on memory using a less stressing 
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sleep deprivation method, the gentle handling. In this study, the SR protocol 
hindered spatial memory in adolescent (but not in adult) rats. 
In parallel, zolpidem (Zolp) is a sleep-enhancing drug prescribed to treat 
insomnia. This drug selectively binds to the α1 subunit-containing GABAA 
receptor subtype (Sancar et al., 2007). While Zolp seems to exhibit fewer 
deleterious psychomotor and cognitive effects, amnestic effects are still 
reported both in humans (Fitzgerald et al., 2014) and laboratory animals (Huang 
et al., 2010; Savić et al., 2005a,b; Zanin et al., 2011, 2013). Specifically, we 
have recently demonstrated that the Zolp-induced memory deficits are dose- 
and time-dependent in mice submitted to the plus-maze discriminative 
avoidance task. Notably, such impairments were not related to state 
dependency, sedation or anxiolysis (Zanin et al., 2013). Still, we have also 
demonstrated that the acute administration of 10 mg/kg Zolp promoted 
habituation deficits in the open filed arena (Zanin et al., 2011). 
The one-trial step-through passive avoidance test is one of the most 
widely used memory tasks in rodents (Myhrer, 2003), and might be considered 
a measurement of explicit memory. In this paradigm, animals with cognitive 
deficits present decreased latency to step through in the test session. Such 
deficits could be induced by pharmacological manipulations (Isomae et al., 
2003; Santucci and Shaw, 2003; Silva et al., 1999), consequent to neural 
lesions (Isomae et al., 2003), related to aging (Silva et al., 1996; Yasui et al., 
2002) or due to sleep deprivation (Fernandes-Santos et al., 2012; Moreira et al., 
2003, Patti et al., 2010; Silva et al., 2004a,b). However, as far as we know, 
there are no studies evaluating the effects of SR protocols in this memory task. 
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From a clinical perspective, Zolp is usually prescribed as a repeated 
treatment for insomnia. To date no studies have characterized the effects of 
Zolp on emotional memory as repeated administration in animal models of SR. 
Thus, considering the previous evidences supporting the impairing effects 
induced by the acute administration of this drug, as well as the absence of 
studies systematically evaluating the effects of Zolp in sleep restricted animals, 
the aim of the present study was to evaluate the effects of the repeated 
administration of Zolp (or its withdrawal) on the different memory phases 
(learning, consolidation and retrieval) of mice submitted to SR for 10 days and 
evaluated in the passive avoidance task (PAT). 
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MATERIAL AND METHODS 
 
Subjects 
Three-month-old Swiss male mice (outbred, raised, and maintained in 
the Centre for Development of Experimental Models in Medicine and Biology of 
Universidade Federal de São Paulo) were used. Animals weighing 35-40 g 
were housed under conditions of controlled temperature (22-23°C) and lighting 
(12h light, 12h dark; lights on at 6:45 a.m.). Food and water were available ad 
libitum throughout the experiments. Animals used in this study were maintained 
in accordance with the National Institute of Health Guide for the Care and Use 
of Laboratory Animals (NIH Publications Nº 8023, revised 2011) and with the 
Brazilian Law for Procedures for Animal Scientific Use (#11794/2008). The 
experimental procedures were approved by the Institutional Animal Care and 
Use Committee under the protocol #1741/10. 
 
Drugs 
Zolp (Sanofi-Aventis®), at the dose of 5 mg/kg, was diluted in saline 0.9% 
solution (Sal), which was also the control solution. The dose of Zolp was chosen 
based on previous experiments of our group, demonstrating both memory 
deficits and weaker sedative effects in mice (Zanin et al., 2013). All the 
solutions were administered intraperitoneally in a volume of 10 ml/kg 
 
Sleep Restriction (SR)  
Mice were submitted to SR through the gentle handling method as 
previously described (Tobler et al., 1990). This method consists of keeping the 
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animal awake by tapping on the cage and, if necessary, by gently touching 
them with a soft brush if behavioral signs of sleep are observed. The animals 
were sleep restricted for 3 h (from 10 AM to 1 PM) during 10 consecutive days. 
This time interval was chosen because this is when paradoxical sleep reaches 
its highest expression and slow wave sleep homeostatic pressure is generated 
(Franken et al., 1991). 
 
Passive avoidance task (PAT) 
PAT was conducted using methods described by Denti and Epstein 
(1972). The apparatus employed was a 2-way shuttle box with a guillotine door 
placed between the 2 modular testing chambers. One chamber was illuminated 
by a 40-W light, while the other remained dark. During the conditioning session, 
the animals were individually placed in the illuminated chamber facing away 
from the guillotine door. When the mouse entered the dark chamber, the door 
was quietly closed and a 0.4 mA foot shock was applied for 1 s through the grid 
floor. A test session was performed 12 days after conditioning using the same 
procedures, except for the foot shock. In both sessions (training and testing), 
the latency to enter the dark chamber was recorded, with a cut-off duration of 
300 s. 
 
Open field evaluation (OF) 
The open-field apparatus used in the present study was a circular 
wooden arena (40 cm in diameter and 50 cm high) with an open top and floor 
divided into 19 squares. Hand-operated counters were used to score total 
locomotion (number of any floor unit entered) and stopwatches were used to 
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quantify duration of immobility (total of seconds of lack of movement). The 
observer was always unaware of the experimental design. 
 
Experimental design 
 
Experiment I: effects of the repeated administration of Zolp or its withdrawal on 
learning and consolidation in mice sleep-restricted 
Animals were kept in their home cages (control condition – CTRL) or 
subjected to SR by gentle handling for 3 h per day during 10 days. Every day, 
after the SR period, mice were treated with Sal (CTRL-Sal and SR-Sal) or Zolp 
(CTRL-Zolp and SR-Zolp). On the 10th day, half of animals treated with Sal 
received an acute Zolp injection while the others received Sal. The same 
procedure was applied for mice daily treated with Zolp. The following groups 
were formed: CTRL-Sal/Sal (n=12), CTRL-Sal/Zolp (n=12), CTRL-Zolp/Sal 
(n=12), CTRL-Zolp/Zolp (n=12), SR-Sal/Sal (n=12), SR-Sal/Zolp (n=12), SR-
Zolp/Sal (n=12) and SR-Zolp/Zolp (n=12). Thirty min after the last injection, 
mice were subjected to training in the PAT. Considering that the PAT can be 
influenced by motor activity, mice were exposed to OF for 5 min immediately 
after training. Twelve days later animals were tested. 
 
Experiment II: effects of the repeated administration of Zolp exclusively on 
memory consolidation in mice sleep-restricted 
Initially, mice were trained in the PAT. Immediately after training, animals 
were kept in their home cages (CTRL) or were subjected to SR. Every day, after 
the SR period, mice were treated with Sal or Zolp and the following groups were 
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formed: CTRL-Sal (n=10), CTRL-Zolp (n=10), SR-Sal (n=10), and SR-Zolp 
(n=10). Forty-eight hours after the last injection (12 days after training) mice 
were tested. 
 
Experiment III: effects of the repeated administration of Zolp or its withdrawal on 
memory retrieval in mice sleep-restricted 
Mice were trained in the PAT. Forty-eight hours after it, animals received 
the same treatment as described for the experiment I, forming the following 
groups: CTRL-Sal/Sal (n=12), CTRL-Sal/Zolp (n=12), CTRL-Zolp/Sal (n=12), 
CTRL-Zolp/Zolp (n=12), SR-Sal/Sal (n=12), SR-Sal/Zolp (n=12), SR-Zolp/Sal 
(n=12) and SR-Zolp/Zolp (n=12). Thirty min after the last injection, mice were 
subjected to testing. Immediately after testing mice were exposed to OF for 5 
min. 
 
Statistical analysis 
MANOVA and Duncan’s test were used to analyze latency to enter the 
dark chamber in the PAT and the parameters in the OF. A probability of p<0.05 
was considered significant for all comparisons made. 
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RESULTS 
 
Experiment I: effects of the repeated administration of Zolp or its withdrawal on 
learning and consolidation in mice sleep-restricted 
In the training session, analyzing the latency to enter the dark chamber, 
MANOVA showed significant effects of treatment (Sal or Zolp) [F(1,88)=6.29; 
p<0.05] and challenge injection (Sal or Zolp) [F(1,88)=6.24; p<0.05]. Duncan’s 
post hoc revealed that in exception of mice sleep-restricted and daily treated 
with Zolp (SR-Zolp/Zolp), all the other groups challenged with Zolp showed an 
increased latency. Still, the animals under CTRL condition and abstinent from 
Zolp-treatment (CTRL-Zolp/Sal) as well as those sleep-restricted treated with 
Zolp (SR-Zolp/Sal and SR-Zolp/Zolp) showed a decreased latency compared to 
their respective control groups (Figure 1A). 
Regarding exploration of the OF, MANOVA revealed significant effects of 
sleep condition (CTRL or SR) [F(1,88)=4.73; p<0.05] and challenge injection 
[F(1,88)=38.01; p<0.001]. Duncan’s test demonstrated that only the group 
sleep-restricted acutely treated with Zolp (SR-Sal/Zolp) did not present a 
decreased motor activity. All the other groups challenged with Zolp (CTRL-
Sal/Zolp, CTRL-Zolp/Zolp and SR-Zolp/Zolp) presented hypolocomotion 
compared to their respective control group challenged with Sal. However, in 
mice sleep-restricted the hypolocomotor effect was of less magnitude because 
there was an increase on motor activity when compared to CTRL groups 
(CTRL-Sal/Zolp x SR-Sal/Zolp and CTRL-Zolp/Zolp x SR-Zolp/Zolp). (Figure 
2A). Analyzing immobility time, MANOVA showed significant effects only for 
challenge injection [F(1,88)=57.50; p<0.001]. The post hoc analysis revealed 
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that all animals challenged with Zolp displayed an increased immobility time, 
irrespective of sleep condition or treatment, when compared to their respective 
control groups (Figure 2B). 
In the test session, MANOVA showed significant effects only for 
challenge injection [F(1,88)=10.92; p=0.001] in the latency to enter the dark 
chamber. Duncan’s test demonstrated that all groups challenged with Zolp, 
except those under SR condition repeatedly treated with Zolp (SR-Zolp/Zolp), 
displayed a decrease in latency compared to their respective control groups 
(Figure 1B). 
 
Experiment II: effects of the repeated administration of Zolp exclusively on 
memory consolidation in mice sleep-restricted 
During training, analyzing the latency to enter the dark chamber, 
MANOVA did not show significant differences (Figure 3A). In the same way, no 
modifications were found in the test session (Figure 3B). 
 
Experiment III: effects of the repeated administration of Zolp or its withdrawal on 
memory retrieval in mice sleep-restricted 
In the training session, as expected, MANOVA did not show significant 
differences in the basal latency to enter the dark chamber (Figure 4A). In the 
test session, MANOVA showed significant effects only of challenge injection 
[F(1,88)=8.21; p=0.005]. Duncan’s post hoc revealed that only mice under 
CTRL condition and acutely treated with Zolp (CTRL-Sal/Zolp) presented an 
increased latency compared to its respective control (Figure 4B). 
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Analyzing the OF parameters, MANOVA showed significant effects of 
challenge injection [F(1,88)=23.41; p<0.001] in total locomotion. Duncan’s test 
revealed that mice challenge with Zolp (CTRL-Sal/Zolp, CTRL-Zolp/Zolp and 
SR-Zolp/Zolp), in exception of those sleep-restricted and acutely treated with 
Zolp (SR-Sal/Zolp), displayed a decreased locomotion compared to the 
respective control group challenged with Sal (Figure 5A). Regarding the 
immobility time, MANOVA demonstrated significant effects of challenge 
injection [F(1,88)=24,41; p<0,001]. The post hoc analysis showed that all 
animals challenged with Zolp, irrespective of sleep condition or treatment, 
presented an increased immobility time compared to their respective controls 
(Figure 5B). 
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Figure 1: Effects of the repeated administration of Zolp or its withdrawal on learning 
and consolidation of a passive avoidance task in mice submitted to sleep restriction 
(SR). Animals were subjected to control condition (CTRL) or SR for 10 days and were 
daily treated with Sal or 5 mg/kg Zolp. On the 10th day, after the last injection, mice 
were trained and 12 later tested. Results are presented as the mean ± S.E. of latency 
to enter the dark chamber in the training (A) and testing (B). +p<0.05 compared to the 
group of same sleep condition and treatment but different challenge injection; p<0.05 
compared to the group of same sleep condition and challenge injection but different 
treatment (MANOVA and Duncan’s test). 
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Figure 2: Effects of the repeated administration of Zolp or its withdrawal on open-field 
exploration in mice submitted to sleep restriction (SR). Animals were subjected to 
control condition (CTRL) or SR for 10 days and were daily treated with Sal or 5 mg/kg 
Zolp. On the 10th day, after the last injection, mice were trained and then exposed to 
the open-field. Results are presented as the mean ± S.E. of number of crossings 
through all quadrants (A) and immobility duration (B) immediately after training in the 
passive avoidance task. +p<0.05 compared to the group of same sleep condition and 
treatment but different challenge injection; p<0.05 compared to the group of same 
treatment and challenge injection but different sleep condition (MANOVA and Duncan’s 
test). 
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Figure 3: Effects of the repeated administration of Zolp exclusively on memory 
consolidation of a passive avoidance task in mice submitted to SR. Firstly, mice were 
trained. Immediately after, animals were subjected to control condition (CTRL) or SR 
for 10 days and were daily treated with Sal or 5 mg/kg Zolp. Forty-eight hours after the 
last injection, mice were tested. Results are presented as the mean ± S.E. of latency to 
enter the dark chamber in the training (A) and testing (B). There were no significant 
differences (MANOVA and Duncan’s test). 
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Figure 4: Effects of the repeated administration of Zolp or its withdrawal on retrieval of 
a passive avoidance task in mice submitted to sleep restriction (SR). Firstly, mice were 
trained. Forty-eight hours later, animals were subjected to control condition (CTRL) or 
SR for 10 days and were daily treated with Sal or 5 mg/kg Zolp. After the last injection, 
mice were tested. Results are presented as the mean ± S.E. of latency to enter the 
dark chamber in the training (A) and testing (B). +p<0.05 compared to the group of 
same sleep condition and treatment but different challenge injection (MANOVA and 
Duncan’s test). 
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Figure 5: Effects of the repeated administration of Zolp or its withdrawal on open-field 
exploration in mice submitted to sleep restriction (SR). Firstly, mice were trained. Forty-
eight hours later, animals were subjected to control condition (CTRL) or SR for 10 days 
and were daily treated with Sal or 5 mg/kg Zolp. After the last injection, mice were 
tested and then exposed to the open-field. Results are presented as the mean ± S.E. of 
number of crossings through all quadrants (A) and immobility duration (B) immediately 
after testing in the passive avoidance task. +p<0.05 compared to the group of same 
sleep condition and treatment but different challenge injection (MANOVA and Duncan’s 
test). 
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DISCUSSION 
 
In the present study we evaluated the effects of Zolp in mice sleep-
restricted for 3 h during 10 consecutive days on memory phases (learning, 
consolidation and retrieval) in the PAT. Thus, we showed that SR per se did not 
impair emotional memory when it occurs before training or testing. Regarding 
the effects of Zolp, in control animals, the acute pre-training administration of 
Zolp hindered memory retention. The same was observed in sleep-restricted 
mice. Notably, neither SR nor Zolp or its interactions promoted consolidation 
deficits. When retrieval was analyzed, all of the animals, irrespective of sleep 
condition or treatment, retrieved the task. This lack of a possible negative effect 
could be due to (1) the stressing characteristic of the PAT and (2) the influence 
of the Zolp-induced hypolocomotion before training or testing. 
In the 1st experiment we analyzed the effects of the repeated treatment 
with Zolp (or its withdrawn) on performance of mice subjected to SR in the PAT. 
Thus, in the training session we observed increase in latency to enter the dark 
chamber in mice acutely treated with Zolp. This result reflects the influence of 
motor activity in the PAT data. In fact, the acute treatment with Zolp promotes 
motor impairments, which in turn enhance the latency during training (Tang et 
al., 1995). On the other hand, sleep-restricted mice that were daily treated with 
Zolp did not differ from those abstinent of treatment and also presented a 
decreased latency compared to animals acutely treated. Although the PAT 
cannot detect alterations in locomotor activity, it could be suggested that in mice 
under SR there was a tolerance to the sedative effect of Zolp after repeated 
administration. Curiously, we observed that drug withdrawal decreased the 
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latency in both control and sleep-restricted groups. This finding could suggest a 
better performance in these groups. However, besides being strongly influenced 
by anxiety-like behaviors and motor activity, the PAT did not allow a specific 
evaluation of learning. 
Considering the strong influence of locomotion on the latency to enter the 
dark chamber in the PAT, after training animals were exposed to the OF to 
evaluate motor activity. Thus, the pre-training administration of Zolp decreased 
locomotion in exception of the group sleep-restricted acutely treated with Zolp. 
Still, we found an increase in immobility time for all groups challenged with Zolp 
irrespective of sleep condition. These findings demonstrate that the acute effect 
of Zolp was of less magnitude in animals submitted to SR, suggesting an 
interaction between SR and Zolp treatment. Although we did not detect an 
increase in motor activity induced by SR, this decrease in the magnitude of the 
hypolocomotor effects of Zolp in mice sleep-restricted could reflect an enhanced 
locomotion promoted by SR. Specifically, sleep deprivation can potentiate both 
spontaneous and amphetamine-induced motor activity in the open-field (Frussa-
Filho et al., 2004; Saito et al., 2014). We acknowledge that the foot shock 
applied during training of the PAT and the anxiogenic effect induced by the 1st 
exposure to a new environment (OF) may have impaired the expression of the 
SR-induced hyperlocomotion. 
With regard to retention of the task, the animals acutely treated with Zolp 
(kept under CTRL condition) presented a decrease in latency suggesting an 
attenuation of memory processes. Indeed, several studies have reported 
deleterious effects of the acute Zolp administration in the PAT (Edgar et al. 
1997; Fitzgerald et al., 2014; Foster et al. 2004; Sanger et al. 1986; Savić et al., 
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2005b; Tang et al. 1995). Similarly, herein we found a negative effect of the 
repeated Zolp administration in the retention of the PAT (Mikolajczak et al., 
1999). Regarding the sleep-restricted groups, only mice acutely treated with 
Zolp presented a decrease in latency to enter the dark chamber. It would be 
expected an impairing effect of SR per se. The absence of effect could be 
explained by the stressing component of the PAT since it involves painful and 
potentially life-threatening aversive stimuli, which could have strengthened the 
memory trace. Indeed, reinforcers can cause strong resistance of memory 
against forgetting (McGaugh, 2006). 
As previously mentioned, the possible influence of Zolp-induced 
hypolocomotion in the performance of mice during the training cannot be 
excluded. Nevertheless, if this was the case, mice sleep-restricted and 
repeatedly treated with Zolp (SR-Zolp/Zolp group) should also present memory 
deficits since they presented decreased exploration in the OF, likewise all of the 
animals challenged with Zolp. This data suggests that, although being 
influenced by motor activity, our findings reflected the memory impairment 
induced by acute Zolp administration. Another possible explanation is the 
duration of SR. Thus, it could be suggested that longer periods of SR would 
precipitate memory deficits. 
Fear-motivated memories involve both an explicit associative (the 
context) and an operant-like conditioning components (the shock) (Quillfeldt, 
2010). Of note, acquisition and consolidation of avoidance tasks depends on 
the hippocampus (Izquierdo and Medina, 1997; Lorenzini et al., 1996; Rossato 
et al., 2006) and is also dependent on the basolateral amygdala, entorhinal and 
parietal cortex functioning (Izquierdo et al., 2006). It is known that neural 
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processing within the amygdala complex is important for assigning emotional 
value to events. In this concern, it was shown that Zolp enhanced the inhibitory 
postsynaptic paths in the basolateral amygdala (Kang-Park et al., 2004), which 
could explain the observed memory deficits. Specifically, after amygdala 
lesions, a cue that signs an aversive event fails to elicit fearful behavior and the 
association between cues and positive experiences is also deficient (Gallagher 
and Holland, 1994; LeDoux, 2000). 
In the experiment II, we analyzed the interactions between SR and Zolp 
exclusively on memory consolidation. As expected, we did not find basal 
differences in the training session. Then, in the testing, neither the repeated 
treatment with Zolp nor the SR or their interactions modified the consolidation of 
the PAT. Concerning the SR lack of effects, it was reported that a similar 
protocol of post-training SR did not promote consolidation deficits in a spatial 
task in adult rats (Yang et al, 2012). Similarly, clinical studies demonstrated that 
the acute administration of Zolp did not promote consolidation deficits in a motor 
skill task (Morgan et al., 2010) or recall of word lists and digit symbol 
substitution test (Meléndez et al., 2005). In the present study, we also 
demonstrated that the repeated administration of Zolp did not impair 
consolidation of an emotional task. Notably, a meta-analysis by Myhrer (2003) 
reported that dopamine is the most influential neurotransmitter in PAT memory 
followed by glutamate. Conversely, drugs with effects on GABAergic or 
cholinergic activity seem to have a weaker participation on PAT memory 
formation. 
While numerous studies have demonstrated that sleep plays a critical 
role in the acquisition and consolidation phases of memory formation (Smith et 
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al., 2009; Stickgold et al., 2001), its effect on memory retrieval remain 
overlooked, although some recent studies have reported an inhibitory effect on 
this stage (Alvarenga et al., 2008; Fernandes-Santos et al., 2012; Patti et al., 
2010). In the present study, we demonstrated that the employed SR protocol 
did not impair emotional memory retrieval. Again, neither Zolp treatment nor its 
withdrawn altered memory recall. Curiously, mice under control condition and 
acutely treated with Zolp displayed increased latency which reflects the 
hypolocomotor effect of this drug that was administered prior to testing. 
In agreement with this assumption, in the OF performance, mice treated 
with Zolp before testing showed increase in immobility time. Accordingly, there 
was a decrease in ambulation after Zolp administration in exception of the 
sleep-restricted group acutely treated with the drug. As mentioned before, it 
would be expected a hiperlocomotor effect of SR which was not detected. 
Again, this discrepancy could be due to the foot shock application and a 
possible anxiogenic effect induced by the novelty during the 1st exposure to the 
OF. Conversely, the attenuation of the Zolp-induced hypolocomotor effect in 
mice sleep-restricted would reflect an increased motor activity induced by SR 
modulating the acute effects of the drug. 
Recently, studies in our laboratory found that the interaction between SR 
and Zolp can positively or negatively modulate memory of a discriminative 
avoidance task (Zanin et al., submitted data). Specifically, SR induced cognitive 
impairments were abolished by the acute administration of Zolp or its 
withdrawal. On the other hand, when administered to control animals, Zolp 
induced memory impairments. Such discrepant results could be due to the 
different memory tasks employed. Accordingly, Tipps and colleagues (2015) 
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have recently shown that ethanol withdrawn exerts a bidirectional effect on 
memory, in which context learning is impaired, but cued learning is improved. In 
line with our study, these results suggest that ethanol – a drug with a 
GABAergic component (Hevers and Lüddens, 1998) –.can also positively or 
negatively modulate memory depending on the task. In addition, compared to 
other animal memory tests that involve painful and potentially life-threatening 
aversive stimuli, the aversive stimuli used in the plus-maze discriminative 
avoidance task (light and sound) seem to be less stressful. 
In summary, our results demonstrated that in the PAT, an animal model 
with a strong emotional component, SR during 10 days did not modify memory 
irrespective of the phase analyzed. Still, we corroborated previous findings 
showing the Zolp-induced anterograde amnesia. Finally, our findings showed 
that the PAT, although being a classical model to evaluate memory, might have 
been influenced by motor activity. 
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3.3.1 Conclusões parciais – manuscrito 3 
 
No paradigma da esquiva passiva, a RS repetida por 10 dias não foi 
capaz de prejudicar a memória quando realizada antes do treino ou teste na 
esquiva passiva. Ainda, ao contrário do observado anteriormente (manuscrito 
2), a administração aguda pré-treino de Zolp prejudicou a retenção da tarefa 
nos animais restritos de sono. Por outro lado, assim como observado na ED-
LCE, a RS, o zolpidem ou suas interações não foram capazes de modificar a 
consolidação da tarefa quando realizadas imediatamente após o treino. 
Essas diferenças podem ter sido ocasionadas por: (1) diferenças 
qualitativas dos modelos, já que a EP poderia ser mais estressante por 
apresentar um estímulo doloroso, de modo que a RS não prejudicou a memória 
ou (2) influência da hipolocomoção induzida pelo zolpidem administrado 
anteriormente à exposição ao aparelho. Assim, considerando a influência do 
modelo de memória utilizado, no próximo manuscrito investigamos os efeitos 
da restrição de sono e o zolpidem em 2 tarefas não aversivas: reconhecimento 
de objetos e reconhecimento social. 
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ABSTRACT 
 
Purpose: Zolpidem (Zolp) and sleep restriction (SR) may have negative effects 
on memory. Preliminary data from our group found that the interaction between 
SR and Zolp can modulate the memory trace of a discriminative avoidance task. 
In the passive avoidance task, only the acute Zolp-treatment hindered memory 
regardless of SR. Herein we evaluated the effects of repeated administration of 
Zolp (or its withdrawal) in mice submitted to SR on spontaneous object 
recognition (SOR) and social discrimination (SD) tasks, which do not involve 
aversive components. Design: Mice were subjected to SR for 3 h per day 
during 10 days or left undisturbed (CTRL) and then were treated with saline 
(Sal) or Zolp. On the 10th day, half of the animals treated with Sal received Zolp 
while the others received Sal. The same occurred for mice daily treated with 
Zolp. One hour after the last injection mice were submitted to behavioral 
sessions. Results: Zolp withdrawal impaired retention of SOR in CTRL mice. In 
the SD task, only the acute Zolp administration prevented memory deficits in 
CTRL animals. SR promoted deficits in the SOR and SD. The short-term 
memory impairment in the SOR task was abolished by Zolp regardless of the 
administration protocol, while only the acute administration of this drug 
counteracted the negative effects of SR in the SD task. Conclusion: The 
effects on memory of Zolp acute and long-term treatments and its withdrawal on 
sleep-restricted animals may vary depending on the task. Our data strengths 
the importance of future studies investigating different periods of SR as well as 
other memory tasks. 
Keywords: zolpidem, sleep restriction, object recognition, social discrimination. 
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INTRODUCTION 
 
There is a great amount of evidence showing that sleep is essential to 
ensure survival. Consequently, sleep loss has several adverse effects on 
endocrine functions, metabolic and inflammatory responses, and may cause a 
range of neurobehavioral deficits (Banks and Dinges, 2007). Partial sleep loss 
may be associated with to sleep fragmentation, specific sleep stages 
deprivation or sleep restriction (SR). Sleep fragmentation is generally present in 
sleep disorders (e.g., obstructive sleep apnea and insomnia), in which the 
normal progression and sequencing of sleep stages is disrupted. SR, which is 
also referred to as sleep debt, is characterized by reduced sleep duration. It 
may be experienced due to sleep disorders or other medical conditions, shift-
work, social and domestic responsibilities and life-style (Banks and Dinges, 
2007), thus representing an important translational model. 
Specifically regarding cognition, it is well-established that sleep plays a 
critical role in learning and memory formation. Indeed, a myriad of studies have 
demonstrated that both paradoxical and total sleep deprivation leads to memory 
deficits in several animal models (Fernandes-Santos et al., 2012; Palchykova et 
al., 2006; Patti et al., 2010). Experimental protocols evaluating the animals 
neurobehavioral effects applying models of SR are less common than the 
considerable amount of work performed with total sleep deprivation or selective 
stage deprivation. In humans, SR impairs behavioral alertness and the 
neurobehavioral effects of SR appear similar to those of total sleep deprivation 
(Belenky et al., 2003; Van Dongen et al., 2003). Regarding animal models, it 
was demonstrated that SR by forced locomotion impaired spatial memory 
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(McCoy et al., 2013; Zielinski et al., 2013). In another study, SR by gentle 
handling hindered consolidation of a spatial memory in adolescent (but not in 
adult) rats (Yang et al., 2012). 
In parallel, zolpidem (Zolp) is a hypnotic drug prescribed to treat 
insomnia. It is an imidazopyridine agent, which selectively binds to the α1 
subunit-containing GABAA receptor subtype (Sancar et al. 2007). While Zolp 
seems to exhibit fewer deleterious effects, psychomotor and amnestic effects 
are still reported both in humans (Fitzgerald et al., 2014) and laboratory animals 
(Huang et al. 2010; Savić et al. 2005a,b; Zanin et al., 2011, 2013). From a 
clinical perspective, Zolp is prescribed as a long-term treatment for insomnia. 
Recently, studies in our laboratory found that the interaction between SR and 
Zolp can positively or negatively modulate memory of a discriminative 
avoidance task (Zanin et al., submitted data). Specifically, SR induced cognitive 
impairments, which were abolished by the acute administration of Zolp or its 
withdrawal. On the other hand, when administered to control animals, Zolp 
induced memory impairments. Conversely, when the same protocol was 
evaluated in the passive avoidance task, the employed SR protocol did not 
induce memory deficits and only the acute Zolp-treatment modified memory 
retention irrespective of sleep condition. Thus, the interaction between Zolp and 
SR may vary according to the task employed. 
Spontaneous object recognition task assess the aspects of declarative 
memory in rodents (Dere et al., 2007; Ennaceur and Delacour, 1988). This task 
is based on the natural tendency of rodents to prefer novel stimuli in relation to 
familiar ones. Thus, animals are allowed to explore two objects. After a delay, 
the animal is again placed in the test arena with one object previous explored 
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(i.e., familiar) while the other object is novel. If memory is preserved, the animal 
spends more time exploring the novel object, signaling recognition memory 
(Winters et al., 2008). Similarly, in the social discrimination paradigm, the 
animal is initially exposed to an unfamiliar conspecific and then, both a familiar 
and a novel conspecific are simultaneously presented (van der Kooij and Sandi, 
2012). The social recognition test measures short-term/working memory, i.e., 
the ability of retaining a small amount of information in a readily available state 
for a short period of time (Mathiasen and DiCamillo, 2010). Both tasks (object or 
social recognition) are simple in design and takes advantage of evaluating 
spontaneous behavior of animals with no artificial stimulus or positive/negative 
reinforcements. 
Considering the increasing prescription of Zolp and the previous 
evidence supporting the influence of the memory task employed, as well as the 
absence of studies systematically evaluating the effects of the repeated 
treatment with Zolp in sleep-restricted animals, the aim of the present study was 
to evaluate the effects of the repeated administration of Zolp (or its withdrawal) 
on learning and memory of mice sleep-restricted in two different tasks without 
an aversive component, the spontaneous object recognition (SOR) and social 
discrimination (SD) tasks. 
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MATERIAL AND METHODS 
 
Subjects 
Three-month-old Swiss male mice (outbred, raised, and maintained in 
the Centre for Development of Experimental Models in Medicine and Biology of 
Universidade Federal de São Paulo) were used. Animals weighing 35-40 g 
were housed under conditions of controlled temperature (22-23°C) and lighting 
(12h light, 12h dark; lights on at 6:45 a.m.). Food and water were available ad 
libitum throughout the experiments. Animals used in this study were maintained 
in accordance with the National Institute of Health Guide for the Care and Use 
of Laboratory Animals (NIH Publications Nº 8023, revised 2011) and with the 
Brazilian Law for Procedures for Animal Scientific Use (#11794/2008). The 
experimental procedures were approved by the Institutional Animal Care and 
Use Committee under the protocol #1741/10. 
 
Drugs 
Zolp (Sanofi-Aventis®), at the dose of 5 mg/kg, was diluted in saline 0.9% 
solution (Sal), which was also the control solution. The dose of Zolp was chosen 
based on previous experiments of our group, demonstrating both memory 
deficits and weaker sedative effects in mice (Zanin et al., 2013). All the 
solutions were administered intraperitoneally in a volume of 10 ml/kg. 
 
Sleep Restriction (SR)  
Mice were submitted to SR through the gentle handling method, 
described elsewhere (Tobler et al., 1990). This method consists of keeping the 
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animal awake by tapping on the cage and, if necessary, by gently touching 
them with a soft brush if behavioral signs of sleep are observed. The animals 
were sleep restricted for 3 h (from 10 AM to 1 PM) during 10 consecutive days. 
This time interval was chosen because this is when paradoxical sleep reaches 
its highest expression and slow wave sleep homeostatic pressure is generated 
(Franken et al., 1991). 
 
Spontaneous Object Recognition (SOR) 
The object recognition test was carried out in an open-field arena, which 
consisted in a circular arena (96 cm diameter) enclosed by matte white walls 
(circumference 40 cm) with an open top and floor divided into 19 quadrants. In 
the familiarization session, the animals were placed in the arena containing two 
similar objects and left to explore them freely for 10 min but exploration of the 
objects was quantified in the first 5 min. The test session occurred 180 minutes 
later, in order to evaluate short-term memory. Twenty-four hours later, long-term 
memory was investigated. In the tests, one of the objects was substituted for a 
new object and the rat was introduced in the arena for more 5 min. In addition, 
herein we opted for not including a habituation session since it was 
demonstrated that the habituation phase does not influence performance and, 
thus, excluding this session reduces the total duration of the experiment (Leger 
et al., 2013). 
The positions of the objects (familiar or novel) were randomly permuted 
for each experimental animal. Exploration was defined as sniffing or touching 
the object with the nose and/or forepaws. Sitting on or turning around the object 
was not considered exploratory behavior. Only in the familiarization session 
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immobility time was recorded in order to discard the possible influence of the 
sedative effects of Zolp. The time spent to explore each object was recorded by 
an observer blind to the treatment. The objects and the apparatus were cleaned 
with a 5% alcohol solution after each behavioral session. 
The measure of discrimination considered was the discrimination ratio 
(DR), as described before (Ennaceur and Delacour, 1988). The DR is the 
difference between time spent exploring the two objects divided by the total time 
spent exploring both objects. DR index ranges from -1 to 1. Thus, a value 
higher than zero reveals an exploratory preference for the novel combination 
during test. Importantly, using the DR index individual differences in the level of 
exploration is taken into account (Akkerman et al., 2012). 
 
Social discrimination task (SD)  
The social recognition was performed in a 3-chambered sociability 
apparatus (Ugo Basile®, Varese, Italy). It is composed by a transparent acrylic 
box, divided into 3 compartments (20 x 40 x 22 cm) with a non-reflective, grey-
colored floor and 2 round grid enclosures (7 x 15 cm high). The thin, widely 
spaced bars of the wire cage allowed nose contact between the bars, but 
prevented any social contact and limited the possibility of aggressive behavior. 
The 2 outer compartments (A and B) contained the grid enclosures and were 
separated by a central compartment with no cage inside and 2 sliding doors in 
order to allow mice moving freely between the compartments. 
Firstly, the experimental animal was placed in the central compartment 
for habituation with the empty grid enclosures during 5 min. Then, an unfamiliar 
animal matched for body weight with the experimental animal was placed into 
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one of the wire cages. After 5 min, a 2nd unfamiliar mouse was inserted into the 
opposite compartment and exploration was allowed for more 5 min. The 
intruders were randomly selected and counterbalanced for each group. Time 
spent in target to the cage or sniffing the strange mouse was recorded by an 
observer blind to the treatment. The apparatus was cleaned with a 5% alcohol 
solution after each behavioral session. 
The interaction with the 1st intruder confined to the small cage in one 
compartment is considered a measure of sociability while the social recognition 
memory is evaluated by the discrimination between the familiar intruder 1 and 
the novel intruder 2. In this condition, the possible preference for the new 
intruder is considered a measurement of retention (Nadler et al., 2004; Riedel et 
al., 2009). 
 
Experimental design 
 
Experiment I: effects of the repeated administration of Zolp or its withdrawal on 
SOR test in mice sleep-restricted 
Animals were kept in their home cages (control condition – CTRL) or 
subjected to SR by gentle handling for 3 h per day during 10 days. Every day, 
after the SR period, mice were treated with Sal (CTRL-Sal and SR-Sal) or Zolp 
(CTRL-Zolp and SR-Zolp). On the 10th day, half of animals treated with Sal 
received an acute Zolp challenge injection while the others received Sal. The 
same procedure was applied for mice daily treated with Zolp. The following 
groups were formed: CTRL-Sal/Sal (n=12), CTRL-Sal/Zolp (n=12), CTRL-
Zolp/Sal (n=11), CTRL-Zolp/Zolp (n=12), SR-Sal/Sal (n=12), SR-Sal/Zolp 
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(n=12), SR-Zolp/Sal (n=12) and SR-Zolp/Zolp (n=12). Sixty min after the last 
injection, mice were subjected to training of SOR. This administration interval 
was chosen because animals present fewer hypolocomotor effects but the drug 
is still available, since its half-life is about 1.5 h in rodents (Garrigou-Gadenne et 
al., 1989). After training, animals were returned to their home-cage. Three hours 
later animals were submitted to test session 1 and after 24 h to test session 2. 
 
Experiment II: effects of the repeated administration of Zolp or its withdrawal on 
SD test in mice sleep-restricted 
Animals were treated as described previously, forming the following 
groups: CTRL-Sal/Sal (n=12), CTRL-Sal/Zolp (n=12), CTRL-Zolp/Sal (n=12), 
CTRL-Zolp/Zolp (n=12), SR-Sal/Sal (n=12), SR-Sal/Zolp (n=12), SR-Zolp/Sal 
(n=12) and SR-Zolp/Zolp (n=12). Sixty min after the challenge injection, mice 
were subjected habituation in the SR box. Five min after habituation, the 1st 
intruder was introduced into the box for 5 min (training session). Then, the 2nd 
intruder was placed in the other compartment during 5 min for testing. 
 
Statistical analysis 
The inter-group analyses were performed by MANOVA and Duncan’s 
test and for intra-group analyses paired samples T-test was applied. A 
probability of p<0.05 was considered significant for all comparisons made. 
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RESULTS 
 
Experiment I: effects of the repeated administration of Zolp or its withdrawal on 
SOR test in mice sleep-restricted 
In the familiarization session, MANOVA for time spending exploring both 
objects revealed significant effects of sleep condition (CTRL vs. SR) 
[F(1,87)=220.06; p<0.001] and sleep condition x challenge injection (Sal vs. 
Zolp) interaction [F(1,87)=4.46; p<0.05]. Duncan’s post hoc showed that mice 
only sleep-restricted (SR-Sal/Sal) and those sleep-restricted and abstinent of 
treatment (SR-Zolp/Sal) explored significantly more the objects compared to its 
respective control (CTRL-Sal/Sal and CTRL-Zolp/Sal, respectively). Still, the 
repeated treatment with Zolp (SR-Zolp/Zolp) decreased exploration compared 
to the group challenged with Sal (SR-Zolp/Sal). In addition, Zolp withdrawal in 
sleep-restricted mice induced an increase in exploration time compared to 
control group repeatedly treated with Zolp (CTRL-Zolp/Zolp) (Figure 1A). 
Regarding immobility time in this session, there were no significant differences 
among groups (Figure 1B). 
In the 1st test session (3 h after the familiarization session), MANOVA for 
the DR showed significant effects of the interactions sleep condition x treatment 
[F(1,87)=9.59; p<0.005] and sleep condition x treatment x challenge injection 
[F(1,87)=9.49; p<0.005]. Duncan’s test revealed that mice only sleep restricted 
(SR-Sal/Sal) displayed a lower DR compared to control (CTRL-Sal/Sal). Still, 
the control group abstinent of treatment (CTRL-Zolp/Sal) presented a 
decreased DR compared to all of the groups (with the exception of the SR-
Sal/Sal group) (Figure 2). 
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In the 2nd test session (24 h after the familiarization session), MANOVA 
for the DR showed significant effects of treatment [F(1,87)=6.38; p<0.05] and 
sleep condition x challenge injection interaction [F(1,87);=5.00; p<0.05]. Thus, 
the post hoc analysis revealed that mice abstinent of treatment (CTRL-Zolp/Sal) 
presented a decreased performance compared to control group (CTRL-Sal/Sal) 
and the repeatedly Zolp-treated group (CTRL-Zolp/Zolp). Still, animals sleep-
restricted and repeatedly treated with Zolp (SR-Zolp/Zolp) presented a worse 
performance compared to mice acutely treated with the drug and subjected to 
the same sleep condition (SR-Sal/Zolp) (Figure 2). 
We performed a within-subjects analysis to compare performance 
between the test sessions. Thus, paired-samples T tests showed that only mice 
sleep-restricted and treated with Zolp (SR-Zolp/Zolp) presented a worse 
performance in the 2nd test compared to the 1st one [T(11)=2.25; p<0.05] 
(Figure 2). 
 
Experiment II: effects of the repeated administration of Zolp or its withdrawal on 
SD test in mice sleep-restricted 
 
In the habituation session, MANOVA did not show significant differences 
among groups for the time spent interacting with the empty cages (Figure 3A). 
In the training session, when the within-subject analysis was performed, all of 
the groups spent significantly more time exploring the 1st intruder than the 
empty cage [T(11)=3.24; p<0.01 for CTRL-Sal/Sal; 3.60; p<0.005 for CTRL-
Sal/Zolp; 4.88; p<0.001 for CTRL-Zolp/Sal; 3.67; p<0.005 for CTRL-Zolp/Zolp; 
3.75; p<0.005 for SR-Sal/Sal; 2.45; p<0.05 for SR-Sal/Zolp; 2.46; p<0.05 for 
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SR-Zolp/Sal; 2.43; p<0.05 for SR-Zolp/Zolp]. In addition, MANOVA followed by 
Duncan’s test revealed significant effects of sleep condition [F(1,88);=4.38; 
p<0.05] and challenge injection [F(1,88);=5.60; p<0.05]. Indeed, sleep-restricted 
mice challenged with Zolp (SR-Sal/Zolp) explored less the empty cage 
compared to mice only sleep-restricted (SR-Sal/Sal). Still, mice subjected to SR 
and abstinent of treatment (SR-Zolp/Sal) presented a higher exploration of the 
empty cage compared to control (CTRL-Sal/Sal) and to the group in the same 
sleep condition continuously treated with Zolp (SR-Zolp/Zolp) (Figure 3B).  
In the test session when the within-subject analysis was performed, 
paired-samples T test showed that among animals subjected to CTRL 
condition, only those treated with Sal (CTRL-Sal/Sal) or challenged with Zolp 
(CTRL-Sal/Zolp) showed an increased exploration of the 2nd intruder in relation 
to the 1st one [T(11)=2.29 and 2.87; p<0.05, respectively]. On the other hand, in 
the sleep-restricted mice, only those acutely treated with Zolp preferred to 
explore the 2nd intruder [T(11)=2.31; p<0.05]. Regarding the between-subject 
analysis, MANOVA did not show significant differences among groups (Figure 
3C). 
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Figure 1: Effects of the repeated administration of Zolp or its withdrawal on object 
recognition task in mice submitted to sleep restriction (SR). Animals were subjected to 
control condition (CTRL) or SR for 10 days and were daily treated with Sal or 5 mg/kg 
Zolp. On the 10th day, after the last injection, mice were trained and tested 3 and 24 h 
later. Results are presented as the mean ± S.E. of total time spent in exploring the 
objects (A) and immobility time (B) in the familiarization session. p<0.05 compared to 
the group of same treatment and challenge injection but different sleep condition; 
+p<0.05 compared to the group of same sleep condition and treatment but different 
challenge injection; ªp<0.05 compared to the CTRL-Zolp/Zolp group (MANOVA and 
Duncan’s test). 
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Figure 2: Effects of the repeated administration of Zolp or its withdrawal on object 
recognition task in mice submitted to sleep restriction (SR). Animals were subjected to 
control condition (CTRL) or SR for 10 days and were daily treated with Sal or 5 mg/kg 
Zolp. On the 10th day, after the last injection, mice were trained and tested 3 and 24 h 
later. Results are presented as the mean ± S.E. of discrimination ratio (DR) in the 
short- (test 1) and long-  to the 
group of same treatment and challenge injection but different sleep condition; +p<0.05 
compared to the group of same sleep condition and treatment but different challenge 
injection; ♦p<0.05 compared to the group of same sleep condition and challenge 
injection but different treatment; ºp<0.05 compared to the CTRL-Zolp/Sal group 
(MANOVA and Duncan’s test); *p<0.05 compared to test 1 into the same group 
(paired-samples T test). 
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Figure 3: Effects of the repeated administration of Zolp or its withdrawal on social 
discrimination task in mice submitted to sleep restriction (SR). Animals were subjected 
to control condition (CTRL) or SR for 10 days and were daily treated with Sal or 5 
mg/kg Zolp. On the 10th day, after the last injection, mice were habituated to the test 
box. Five min later were trained and 5 min after, tested. Results are presented as the 
mean ± S.E. of time spent interacting with the empty cages or the unfamiliar animal 
during habituation (A), training (B) and test (C) sessions. p<0.05 compared to the 
group of same treatment and challenge injection but different sleep condition; +p<0.05 
compared to the group of same sleep condition and treatment but different challenge 
injection; (MANOVA and Duncan’s test); £p<0.05 compared to time exploring intruder 1 
into the same group (paired-samples T test). 
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DISCUSSION 
 
In the current study we showed that SR during 3 h for 10 consecutive 
days promoted short- and long-term memory deficits in 2 non-aversive tasks 
(SOR and SD). While the SR-induced short-term memory impairment in the 
SOR task was abolished by Zolp (regardless of the administration protocol), the 
administration of this hypnotic did not preserve long-term memory in SOR task. 
Moreover, Zolp withdrawal alone (but not the acute or repeated administration) 
was able to impair mice performance on SOR. In the SD task, SR promoted 
amnestic effects, which were counteracted by the acute Zolp administration. On 
the other hand, in the SD task, only the acute Zolp administration did not hinder 
memory in CTRL animals. 
To the best of our knowledge, this is the first study that systematically 
evaluated the effects of the repeated treatment with Zolp or its withdrawal in 
non-aversive tasks in mice subjected to a repeated SR protocol. Thus, in 
experiment I we assessed the effects of this treatment on the SOR task. In the 
familiarization session, Zolp administration did not modify objects exploration. 
Conversely, SR induced an increase in exploration level, which was attenuated 
by the acute administration of Zolp and abolished by the repeated treatment 
with this drug. This Zolp-induced reduction in exploration could be due to the 
sedative effect of Zolp. Alternatively, a blockade of a possible SR-induced 
increase on impulsivity or motor activity may have occurred. Since there were 
no differences among groups on immobility time, it is unlike that the sedative 
effect of Zolp had influenced exploration. In addition, we have chosen the 1-h 
administration interval to minimize such hypolocomotor effect. 
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Distinct sleep deprivation protocols may increase impulsivity (Berro et al., 
2014) as well as motor activity in laboratory animals. In fact, it was 
demonstrated that sleep deprivation potentiated both spontaneous (Frussa-
Filho et al., 2004) and drug-induced (Arriaga et al., 1988; Ferguson and 
Dement, 1969; Frussa-Filho et al., 2004) motor activity in the open-field. Of 
note, motor activity is closely related to dopaminergic neurotransmission (Kelly 
et al., 1975; Kelly and Iversen, 1976). Similarly, preclinical and clinical studies 
have pointed that high impulsivity involves a dysregulation of the dopaminergic 
system (Dalley et al., 2011; Fineberg et al., 2010; Volkow et al., 2009). Although 
it is well-established that paradoxical sleep deprivation increase several 
behaviors related to the dopaminergic system (Frussa-Filho et al., 2004; Tufik et 
al., 1978; Tufik, 1981a,b; Troncone et al., 1988), it was shown that this 
procedure by the multiple platforms method also deprives time spent in slow 
wave sleep (Silva et al., 2004). Thus, it is tempting to speculate that SR could 
also have induced dopaminergic supersensitivity, which was suppressed by 
Zolp administration. Accordingly, it was demonstrated that GABA-modulating 
drugs such as benzodiazepines inhibits the GABAergic interneurons in 
important areas of dopaminergic transmission such as the ventral tegmental 
area and substantia nigra (Grace et al., 1980; Tan et al., 2010). As a result, 
GABA neurons no longer inhibit dopaminergic cells increasing dopamine 
release. Notably, it was shown that these inhibitory interneurons express mainly 
α1 subunit (Gao et al., 1993, 1994) – Zolp preferential site of action. 
There is several discrimination measures used to evaluate memory in the 
SOR task. The most frequently used are the absolute difference in exploration 
(difference between time exploring the novel and the familiar objects) (King et 
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al., 2004; Messier et al., 1997) and the relative measure DR (Gaskin et al., 
2003; Lieben et al., 2005). Comparing these measures, Akkerman and 
colleagues (2012) showed that the absolute difference in exploration was more 
vulnerable to differences in exploratory activity, while the DR, which corrects for 
exploratory differences, was more sensitive to subtle differences when 
exploration levels varied among groups. Considering that both the SR and Zolp 
may modify motor activity, we opted to apply the DR. Thus, in the short-term 
memory test (test 1), only Zolp withdrawal hampered retention in CTRL mice. 
Although mice subjected to SR presented a positive DR value, there was a 
significant decrease compared to animals in the CTRL-Sal/Sal group, 
suggesting that SR per se hindered short-term memory. Interestingly, 
irrespective from the administration regimen, Zolp counteracted the amnestic 
effect of SR. 
As far as we know, no studies have addressed the effects of SR protocol 
or its interaction with Zolp on memory of SOR task. Notably, we have recently 
observed a similar behavioral pattern, i.e., Zolp-induced reversal of SR 
amnestic effects, when mice were exposed to an aversive task, the plus-maze 
discriminative avoidance (Zanin et al., submitted data). Although highly 
speculative, it could be suggested that, as happened for motor activity, Zolp 
administration increased dopamine release, which attenuated the SR-induced 
dopaminergic supersensitivity, blocking its deleterious effects on memory. In 
this regard, it has been suggested that hippocampal dopamine modulates 
memory encoding and consolidation during or early after training (Jay, 2003; 
O'Carroll et al., 2006; Talhati et al., 2014). This hypothesis deserves further 
investigations. 
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When long-term memory was evaluated (test 2), among animals which 
had their sleep undisturbed, in exception of the group abstinent of Zolp 
treatment, all of the groups presented high DR levels in the same magnitude of 
those observed during test 1, thus displaying a unmodified performance. Of 
note, Kleykamp and colleagues (2012) showed a trend towards a cognitive 
impairing effect induced by Zolp withdrawal in humans. Among sleep-restricted 
animals, although SR per se promoted short-term memory impairments, when 
long-term memory was evaluated this effect seems of less magnitude. This 
apparently improvement effect could be due to the 2nd exposition to the objects 
during the test 1. Thus, considering that mice were allowed 3-h sleep before 
being exposed to test 1, this session may have reinforced the memory trace for 
the familiar object or even worked like a new learning session. Still, in sleep-
restricted mice repeatedly treated with Zolp, the long-term memory was 
attenuated although it did not modify short-term memory. In spite of a few 
studies evaluating the effects of the repeated treatment with Zolp on cognition, 
Stoops and Rush (2003) have demonstrated that the acute administration of 
Zolp promoted memory deficits in humans without toleration development after 
the repeated treatment. 
No studies have evaluated the effects of SR protocols on long-term 
memory of a SOR task. Only few studies investigated the effects of acute total 
or paradoxical sleep deprivation protocols specifically on the consolidation 
phase using several variations of the SOR task however the results were 
controversial. When memory was evaluated in short periods after training, total 
sleep deprivation impaired object-place recognition (but not SOR), which is a 
hippocampal-dependent task (Binder et al., 2012; Inostroza et al., 2013). On the 
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other hand, when memory was evaluated 24 h after training, paradoxical sleep 
deprivation for 4 h impaired consolidation of object-place task (Ishikawa et al., 
2014) and when extended for 6 h, it impaired the SOR (Chen et al., 2014). 
Conversely, when using the gentle handling method, sleep deprivation impaired 
consolidation immediately after training (Palchykova et al., 2006) as well as with 
a 1-h delay (Prince et al., 2014), depending on the duration of sleep deprivation. 
This discrepancy may be accounted for differences in the number of objects 
used or additional contextual cues and the duration of sleep deprivation. In 
addition, lesion studies demonstrated that the hippocampus is involved in 
object-place recognition, while SOR is dependent on the prefrontal and 
entorhinal cortex (Barker and Warburton, 2011; Mumby et al., 2002). 
In the present study, we assessed social interaction in mice and 
determined sociability. Within this context, sociability is evaluated by social 
interaction with a 1st stranger confined to a small cage in one compartment, and 
after an interval, social recognition memory is evaluated by discrimination of a 
familiar stranger 1 from a novel stranger 2. This discrimination is typically 
observed in mice (Moy et al., 2004; Nadler et al., 2004; Riedel et al., 2009). We 
found that besides all of the groups preferred to explore the 1st intruder rather 
than the empty cage, in sleep-restricted mice, Zolp withdrawal increased the 
time exploring the empty cage. This increased exploratory behavior could be a 
result of a higher locomotor activity induced by SR, which was potentiated by 
Zolp withdrawal. Another explanation would be a reduction in sociability. This 
last explanation does not seem to be the case since the amount of time these 
animals spent exploring the 1st intruder was similar compared to the others. In 
addition, the increased cage exploration time was abolished by Zolp 
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administration in the repeatedly-treated group. This effect does not seem to be 
due to sedation. Specifically, Riedel and colleagues (2009) reported an 
enhanced sociability in diazepam-treated mice, which also expressed 
heightened activity, suggesting that locomotor activity may be independent of 
the amount of social activity. 
During the testing, only the acute Zolp treatment did not impair memory 
in CTRL animals. No studies have investigated the effects of Zolp on SD, 
nevertheless it was shown that diazepam may induce SD deficits in mice 
(Riedel et al., 2009). Still, SR induced memory deficits, which were abolished by 
the acute administration of Zolp, but not its withdrawal or repeated treatment. Of 
note, previous studies have already reported that this drug promotes 
anterograde amnesia, i.e. forgetfulness of events that occurred shortly after 
drug intake (Danjou et al., 1999; Tsai et al., 2007). Additionally, these results 
gives further evidence that Zolp-induced negative or positive effects may vary 
depending on the emotional characteristic of the task (aversive vs. non-
aversive) as well as the type of memory analyzed. In this respect, the SD test is 
designed to measure short-term/working memory (Mathiasen and DiCamillo, 
2010), which refers to the capacity for holding a small amount of information in 
the mind in an active, readily available state for a short period of time. 
Group or individual odors have great importance for rodents, since it is 
necessary for the determination of threat, communication of food sources, 
social hierarchy and for mate choice (Berry and Bronson, 1992; Jiming et al., 
1994). Therefore, a memory for olfactory-based recognition represents a critical 
cognitive skill for these species. Herein we did not evaluate long-term memory 
for SD. However, as previously noted, rodents show poor memory in this 
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paradigm and generally remember a previous single encounter with 
companions for less than 1–2 h (Bluthé and Dantzer, 1993; Gheusi et al., 1994; 
Perio et al., 1989; Sekiguchi et al., 1991; Thor and Holloway,1982). Long-term 
memory of SD requires castration of males (Bluthé and Dantzer, 1990), a 
training to criterion procedure (Koogan et al., 2000) or stress application (Penka 
et al., 2004). 
Collectively, our results suggest that the interaction between SR and Zolp 
is intriguing. Specifically, the short-term memory impairment in the SOR task 
was abolished by Zolp in all administration protocols, while only the acute 
administration of this drug counteracted the negative effects of SR in the SD 
task. In addition, albeit the repeated administration of Zolp reversed the effects 
of SR on short-term memory, it did not preserve long-term memory of SOR 
task. Thus, the positive or negative effects of Zolp are critically dependent on 
the task and the administration regimen. Therefore, the present findings point 
out to the need of future studies evaluating the interaction between Zolp and 
different SR periods, once that depending on the task, the effects of SR seems 
to be more deleterious than the effects of Zolp. 
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3.4.1 Conclusões parciais – manuscrito 4 
 
A RS promoveu déficits de memória de curta e longa durações em duas 
tarefas de conteúdo não-aversivo: o reconhecimento de objetos e o 
reconhecimento social. A administração de Zolp, independentemente do 
protocolo, reverteu o prejuízo da memória de curta-duração induzido pela RS 
no reconhecimento de objetos. Por outro lado, a administração repetida desse 
hipnótico não foi suficiente para preservar a memória de longa-duração. Ainda, 
a retirada do tratamento por si só prejudicou o desempenho. 
No que diz respeito ao reconhecimento social, a RS promoveu amnésia, 
o que foi revertido apenas pela administração aguda de Zolp. Contudo, nesse 
paradigma, apenas a administração aguda da droga não prejudicou o 
desempenho na tarefa nos animais controle. 
Em conjunto com os resultados obtidos nos manuscritos anteriores, os 
efeitos do Zolp sobre os processos de formação da memória são criticamente 
dependentes da tarefa e do regime de administração empregados. Dessa 
forma, nossos resultados reforçam a importância de estudos futuros avaliando 
a interação com Zolp e diferentes períodos de restrição de sono RS que 
mimetizem as situações clínicas. 
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ABSTRACT 
 
Purpose: Zolpidem (Zolp) is a hypnotic drug prescribed to treat insomnia. 
Although polysomnographic findings after Zolp administration have already 
been described, they remain controversial. Additionally, no studies have 
characterized the effects of Zolp in animal models of sleep restriction (SR). 
Thus, the aim of this study was to investigate the effects of the repeated 
administration of Zolp on sleep parameters in mice submitted to SR. Design: 
Mice were subjected to control condition (CTRL) or to SR by gentle handling for 
3 h per day during 10 days. The sleep pattern of mice was recorded before 
treatment to evaluate baseline parameters. After it, mice were subjected to 
CTRL or SR and after it were treated with saline (Sal) or Zolp during 10 days, 
forming the groups: CTRL-Zolp, SR-Sal and SR-Zolp. The parameters 
considered were: total sleep time (TST), slow-wave sleep (SWS), paradoxical 
sleep (PS) and wake (W). Results: The SR protocol enhanced W time and 
decreased SWS, PS and TST. Zolp administration increased SWS in both 
CTRL and SR groups. In the SR-Zolp group, the compensatory sleep 
enhancement was observed in the light phase. Still, only in the SR-Zolp group, 
the modifications persisted during rebound compared to baseline. 
Conclusions: Zolp increased SWS in both sleep conditions, but in CTRL mice 
it seemed to be tolerated. Still, in SR-Sal the SWS (but not PS) enhancement 
was reduced throughout days. Importantly, SR-Zolp group did not completely 
recover the sleep parameters to baseline levels during rebound. 
 
Keywords: zolpidem, sleep restriction, sleep architecture 
Karina Agustini Zanin  Manuscrito 5 
 
 170 
INTRODUCTION 
 
Insomnia is the most prevalent sleep disturbance, affecting 10 to 25% of 
the general adult population in most countries (Léger et al., 2008; Morin et al., 
2006; Ohayon, 2002; Sivertsen et al., 2009; Soldatos et al., 2005). Occasional 
episodes of insomnia symptoms are reported by one half of all American adults 
while chronic insomnia is estimated to affect 10–14% of this population in the 
US (Léger et al., 2008; Roehrs and Roth, 2004). In Brazil, a national survey 
based on screening questions revealed that 35% of the interviewed people 
complained of insomnia symptoms with frequencies greater than 3 times per 
week (Bittencourt et al., 2009). Specifically, a recent survey in São Paulo using 
polysomnography demonstrated that the prevalence of objective insomnia was 
32% (Castro et al., 2013). This disorder negatively impacts physical and social 
performances becoming an important public health issue with remarkable socio-
economic implications. 
The current treatments for insomnia involve sleep hygiene measures, 
behavioral therapies and pharmacological treatments (Roth and Drake, 2004; 
Zammit, 2007). Concerning the pharmacological treatments, till the 80’s the 
most employed drugs to treat insomnia were the benzodiazepines. Although its 
efficacy in inducing sleep, these drugs promote several adverse effects such as 
persistent sedation, ataxia, amnesia and tolerance as well as a high abuse 
potential (Akhondzaded et al., 2002; Allison and Pratt, 2003). In order to prevent 
such effects, new selective drugs were developed. Thus, in 1992 zolpidem 
(Zolp) was introduced into clinical practice in the USA becoming the most 
commonly prescribed hypnotic (Rush, 1998). 
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In this way, Zolp is an imidazopyridine agent which selectively binds to 
the α1 subunit-containing GABAA receptor subtypes (Lloyd and Zivkovic 1988; 
Puia et al. 1991; Sancar et al. 1997; Sanger et al. 1994). Due to this given 
selectivity, Zolp has mainly hypnotic properties with weaker anticonvulsant and 
myorelaxant effects (Depoortere et al., 1986; Lloyd and Zivkovic 1988; Zivkovic 
et al., 1988). While Zolp seems to exhibit fewer deleterious psychomotor and 
cognitive effects, amnestic effects are still reported (Danjou et al. 1999; 
Dingemanse et al. 2000; Huang et al. 2010; Salvà and Costa, 1995; Zanin et 
al., 2011, 2013). Of note, concerning sleep pattern, Zolp seems to decrease 
sleep latency and increase total sleep time (American Sleep Disorders 
Association, 1990). Still, it may enhance slow wave sleep which is usually 
reduced in insomniac patients (Besset et al., 1995). On the other hand, studies 
report no effects of Zolp on REM sleep or in S2 sleep stage (Colle et al., 1991; 
Poyares et al., 2005). 
Although Zolp has proven to be safe and effective, some issues remain 
regarding its effects on sleep architecture, on tolerance development, and on 
possible rebound after the medication stops. From a clinical perspective, Zolp is 
usually prescribed as a repeated treatment for insomnia. However, as far as we 
know, no studies have systematically characterized the effects of Zolp on sleep 
pattern as repeated administration in animal models of sleep restriction (SR). 
Thus, the aim of this study was to evaluate the effects of the repeated 
administration of Zolp on sleep parameters of mice submitted to SR during 10 
consecutive days. 
Karina Agustini Zanin  Manuscrito 5 
 
 172 
MATERIAL AND METHODS 
 
Subjects 
Three-month-old Swiss male mice (outbred, raised, and maintained in 
the Centre for Development of Experimental Models in Medicine and Biology of 
Universidade Federal de Sao Paulo) were used. Animals weighing 35-40 g 
were housed under conditions of controlled temperature (22-23°C) and lighting 
(12h light, 12h dark; lights on at 7:00 a.m.). Food and water were available ad 
libitum throughout the experiments. Animals used in this study were maintained 
in accordance with the National Institute of Health Guide for the Care and Use 
of Laboratory Animals (NIH Publications Nº 8023, revised 2011) and with the 
Brazilian Law for Procedures for Animal Scientific Use (#11794/2008). The 
experimental procedures were approved by the Institutional Animal Care and 
Use Committee under the protocol #1741/10. 
 
Drugs 
Zolp (Sanofi-Aventis®), at the dose of 5 mg/kg, was diluted in saline 0.9% 
solution (Sal), which was also the control solution. The solutions were 
administered intraperitoneally in a volume of 10 ml/kg body weight. The dose of 
Zolp was chosen based on previous experiments of our group (Zanin et al., 
2013). 
 
Sleep Restriction (SR)  
Mice were submitted to SR through the gentle handling method, 
described elsewhere (Tobler et al., 1990). This method consists of keeping the 
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animal awake by tapping on the cage and, if necessary, by gently touching 
them with a soft brush if behavioral signs of sleep are observed. The animals 
were sleep deprived for 3 h (from 10 AM to 01 PM) during 10 consecutive days. 
This time interval was chosen because this is when paradoxical sleep reaches 
its highest expression and slow wave sleep homeostatic pressure is generated 
(Franken et al., 1991). 
 
Sleep pattern recording 
Mice were surgically prepared with electrodes for electrocorticographic 
and electromyographic recordings in order to assess sleep-wake cycles. 
Anesthesia was induced by i.p. administration of 0.1ml/10g ketamine-xylazine 
solution. Two pairs of electrodes (steel screws) were implanted above the dura 
mater of the parietal cortex (above the hippocampus) in both hemispheres in 
the fronto-parietal medial derivation (1 pair on each side of the skull) for 
electrocorticographic recording. The following coordinates were used for each 
screw relative to the bregma (antero-posterior and medio-lateral coordinates, 
respectively): screw 1: 0.5, 0.8 mm; screw 2: -1.2, 1.8 mm; screw 3: -0.5, -0.5 
mm; screw 4: -2.0, -2.0 mm. Bipolar derivations (screws 1 vs 2, and screws 3 vs 
4; ipsilateral derivations) were used to access and classify brain activity in both 
hemispheres (Queiroz et al., 2013). One additional pair of nickel-chrome 
electrodes was implanted in the dorsal muscle of the neck for 
electromyographic recording. The electrodes were soldered to a connector, 
which was fixed to the cranium with acrylic dental cement. After surgery, mice 
were given antibiotic (veterinary pentabiotic® 0.5 ml/kg, intramuscularly) and 
anti-inflammatory (diclofenac, 25 mg/ml, i.p.) for 3 days, and were allowed to 
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recover from surgery for 2 weeks. After recovery, mice were habituated to the 
sleep recording system during 3 days. 
After habituation, sleep recording was performed using the Somnologica 
software (EMBLA Medical digital polygraph, Reykjavik, Iceland). The sleep 
pattern was visually and manually scored in 10-second segments by a single 
blinded researcher to ensure consistency of the data. The following sleep 
parameters were considered: total sleep time in minutes (TST), percentage of 
slow-wave sleep time (time in slow wave sleep/TST – SWS), percentage of 
paradoxical sleep time (time in paradoxical sleep/TST – PS) and percentage of 
wake time (time awake/total recording time – W). SWS was classified as 
electrocortiographic voltage of 20–30 μV (usually 200–400 μV, peak to peak) 
and low frequency activity (delta waves, 1–4 Hz). Paradoxical sleep was 
classified as eletrocorticographic voltage below 20 μV with high and regular 
theta activity (6–10 Hz), especially in the fronto-parietal medial 
eletrocorticographic derivation, and muscle atonia in eletromiographic 
recording. The electrocorticographic and electromyographic signs were 
amplified and filtered by the system in 0,3-100 Hz and 30-300 Hz, respectively 
and the sampling frequency was fixed in 200 Hz. 
 
Experimental design 
Considering that the sleep record is performed in individual cages, 30 
days before the beginning of treatment, all of the animals were placed 
individually in homecage to habituate to isolation. After this period, mice were 
subjected to surgery and then were habituated to the recording system, as 
described before. 
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All of the animals had their sleep recorded during 48 h before treatment 
for acquisition of basal sleep. On the 3rd day after the beginning of recording, 
mice were subjected to control condition (CTRL) or sleep restricted during 3 h 
for 10 consecutive days (SR). After the sleep deprivation period mice were 
treated with saline (Sal) or Zolp forming the following groups: CTRL-Zolp (n=4), 
SR-Sal (n=4) and SR-Zolp (n=4), which continued to be recorded till the 
beginning of sleep deprivation on the next day. On the 4th day the animals were 
disconnected of the system before the sleep deprivation period. On the 12th day 
(the 10th treatment-day) mice were connected to the recording system before 
the sleep deprivation protocol. Again, the animals had their sleep pattern 
recorded during the last treatment-day and then for 48 h after the end of 
treatment to evaluate rebound. 
 
Statistical analysis 
The sleep parameters throughout the treatment were compared using 
ANOVA with repeated measures. ANOVA and Duncan’s test were used to 
analyze the parameters between groups and a paired-samples T test for intra-
group analysis specifically during the sleep deprivation period. A probability of 
p<0.05 was considered significant for all comparisons made. 
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RESULTS 
 
Considering that there were no significant differences among groups 
comparing the 1st and 2nd days of basal recording or rebound, we will show the 
results of the 24 h baseline record before the beginning of treatment and 24 h of 
rebound record after the end of treatment. 
Analyzing the sleep parameters during the period of sleep deprivation (10 
AM to 01 PM) in the 1st day, as expected, one-way ANOVA followed by 
Duncan’s test revealed that mice subjected to SR presented a decrease in the 
percent time in SWS [F(2,9)=345.37; p<0.001] and in PS [F(2,9)=24.09; 
p<0.001] when compared to CTRL group (Figures 1A and 1B, respectively). On 
the other hand, analyzing the percent time awake, one-way ANOVA and 
Duncan’s test showed an increase in this parameter [F(2,9)=407.80; p<0.001] in 
mice sleep-restricted compared to CTRL (Figure 1C). Still, analyzing TST 
animals subjected to SR presented a significant decrease compared to CTRL 
[F(2,9)=406.67; p<0.001] (Figure 1D). 
Similarly, in the last day of SR (10th day) there was a decrease in the 
SWS [F(2,9)=14.90; p=0.001] and PS [F(2,9)=7.58; p<0.05] (Figures 1A and 
1B, respectively). Still, there was an increase in W time [F(2,9)=14.22; p=0.002] 
in mice sleep deprived compared to CTRL group and consequently a decrease 
in TST [F(2,9)=84.44; p<0.001] (Figures 1C and 1D, respectively). Importantly, 
comparing the 1st to the 10th SR-day paired-samples T test did not show 
significant differences between days for all parameters analyzed (Figure 1), 
demonstrating no modifications in the magnitude of SR throughout time. 
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In order to evaluate the sleep pattern throughout the 10 SR-days in the 
light and dark phases we performed a repeated measures analysis from the 
beginning of baseline recording till the end of the 1st SR-day (1st period) and 
another analysis from the 10th SR-day till the end of rebound period (2nd period). 
The analysis was performed in an interval of every 3 h for all sleep parameters 
evaluated. 
Regarding W time in the 1st period, ANOVA with repeated measures 
revealed significant effects of time [F(15,135)=24.03; p<0.001] and time x group 
interaction [F(30,135)=7.17; p<0.001]. In this way, in the 2nd period there were 
significant effects of time [F(15,135)=17.95; p<0.001] and time x group 
interaction [F(30,135)= 2.95; p<0.001]. Paired-samples T test demonstrated that 
in animals subjected to CTRL condition Zolp induced a decrease in W time 
during the dark phase (07 to 10 PM and 04 to 07 AM intervals) when compared 
to the same period during baseline record [T(3)=3.25; p<0.05 and 7.21; 
p=0.005, respectively]. Conversely, there was an increase in W during the 
rebound when compared to the 1st SR-day (07 to 10 PM interval) [T(3)=5.57; 
p<0.05] and to the 10th SR-day from 4 to 7 PM in the light phase [T(3)=6.33; 
p=0.008] and in the intervals from 07 to 10 PM [T(3)=3.25; p<0.05] and 10 PM 
to 01 AM [T(3)=6.84; p=0.006] in the dark phase, suggesting recovery to 
baseline levels (Figure 2). 
Still analyzing the percent W, paired-samples T test showed that in mice 
only sleep-restricted (SR-Sal group), as expected there was an increase of this 
parameter in the interval from 10 AM to 01 PM in both the 1st and 10th days 
compared to baseline [T(3)=44.96; p<0.001 and 26.80; p<0.001, respectively], 
which decreased in relation to rebound [T(3)=10.37; p<0.05 and 8.87; p=0.003, 
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respectively]. Regarding de post-SR intervals, paired-samples T test revealed a 
reduction in W during the dark phase from 01 to 04 AM [T(3)=3.02; p<0.05] and 
from 04 to 07 AM [T(3)=3.81; p<0.05] in the 1st SR-day compared to same 
interval during baseline. Accordingly, there was also a decrease in this 
parameter from 10 PM to 01 AM in the 10th day compared to baseline. 
Comparing the SR days, there was an augment in W in the 10th day compared 
to the 1st day from 07 to 10 PM [T(3)=17.25; p<0.001]. In the rebound period, 
we observed an increase in W from 07 to 10 PM compared to the same interval 
in the 1st SR-day [T(3)=3,16; p<0,05] (Figure 2). 
Concerning sleep restricted mice treated with Zolp (SR-Zolp group), 
there was an increase in W from 10 AM to 01 PM in the 1st and 10th days 
compared to the same period in baseline [T(3)=9.81; p=0.002 and 7.57; 
p=0.005, respectively], which decrease compared to rebound [T(3)=8.33; 
p=0.004 and 9.63; p=0.002, respectively]. Conversely, in the SR-Zolp group the 
decrease in W occurred already in the light phase from 04 to 07 PM [T(3)=3,71; 
p<0,05] in the 1st SR-day compared to baseline. In the same way, W was also 
reduced in the dark phase from 10 PM to 01 AM comparing the 1st day to 
baseline [T(3)=21.17; p<0.001]. Still, in the 10th day animals presented a 
decrease in W compared to baseline in the dark phase from 10 PM to 01 AM 
[T(3)=3.64; p<0.05] and from 01 AM to 04 AM [T(3)=3.62; p<0.05]. On the other 
hand, there was an augment in W during rebound compared to 10th day from 04 
to 07 PM in the light phase [T(3)=5.07; p<0.05] and from 01 to 04 AM in the 
dark phase [T(3)=5.22; p<0.05]. However, unlike to what was observed for the 
other groups, during rebound a reduced W time was still observed from 10 PM 
to 01 AM compared to baseline [T(3)=3.42; p<0.05] (Figure 2). 
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Analyzing sleep, ANOVA with repeated measures revealed a significant 
time [F(15,135)=24.48; p<0.001] and time x group interaction [F(30,135)=7.08; 
p<0.001] for SWS in the 1st period. In the same way, in the 2nd period, there was 
a significant effect of time [F(15,135)=19.44; p<0.001] and time x group 
interaction [F(30,135)=3.21; p<0.001]. Regarding the CTRL-Zolp group, paired-
samples T test showed that there was an increase in SWS in the end of the light 
phase (from 04 to 07 PM) during the 1st day and in the dark phase (from 07 to 
10 PM and from 04 to 07 AM) during the 10th day compared to the same 
periods in baseline [T(3)=3.97; p<0.05; 3.27; p<0.05 and 3.96;p<0.05, 
respectively]. In the 10th day there was a decrease in SWS from 07 to 10 PM 
compared to the 1st day [T(3)=3.27; p<0.05], although being still higher than 
baseline. Still, there was a decrease in SWS during rebound compared to the 
1st day from 04 to 07 PM [T(3)=3.79; p<0.05] and from 07 to 10 PM [T(3)=6.45; 
p=0.008] as well as compared to the 10th day from 04 to 07 PM [T(3)=10.04; 
p=0.002] and from 10 PM to 01 AM [T(3)=3.91; p<0.05], showing the recovery 
to baseline levels (Figure 3). 
Regarding the SR-Sal group, paired-samples T test showed a significant 
decrease in SWS during the sleep deprivation periods (10 AM to 01 PM) in the 
1st and 10th days compared to baseline [T(3)=31.28; p<0.001 and 21.99; 
p<0.001, respectively]. Consequently, there was an increase in SWS in those 
periods during rebound [T(3)=8.86; p=0.003 and 7.59; p=0.005, respectively]. 
Concerning the post-SR intervals, paired-samples T test demonstrated an 
increase in SWS during the dark phase from 10 PM to 01 AM in the 10th day 
compared to baseline [T(3)=3.40; p<0.05]. Still, in the 10th day there was a 
decrease in SWS from 07 to 10 PM compared to the 1st day [T(3)=8.88; 
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p=0.003]. During rebound, there was a decrease in this parameter from 04 to 07 
PM compared to the same period in the 10th day [T(3)=4.10; p<0.05] (Figure 3). 
Analyzing the group sleep restricted and treated with Zolp (SR-Zolp), 
paired-samples T test revealed a decrease in SWS during SR periods in the 1st 
and 10th days compared to the same period in baseline [T(3)=10.80; p=0.002 
and 8.73; p=0.003, respectively], which in turn was enhanced during rebound 
[T(3)=7.78; p=0.004 and 8.90; p=0.003, respectively]. In the following periods, 
paired-samples T test showed an increase in SWS in the end of the light phase 
from 04 to 07 PM [T(3)=4.73; p<0.05] and from 10 PM to 01 AM [T(3)=15.29; 
p=0.001] during the 1st day compared to the same period in baseline. In the 
same way, there was an increase in this parameter in the dark phase from 01 to 
04 AM [T(3)=3.15; p<0.05] in the 10th day compared to baseline. Still, the SWS 
was decreased during rebound compared to 10th day from 04 to 07 PM 
[T(3)=3.75; p<0.05] and from 07 to 10 PM [T(3)=3.11; p<0.05]. Conversely, 
during rebound, it was still observed an increased SWS from 10 PM to 01 AM 
compared to baseline [T(3)=3,53; p<0,05] (Figure 3). 
Concerning PS during the 1st period, ANOVA with repeated measures 
showed a significant time [F(15,135)=7.44; p<0.001] and time x group 
interaction [F(30.135)=2,33; p<0.001]. Similarly, in the 2nd period there was a 
significant effect of time [F(15,135)=4.80; p<0.005] and time x group interaction 
[F(30,135)=1.83; p<0.05]. Analyzing the CTRL-Zolp group, paired-samples T 
test revealed a decrease in PS in the 1st and 10th days from 01 to 04 PM 
compared to the same period in baseline [T(3)=4.47; p<0.05 and 5.42; p<0.05, 
respectively]. Oppositely, in the end of the dark phase (from 04 to 07 AM) in the 
1st and 10th days there was an increase in PS compared to baseline [T(3)=3.21; 
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p<0.05 and 4.47; p<0.05, respectively]. Still, during the 10th day, there was an 
increase in PS from 04 to 07 PM compared to the 1st day [T(3)=3.79; p<0.05]. 
Regarding the rebound period, there was an increase in PS from 01 to 04 PM 
compared to the 1st and 10th days [T(3)=7.62; p<0.005 and 4.29; p<0.05] 
(Figure 4). 
In the SR-Sal group, paired-samples T test showed that, as expected, 
there was a decrease in PS during the SR periods (from 10 AM to 01 PM) in the 
1st and 10th days compared to baseline [T(3)=8.38; p<0.005 and 8.37; p<0.005, 
respectively], which was enhanced in rebound [T(3)=9.97; p=0.002 and 9.96; 
p=0.002, respectively]. Regarding the post-SR periods, paired-samples T test 
revealed an increase in PS in the 1st day during the dark phase from 01 to 04 
AM [T(3)=4.23; p<0.05] and in the 10th day from 10 PM to 01 AM [T(3)=3.30; 
p<0.05] and from 01 to 04 AM [T(3)=3.25; p<0.05] compared to the same 
intervals in baseline. Still, there was a decrease in this parameter during 
rebound compared to 10th day from 07 to 10 PM [T(3)=4.75; p<0.05], 10 PM to 
01 AM [T(3)=4.06; p<0.05] and 01 to 04 AM [T(3)=4.45; p<0.05] (Figure 4). 
Analyzing the SR-Zolp group, paired-samples T test showed, again, a 
decrease in PS from 10 AM to 01 PM during the SR period in the 1st and 10th 
days compared to baseline [T(3)=3.32; p<0.05 and 3.12; p<0.05, respectively] 
and a subsequent increase during rebound [T(3)=5.15; p<0.05 and 6.37; 
p=0.008, respectively]. During the following periods, paired-samples T test 
revealed and increase in PS from 10 PM to 01 AM [T(3)=6.28; p=0.008] in the 
1st day compared to baseline. Still, there was an increase in PS in the 10th day 
from 01 to 04 AM [T(3)=5.36; p<0.05] compared to baseline. Concerning the 
rebound period, there was a decrease in PS from 04 to 07 PM [T(3)=3.06; 
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p<0.05] compared to the 1st day and from 01 to 04 AM [T(3)=4.54; p<0.05] and 
04 to 07 AM [T(3)=7.37; p<0.005] compared to the 10th day. Conversely, during 
the rebound it was still observed an increase in PS from 07 to 10 AM compared 
to baseline [T(3)=3.31; p<0.05] (Figure 4). 
Finally, we analyzed the TST. Thus, ANOVA with repeated measures 
revealed significant effects of time [F(15,135)=15.16; p<0.001] and time x group 
interaction [F(30,135)=4.74; p<0.001] in the 1st period. In the same way, in the 
2nd period there was a significant effect of time [F(15,135)=16.71; p<0.001] and 
time x group interaction [F(30,135)=5.16; p<0.001]. Regarding the CTRL-Zolp 
group, paired-samples T test showed an increase in TST in the 10th day from 07 
to 10 PM [T(3)=3.26; p<0.05] and 04 to 07 AM [T(3)=7.18; p=0.006] compared 
to baseline. On the other hand, in the 10th day there was a decrease in TST 
from 07 to 10 PM compared to the 1st day [T(3)=2.99; p<0.05]. During the 
rebound period, there was a decrease in TST from 07 to 10 PM compared to 
the 1st and 10th days [T(3)=16.95; p<0.001 and 3.25; p<0.05, respectively] 
(Figure 5). 
In the SR-Sal group, paired-samples T test demonstrated that during the 
SR period there was a decrease in TST in the 1st and 10th days compared to 
baseline [T(3)=44.32; p<0.001 and 27.29; p<0.001, respectively] and that this 
parameter was increased in rebound [T(3)=10.42; p=0.002 and 9.10; p=0.003, 
respectively]. In the other intervals, paired-samples T test showed an increase 
in TST in the 1st day from 01 to 04 AM [T(3)=3.04; p<0.05] and in the 10th day 
from 10 PM to 01 AM [T(3)=3.57; p<0.05] compared to baseline. Nevertheless, 
in the 10th day there was a decrease in TST from 07 to 10 PM compared to the 
same period in the 1st day [T(3)=17.61; p<0.001]. Still, there was a decrease in 
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this parameter during rebound from 07 to 10 PM compared to the 1st day 
[T(3)=3.14; p<0.05] (Figure 5). 
Finally, in the SR-Zolp group, paired-samples T test showed the 
expected decrease in TST from 10 AM to 1 PM (SR period) in the 1st and 10th 
days compared to baseline [T(3)=9.79; p=0.002 and 7.88; p=0.004, 
respectively] and, then, an increase compared to rebound [T(3)=8.31; p<0.05 
and 9.88; p=0.002, respectively]. Analyzing the post-SR intervals, paired-
samples T test revealed an increase in TST from 10 PM to 01 AM in the 1st day 
compared to baseline [T(3)=21.97; p<0.001]. Still, there was an increase in this 
parameter from 10 PM to 01 AM [T(3)= 3,63; p<0,05] and from 01 to 04 AM 
[T(3)=3,62; p<0,05] in the 10th day compared to baseline. Conversely, the TST 
in the 10th day was higher than in the 1st day from 04 to 07 PM [T(3)=3.61; 
p<0.05]. In the rebound period, there was a decrease in this parameter 
compared to the 10th day from 04 to 07 PM [T(3)=5.11; p<0.05] and from 01 to 
04 AM [T(3)=5.21; p<0.05]. However, during the rebound, there was still an 
increase in TST from 10 PM to 01 AM compared to baseline [T(3)=3.43; p<0.05] 
(Figure 5). 
Karina Agustini Zanin  Manuscrito 5 
 
 184 
 
 
Figure 1: Electrophysiological recording of sleep parameters during the sleep 
restriction (SR) period in the 1st and 10th days. Results are presented as mean ± SE of 
percent time spent awake (A), percent time in slow wave sleep (B), percent time in 
paradoxical sleep (C) and total sleep time (D). At the end of sleep deprivation mice 
were treated with saline (Sal) or 5 mg/kg zolpidem (Zolp). □ p<0.05 compared to CTRL-
Zolp group in the 1st day; ■ p<0.05 compared to CTRL-Zolp group in the 10th day 
(ANOVA and Duncan’s test). 
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DISCUSSION 
 
In the present study, we showed that the chosen SR regimen was 
effective in enhancing wake time and as a consequence decreasing SWS, PS 
and TST. Of note, SR induced an increase in SWS, PS and TST in the dark 
phase, suggesting a compensatory effect. However, those alterations are 
tolerated throughout treatment, in exception of PS (still augmented in the last 
day). Regarding Zolp treatment, it induced an increase in SWS and reduced PS 
during the light phase in control animals. These modifications seem to be 
compensated in the dark phase as well as to be tolerated during treatment. 
Concerning the interaction between SR and Zolp, such compensatory increase 
in sleep parameters was already observed in the light phase and remained 
elevated during the role treatment. Curiously, only in the group SR-Zolp we still 
observed modifications on sleep pattern during rebound. 
People in modern society sleep less than recommended for vocational or 
lifestyle reasons or sleep disturbances. Notably, significant impairments in 
cardiovascular, immune, endocrine, and cognitive functions have been reported 
in humans who sleep less than recommended (Banks and Dinges). Although 
animal models of SR have been recently developed (Everson and Szabo, 2009; 
Kim et al., 2007, 2012; Leemburg et al., 2010; McCoy et al., 2013; Zielinski et 
al., 2013; Yang et al., 2012), experimental research with models of SR are less 
used compared to the considerable amount of work evaluating the 
neurobehavioral effects of total sleep deprivation or selective PS deprivation. 
Thus, it remains unclear whether similar effects might be observed after SR, 
which is more common in humans representing a better translational model. 
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Herein, we specifically evaluated the effects of a SR protocol on sleep pattern. 
In addition, considering the increasing prescription of Zolp in the treatment of 
sleep disturbs (Rush, 1998), its interaction with SR was also analyzed. 
Ideally, an insomnia animal model should exhibit decreased sleep quality 
or quantity during the period that the animal is supposed to be physiologically 
sleeping. Thus, there are potential models such as: electrical stimulation, drug-
induced methods and those related to the interruption of sleep as the single or 
multiple water platform techniques and forced locomotion (Revel et al., 2009). 
However, these sleep deprivation methods may cause excessive stress or 
result in incomplete sleep loss, having unfavorable effects on experimental 
results. Considering this, we employed the gentle handling method, which 
seems to be less stressful, to keep mice awake for 3 h per day during 10 
consecutive days. Through EEG monitoring, the animals had almost no SWS or 
PS and a consequent increase in wake time during the 3-h sleep deprivation 
period, showing the effectiveness of the method. Importantly, in the 10th day this 
increased wake time followed by a decreased sleep time was still observed. 
Analyzing the intervals after the SR period, there was a decrease in wake 
time in the dark phase both in the 1st and 10th days. Furthermore, SWS was 
augmented in the last day. On the other hand, comparing the 1st and the 10th 
days, in the last day there was an increase in wake and a decrease in SWS, 
suggesting an adaptation to the effects of SR. The TST followed the same 
pattern of SWS. Concerning PS, we observed an increase in both the 1st and 
last days in the dark phase compared to baseline, characterizing the sleep 
rebound, a common outcome after sleep deprivation regulated by homeostatic 
process (Franken et al., 1991; Friedman et al., 1979; Machado et al., 2004, 
Karina Agustini Zanin  Manuscrito 5 
 
 191 
2005). Oppositely to which was observed for SWS, the modification in PS was 
not compensated throughout days, which may explain the negative effects after 
SR. Regarding the acute effects of sleep deprivation (after the 1st day), there 
was an increase only in PS and a minor modification in SWS. This result is in 
line with previous work reporting a slight enhancement of sleep concomitant 
with a reduction in waking induced by 3-h sleep deprivation (Tobler et al., 1990). 
Recently, Yang and colleagues (2012) evaluated the EEG of rats 
subjected to 4-h daily sleep deprivation during 7 consecutive days using the 
gentle handling method. The authors reported both SWS and PS increment 
even in the last days of SR while we observed a possible adaptation to the 
effects of SR instead. This discrepancy may be due to the different SR periods 
(7 vs. 10 days) and the animal model (rats vs. mice). Nevertheless, it was 
reported that acute sleep deprivation enhances SWS, although this 
enhancement is reduced after daily SR (Deurveilher et al., 2012; Kim et al., 
2007, 2012; Zielinski et al., 2013). As suggested by other authors, we 
acknowledge that unlike the homeostatic response to acute sleep loss, SR 
induces an allostatic response (Kim et al., 2007, 2012). Specifically, after SR it 
may occur 2 physiological responses – homeostatic and allostatic. The 1st one 
maintains equilibrium by compensation to disrupt changes, while the allostatic 
response maintains stability through change (McEwen and Wingfield, 2003). 
Concerning the effects of Zolp treatment, it induced a decrease in wake 
which was accompanied by an increase in all sleep parameters in the dark 
phase. Oppositely, although there was an increase in SWS in the light phase, 
we also observed a decrease in PS in the 1st day. Curiously, this increase in 
SWS remained till the last day followed by an increase in PS. These results 
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corroborate clinical findings in which Zolp was able to enhance SWS (Besset et 
al., 1995; Bettica et al., 2012). Probably, this increased time in SWS was 
responsible for the decrease in PS in the light phase. Likewise, the later 
increase in PS in the dark phase could be a compensation to its reduction 
during the light phase. Additionally, although still higher then baseline, in the 
10th day there was a decrease in SWS in relation to the 1st day, suggesting a 
tolerance to Zolp effects on sleep architecture.  
These results corroborate previous studies showing that Zolp has 
hypnotic effects increasing SWS sleep at the cost of waking and PS, but 
generally produces a milder suppressing effect on PS (Bettica et al., 2012; 
Chen et al., 2005; Depoortere et al., 1991; Fitzgerald et al., 2014; Mailliet et al., 
2001; Renger et al., 2004). The effects of Zolp on PS are controversial. Some 
reports suggest that Zolp did not alter REM sleep in humans (Colle et al., 1991; 
Poyares et al., 2005) while others describe a decrease in PS but of less 
magnitude compared to benzodiazepines (Feinberg et al., 2000) or even a 
significant reduction in this sleep stage (Bettica et al., 2012; Brunner et al., 
1991). Regarding laboratory animals, some authors reported that Zolp 
administration may decrease PS in rats (Fanselow and Bolles, 1979; Kopp et 
al., 2004; Renger et al., 2004) or even did not modify it in guinea pigs (Xi and 
Chase, 2008, 2009). 
Few studies have examined the effects of Zolp on sleep architecture over 
extended administration schedules. Corroborating our data, Alexandre and 
colleagues (2008) showed that 5 mg/kg Zolp throughout 10 days increased 
SWS time and decreased PS time with no evidence of tolerance. Notably, this 
study reported that the values returned to baseline during withdrawal. Similarly, 
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Renger and colleagues (2004) demonstrated the same pattern of modifications 
after daily administration of at 10 mg/kg Zolp. In this case, the absence of a 
possible tolerating effect could be due to the duration of treatment (7 vs. 10 
days). Indeed, when daily administered during 3 weeks Zolp increased SWS in 
the 1st week returning to baseline level in the following weeks (Ebert et al. 
2008), suggesting that tolerance to the sleep-inducing effects of Zolp would 
develop with longer treatments. Of note, studies showed that tolerance to the 
sedative effects of Zolp may be developed after long periods in baboons 
(Griffiths et al., 1992) and humans (Ware et al., 1997). Importantly, all these 
alterations were completely abolished during recovery in the present study, 
while others (Renger et al., 2004) reported rebound effects after the repeated 
administration of Zolp. This discrepancy could be due to the employed doses 
(10 vs. 5 mg/kg). 
Considering that Zolp is usually prescribed to insomniac patients, the 
evaluation of its effects after SR is important. Thus, oppositely to which was 
observed in the SR-Sal group, in the SR-Zolp group the decrease in wake 
occurred already in the light phase in the 1st day as well as in the dark phase 
both in the 1st and last treatment days. Concerning sleep, there was an increase 
in SWS in both cycle periods, similarly to the effects found in the CTRL-Zolp 
group. However, in the SR-Zolp group this effect persisted throughout treatment 
since there was no difference in the 10th day compared to the 1st. Analyzing PS, 
unlike the CTRL-Zolp group, Zolp administration after SR induced an increase 
in PS in the dark phase in both recording days. Thus, it could be suggested that 
such increase in PS would be due to sleep deprivation and not a Zolp effect per 
se. Regarding TST, as a consequence of the reduction in wake, there was an 
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increase of this parameter in the dark phase. However, differently from the 
control group, which tolerated Zolp effects, in the SR-Zolp group this 
enhancement was higher in the 10th day compared to the 1st one, suggesting 
that in sleep-restricted animals Zolp effects may be sensitized. To the best of 
our knowledge, this is the 1st study evaluating the effects of Zolp under 
conditions of SR. Thus, from a clinical perspective, our results suggest that Zolp 
may have interesting effects for insomniac patients once it sleep-inducing 
effects were not tolerated in sleep-restricted mice. However, under conditions of 
normal sleep, Zolp should be taken with cautions. Importantly, in exception of 
SR-Zolp group, after the end of treatment all of the animals recovered sleep to 
baseline levels. Although this group presented an increase in wake and a 
decrease in sleep parameters during rebound compared to the last treatment 
day, it was not sufficient to reach baseline. 
Studies in our laboratory found that the interaction between SR and Zolp 
can positively or negatively modulate memory of a discriminative avoidance 
task (Zanin et al., submitted data). Specifically, SR induced cognitive 
impairments that were abolished by the acute administration of Zolp. On the 
other hand, when administered to control animals, Zolp induced memory 
impairments. In this respect, we could hypothesize that the unbalance between 
SWS and PS induced by Zolp in control mice observed herein may have 
impaired the task performance. In the same way, the modifications in PS found 
after SR, which were not tolerated over time, could explain the negative effects 
of SR on memory. Notably, several studies reported the important role of PS on 
mnemonic processes both in humans (Plihal and Born, 1999; Stickgold et al., 
2000) and laboratory animals (Guan et al., 2004; Silvestri, 2005; Yang et al., 
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2008). The curious positive effect of Zolp on memory of sleep-restricted mice 
could also be explained by the present findings. In this way, the SR-Zolp group 
displayed an anticipation of rebound after SR period, i.e., differently to which 
was observed in the SR-Sal group, the augment in SWS as well as in PS 
occurred still in the light phase and remained in the same magnitude over 
treatment, which could have contributed to a better sleep homeostasis. 
The balance between SWS and PS seems to be crucial to memory 
processes. Although PS has been largely related to memory encoding, SWS 
sleep also plays a critical role in memory processing. Thus, the functional 
significance of SWS and the value of SWS-enhancing agents remain of interest 
(Dijik, 2009, 2010; Dijik et al., 2010; Maquet, 2010; Walsh, 2009). It was shown 
that the administration of gabaxadol, a GABAA receptor agonist, protected the 
body from the prejudicial effects of SR and that this protection would be related 
to changes in SWS (Walsh et al., 2008). Still, the enhancement of low-
frequency EEG by electric stimulation increased memory consolidation 
(Marshall et al., 2006). Indeed, as reviewed by Walker (2009), SWS may be 
important for memory processing by preparing the brain for initial encoding 
before learning and facilitating the off-line memory consolidation after learning. 
Collectively, the present study showed that the employed SR protocol 
adequately induced an increase in wake during sleep deprivation period, which 
was followed by a compensatory increase in sleep. Still, the enhancement in PS 
(but not in SWS) was not tolerated throughout days. In addition, although Zolp 
increased SWS in both conditions, in CTRL mice it seemed to be tolerated. 
Thus, we could hypothesize that the modifications in PS after SR contributed to 
its impairing effects, while the Zolp administration would facilitate the sleep 
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homeostasis mainly through its effects on SWS, counteracting the effects of SR. 
Finally, our results strengthened the importance of an adequate sleep balance 
as well as the need for further studies evaluating the effects of Zolp under 
conditions of reduced sleep. 
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3.5.1 Conclusões parciais – manuscrito 5 
 
No 5º manuscrito da presente Tese, demonstramos que o protocolo de 
RS empregado se mostrou efetivo em aumentar a vigília e, consequentemente, 
reduzir significativamente o sono de ondas lentas (SOL), o sono paradoxal e o 
tempo total de sono (TTS). 
 A administração de Zolp aumentou o SOL e diminuiu o sono paradoxal 
durante a fase clara nos animais controle, sendo que essa diminuição parece 
ser compensada durante a fase escura do ciclo e, ainda, todas as alterações 
tendem a ser toleradas ao longo do tratamento. Com relação aos efeitos 
observados após a restrição de sono por 3 h durante 10 dias, ocorreu um 
aumento compensatório no SOL, no sono paradoxal e no TTS na fase escura 
do ciclo. Ainda, ao longo do procedimento, exceto para o sono paradoxal que 
se manteve elevado até o 10º dia de privação de sono, parece haver uma 
adaptação do organismo às alterações induzidas pela RS. 
Nos animais submetidos à RS e tratados com zolpidem o aumento 
compensatório em todos os parâmetros de sono ocorreu ainda na fase clara e 
se manteve elevado durante todo o experimento. De importância, ao contrário 
do observado nos demais grupos, os animais do grupo restrito de sono e 
tratado com Zolp ainda apresentavam alterações no padrão de sono durante o 
rebote quando comparado ao registro basal. 
Em conjunto com os dados comportamentais, poderíamos sugerir que as 
modificações no sono paradoxal observadas após a restrição de sono teriam 
contribuído para os prejuízos induzidos pela diminuição do sono per se. Por 
outro lado, a antecipação do aumento compensatório de sono induzido pelo 
Zolp poderia explicar, ao menos em parte, a reversão dos déficits de memória 
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induzidos pela RS. Assim, esse hipnótico poderia ter facilitado a homeostase 
do sono, principalmente com relação ao SOL. Finalmente, nossos resultados 
demonstram a importância de um balanço adequado das fases do sono bem 
como sugerem que o Zolp pode apresentar efeitos positivos em condições 
semelhantes à insônia. 
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4. CONCLUSÕES 
 
4.1 Conclusões específicas 
 
Avaliar os efeitos da privação de sono total por 3 ou 6 h agudamente ou 
durante 10 dias consecutivos na tarefa de esquiva discriminativa em labirinto 
em cruz elevado e a posterior expressão de c-Fos 
A privação de sono total aguda por 3 h promoveu uma diminuição nos 
níveis de ansiedade e um aumento da atividade locomotora. Esses efeitos 
foram abolidos quando a privação foi estendida para 6 h. Por outro lado, 
apenas a privação de sono total aguda por 6 h induziu déficits de memória. Já 
a privação de sono total repetida por 10 dias, independentemente de sua 
duração (3 ou 6 h), não promoveu modificações no aprendizado da tarefa 
discriminativa, nos níveis de ansiedade ou na atividade locomotora dos 
animais. Ainda, enquanto a privação aguda por 3 h promoveu efeito ansiolítico 
e hiperlocomotor, quando realizado repetidamente, esses efeitos não foram 
observados, sugerindo que houve tolerância comportamental. Ao contrário, 
após a repetição do protocolo, a privação por 3 h induziu déficits de memória, 
sugerindo uma sensibilização. Com relação ao período de 6 h, com a repetição 
da privação, o prejuízo cognitivo induzido pela privação aguda foi abolido. Os 
protocolos de privação de sono induziram um aumento da expressão de c-fos 
na amígdala basolateral e no giro denteado. Este último parece estar 
relacionado aos efeitos cognitivos da restrição de sono. 
Em conjunto, nossos resultados sugerem que parece haver tolerância às 
alterações comportamentais promovidas pela privação de sono total aguda por 
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3 h (efeitos ansiolítico e hiperlocomotor) e ao efeito cognitivo deletério induzido 
pela privação de sono total aguda por 6 h (déficit de memória) e sensibilização 
do efeito cognitivo deletério quando a privação de sono total por 3 h é realizada 
de forma repetida. Ainda, esses dados sugerem que a privação de sono total 
desencadeia fenômenos plásticos de adaptação no sistema nervoso central. 
 
Avaliar os efeitos da administração repetida de zolpidem (ou de sua retirada 
abrupta) sobre o aprendizado, consolidação e evocação da tarefa de esquiva 
discriminativa em labirinto em cruz elevado em animais restritos de sono 3 h 
por dia durante 10 dias 
A administração aguda pré-treino de zolpidem, bem como a 
administração repetida, promoveu amnesia nos animais controle. 
Curiosamente, nos animais restritos de sono, tanto a administração aguda de 
zolpidem como a sua retirada abrupta foram capazes de reverter o prejuízo 
cognitivo induzido pelo protocolo de restrição de sono de 3 h por dia durante 10 
dias. Com relação à consolidação, não houve efeitos do protocolo de restrição 
de sono ou de sua interação com o tratamento com zolpidem quando aplicados 
imediatamente após o treino. Contudo, quando o zolpidem foi administrado 
imediatamente (mas não 2 h) após o treino em animais que foram restritos de 
sono durante os 10 dias anteriores ao treino, o efeito deletério da restrição de 
sono foi abolido. Curiosamente, ao avaliar a evocação, apenas o tratamento 
repetido com zolpidem reverteu os prejuízos da restrição de sono. De 
importância, a administração do β-cct (antagonista seletivo α1) impediu o efeito 
benéfico da administração aguda de zolpidem em animais restritos de sono, 
mas não foi capaz de mimetizar o efeito da retirada abrupta. Esses resultados 
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sugerem que o efeito agudo do zolpidem pode ser mediado por receptores 
GABAérgicos, enquanto que os efeitos do tratamento repetido não parecem 
estar relacionados exclusivamente a esse sistema de neurotransmissão. 
Dessa forma, nossos resultados sugerem que a interação entre a 
restrição de sono e o zolpidem pode modular a memória de maneira positiva ou 
negativa, dependendo da fase analisada. Esse efeito positivo do zolpidem 
poderia estar relacionado especificamente ao processo de consolidação, visto 
que mesmo quando administrado antes do treino a droga estaria presente no 
início da consolidação. Ainda, o efeito agudo dessa droga, mas não de sua 
retirada, pode ser explicado pela ativação GABAérgica, uma vez que o β-cct 
reverteu o efeito benéfico do zolpidem. Esses resultados fortalecem a 
importância de estudos futuros analisando a interação entre períodos de 
restrição de sono e o zolpidem sobre a memória, particularmente no que diz 
respeito à consolidação. 
 
Avaliar os efeitos da administração repetida de zolpidem (ou de sua retirada 
abrupta) sobre o aprendizado, consolidação e evocação da tarefa de esquiva 
passiva em animais restritos de sono 3 h por dia durante 10 dias 
Os resultados demonstram que, ao contrário do observado na esquiva 
discriminativa, no modelo da esquiva passiva, a restrição de sono per se não 
foi capaz de promover déficits de retenção quando realizada antes do treino ou 
do teste. Nos animais controle, assim como havíamos observado na esquiva 
discriminativa, a injeção desafio pré-treino de zolpidem promoveu déficits de 
retenção. Contudo, a injeção aguda de dessa droga também promoveu déficits 
de memória nos animais restritos de sono, diferentemente do observado para 
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esquiva discriminativa. Ainda, novamente nem a restrição de sono, o zolpidem 
ou suas interações foram capazes de promover déficits de consolidação 
quando o tratamento foi realizado imediatamente após o treino. Com relação ao 
tratamento pré-teste, não foram observadas modificações na evocação da 
tarefa. Essas diferenças observadas podem ter sido ocasionadas por: (1) 
diferenças qualitativas dos modelos, já que a esquiva passiva poderia ser mais 
estressante por utilizar um estímulo doloroso, de modo que a restrição de sono 
não prejudicou a retenção da tarefa ou (2) influência da hipolocomoção 
induzida pelo zolpidem administrado anteriormente ao treino ou ao teste. 
Em conjunto com os experimentos anteriores, demonstramos que além 
da interação entre restrição de sono e o tratamento com zolpidem modular a 
memória de forma negativa ou positiva dependendo da fase da memória 
analisada, também pode apresentar diferenças dependendo do modelo de 
memória utilizado. Nesse sentido, no modelo da esquiva passiva as 
modificações cognitivas podem ser discrepantes se comparadas aos resultados 
obtidos na esquiva discriminativa. Nesse contexto, nossos resultados 
demonstram que a esquiva passiva, apesar de ser um modelo clássico para 
avaliação da memória, é fortemente influenciada pela atividade locomotora. 
 
Avaliar os efeitos da administração repetida de zolpidem (ou de sua retirada 
abrupta) sobre o aprendizado/consolidação das tarefas de reconhecimento de 
objetos ou social em animais restritos de sono 3 h por dia durante 10 dias 
A restrição de sono promoveu déficits de memória de curta e longa 
duração no modelo de reconhecimento de objetos, bem como no modelo de 
reconhecimento social. Curiosamente, independente do protocolo de 
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administração, o zolpidem reverteu o déficit de memória de curta duração na 
tarefa de reconhecimento de objetos, enquanto que apenas a administração 
aguda dessa droga aboliu o prejuízo observado na tarefa de reconhecimento 
social. Contudo, apesar de ter revertido o prejuízo na memória de curta 
duração, o tratamento repetido com zolpidem não foi capaz de preservar a 
memória de longa duração. 
 
Avaliar os efeitos do tratamento repetido com zolpidem no padrão de sono de 
camundongos restritos ou não de sono 3 h por dia durante 10 dias por meio de 
registro eletroencefalográfico 
O protocolo de restrição de sono se mostrou efetivo em aumentar a 
vigília e, consequentemente, reduzir significativamente o sono de ondas lentas 
(SOL), o sono paradoxal e o tempo total de sono (TTS). Ainda, a administração 
de zolpidem aumentou o SOL e diminuiu o sono paradoxal durante a fase clara 
nos animais controle, sendo que essa diminuição parece ser compensada 
durante a fase escura do ciclo. Ainda, essas alterações tendem a ser toleradas 
ao longo do tratamento. Com relação aos efeitos observados após a restrição 
de sono, ocorreu um aumento compensatório no SOL, no sono paradoxal e no 
TTS na fase escura do ciclo. Ao longo do procedimento, parece haver uma 
adaptação do organismo às alterações induzidas pela restrição de sono, exceto 
para o sono paradoxal que se manteve elevado durante todo tratamento. Nos 
animais restritos de sono e tratados com zolpidem, o aumento compensatório 
em todos os parâmetros de sono ocorreu ainda na fase clara e se manteve 
elevado durante todo o experimento. De importância, apenas esse grupo de 
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animais ainda apresentava alterações no padrão de sono durante o rebote 
quando comparado ao registro basal. 
Em conjunto com os dados comportamentais, poderíamos sugerir que as 
modificações no sono paradoxal observadas após a restrição de sono teriam 
contribuído para os prejuízos induzidos pela diminuição do sono. Por outro 
lado, a administração de zolpidem pode ter facilitado a homeostase do sono, 
principalmente com relação ao SOL, impedindo os prejuízos da restrição de 
sono. Finalmente, nossos resultados demonstram a importância de um balanço 
adequado das fases do sono bem como sugerem que o zolpidem pode 
apresentar efeitos positivos em condições semelhantes à insônia. 
 
4.2 Conclusão geral 
 
Considerando a crescente utilização do zolpidem no tratamento da 
insônia, as evidências prévias observadas por nosso grupo de pesquisa que 
sugerem alterações cognitivas induzidas pela administração aguda dessa 
droga, e a falta de estudos que abordem sistematicamente os efeitos do 
tratamento repetido com zolpidem sobre os processos mnemônicos, a presente 
tese tem por objetivo analisar os efeitos do tratamento repetido com zolpidem 
ou de sua retirada abrupta sobre as diversas fases da formação da memória 
por meio dos modelos de esquiva discriminativa em labirinto em cruz elevado, 
esquiva inibitória, reconhecimento de objetos e reconhecimento social. Ainda, 
visto que clinicamente o tratamento com zolpidem é iniciado após períodos 
variáveis de privação de sono, compararemos os resultados obtidos em 
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camundongos mantidos em condições controle de sono ou submetidos à 
restrição de sono 
O protocolo de restrição de sono de 3 h por dia durante 10 dias 
promoveu prejuízos de memória nas tarefas de esquiva discriminativa, 
reconhecimento de objetos e reconhecimento social. Por outro lado, em uma 
tarefa com grande conteúdo emocional aversivo (esquiva passiva), esses 
déficits não foram observados. Curiosamente, os resultados da presente Tese 
demonstram que a administração de zolpidem pode modular de maneira 
positiva a memória em animais restritos de sono, uma vez que reverteu a 
amnésia induzida pelo encurtamento do período de sono. Contudo, esse efeito 
benéfico é influenciado tanto pelo regime de administração da droga quanto 
pela tarefa de memória empregada. Ainda, a administração de zolpidem ou a 
restrição de sono separadamente alteraram a arquitetura do sono, mas esse 
efeito parece ser tolerado ao longo do tratamento. Por outro lado, quando 
somados, o zolpidem pode ter facilitado a homeostase do sono nos animais 
restritos, principalmente com relação ao sono de ondas lentas. Essa facilitação 
do processo de homeostase poderia justificar, ao menos parcialmente, a 
reversão dos efeitos negativos da restrição de sono após a administração de 
zolpidem. 
Os achados da presente Tese demonstram a importância da validação 
de modelos experimentais de insônia bem como a avaliação dos efeitos do 
tratamento com zolpidem em condições de restrição sono, uma vez que os 
efeitos dessa droga podem ser discrepantes dependendo das condições de 
sono e do método de avaliação. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referências Bibliográficas 
 
Karina Agustini Zanin  Referências Bibliográficas 
 
213 
 
5. REFERÊNCIAS BIBLIOGRÁFICAS 
 
AKHONDZADEH, S.; MOHAMMADI, M.R.; KASHANI, L. Potentiation of 
muscimol-induced long-term depression by benzodiazepines but not 
zolpidem. Prog. Neuropsychopharmacol. Biol. Psychiatry. v.26, p.1161-1166, 
2002. 
ALLISON, C.; PRATT, J.A. Neuroadaptive process in GABAergic and 
glutamatergic systems in benzodiazepine dependence. Pharmacol. Ther. 
v.98, p.171-195, 2003. 
ALVARENGA, T.A.; PATTI, C.L.; ANDERSEN, M.L.; SILVA, R.H.; 
CALZAVARA, M.B.; LOPEZ, G.B.; FRUSSA-FILHO, R.; TUFIK, S. 
Paradoxical sleep deprivation impairs acquisition, consolidation, and retrieval 
of a discriminative avoidance task in rats. Neurobiol. Learn. Mem. v.90, 
p.624-632, 2008. 
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual 
of Mental Disorders. 5th ed. Washington (DC): American Psychiatric 
Association; 2013. 
AMERICAN SLEEP DISORDERS ASSOCIATION. Diagnostic Classification 
Steering Committee of the American Sleep Disorders Association. 
International classification of sleep disorders – diagnostic and coding manual. 
Rochester (MN): American Sleep Disorders Association; 1990. 
ANOKHIN, U.S.; LYNCH, G.; GALL, C.M. Regional patterns of c-fos mRNA 
expression in rat hippocampus following exploration of a novel environment 
versus performance of a well-learned discrimination. J. Neurosci. v.15, 
p.7796-7809, 1995. 
ARRIAGA, F.; DUGOVIC, C.; WAUQUIER, A. Effects of lithium on dopamine 
behavioural supersensitivity induced by rapid eye movement sleep 
deprivation. Neuropsychobiol. v.20, p.23-27, 1988. 
ASERINSKY, E.; KLEITMAN, N. Regularly occurring periods of eye motility, and 
concomitant phenomena, during sleep. J. Neuropsychiatry Clin. Neurosci. 
v.15, p.454-455, 2003. 
ASTON-JONES, G.; HARRIS, G.C. Brain substrates for increased drug seeking 
during protracted withdrawal. Neuropharmacology. v.47, p 67-79, 2004. 
BANKS, S.; DINGES, D.F. Behavioral and physiological consequences of sleep 
restriction. J. Clin. Sleep Med. v.3, p.519-528, 2007. 
BARATTI, C.M.; HUYGENS, P.; MINO, J.; MERLO, A.; GARDELLA, J. Memory 
facilitation with post-trial injection of oxotremonine and physostigmine in 
mice. Psycopharmacol. v.64, p.85-88, 1979. 
BASHEER, R.; SHERIN, J.E.; SAPER, C.B.; MORGAN, J.I.; MCCARLEY, 
R.W.; SHIROMANI, P.J. Effects of sleep on wake-induced c-fos expression. 
J. Neurosci. v.17, p.9746-9750, 1997. 
Karina Agustini Zanin  Referências Bibliográficas 
 
214 
 
BATTIG, K. The effect of pre- and post-trial application of nicotine on the 12 
problems of Hebb-Willians. Test in the rat. Psycopharmacol. v.18, p.68-76, 
1970. 
BELENKY, G.; WESENSTEN, N.J.; THORNE, D.R.; THOMAS, M.L.; SING, 
H.C.; REDMOND, D.P.; RUSSO, M.B.; BALKIN, T.J. Patterns of 
performance degradation and restoration during sleep restriction and 
subsequent recovery: a sleep dose-response study. J. Sleep Res. v.12, p.1-
12, 2003. 
BESNARD, F.; AVENET, P.; ITIER, V.; GRANGER, P.; PARTISÉTI, M.; 
DEPOORTERE, H.; GRAHAM, D.; LANGER, S.Z. GABAA receptor subtypes 
and the mechanism of action of zolpidem. In: FREEMAN, H.; PUECH, A.J.; 
ROTH, T. (Eds.). Zolpidem: An Update of its Pharmacological Properties and 
Therapeutic Place in the Management of Insomnia. Paris: Elsevier, 1996. p. 
21-31. 
BESSET, A.; TAFTI, M.; VILLEMIN, E.; BORDERIES, P.; BILLIARD, M. Effects 
of zolpidem on the architecture and cyclical structure of sleep in poor 
sleepers. Drugs Exp. Clin. Res. v.21, p.161-169, 1995. 
BILLIARD, M.; BENTLEY, A. Is insomnia best categorized as a symptom or a 
disease? Sleep Med. v.5, p.35-40, 2004. 
BITTENCOURT, L.R.; SANTOS-SILVA, R.; TADDEI, J.A.; ANDERSEN, M.L.; 
DE MELLO, M.T.; TUFIK, S. Sleep complaints in the adult Brazilian 
population: a national survey based on screening questions. J. Clin. Sleep 
Med. v.5, p.459-463, 2009. 
BONTEMPI, B.; LAURENT-DEMIR, C.; DESTRADE, C.; JAFFARD, R. Time-
dependent reorganization of brain circuitry underlying long-term memory 
storage. Nature. v.400, p.671-675, 1999. 
BUENO, O.F.; LOBO, L.L.; OLIVEIRA, M.G.; GUGLIANO, E.B.; POMARICO, 
A.C.; TUFIK, S. Dissociated paradoxical sleep deprivation effects on 
inhibitory avoidance and conditioned fear. Physiol. Behav. v.56, p.775-779, 
1994. 
CAHILL, L.; McGAUGH, J.L. Amygdaloid complex lesions differentially affect 
retention of tasks using appetitive and aversive reinforcement. Behav. 
Neurosci. v.104, p.532-543, 1990. 
CAMMAROTA, M.; BEVILAQUA, L.R.; ARDENGHI, P.; PARATCHA, G.; LEVI 
DE STEIN, M.; IZQUIERDO, I.; MEDINA, J.H. Learning-associated activation 
of nuclear MAPK, CREB and Elk-1, along with Fos production, in the rat 
hippocampus after a one-trial avoidance learning: abolition byNMDA receptor 
blockade. Brain Res. Mol. Brain Res. v.76, p.36-46, 2000. 
CASHMAN, J.N.; POWER, S.J.; JONES, R.M. Assessment of a new hypnotic 
imidazo-pyridine (zolpidem) as oral premedication. Br. J. Clin. Pharmac. v.24, 
p.85-92, 1987. 
CASTRO, L.S.; POYARES, D.; LEGER, D.; BITTENCOURT, L.; TUFIK, S. 
Objective prevalence of insomnia in the São Paulo, Brazil epidemiologic 
sleep study. Ann Neurol. v.74, p.537-546, 2013. 
Karina Agustini Zanin  Referências Bibliográficas 
 
215 
 
CHEN, J.; NYE, H.E.; KELZ, M.B.; HIROI, N.; NAKABEPPU, Y.; HOPE, B.T.; 
NESTLER, E.J. Regulation of delta FosB and FosB-like proteins by 
electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. v.48, 
p.880-889, 1995. 
CHODERA, A.; NOWAKOWSKA, E.; BARTCZAK, G. Tolerance to a new class 
of non-benzodiazepine anxiolytics. Pol. J. Pharmacol. v.46, p.479-481, 1994. 
CIRELLI, C.; POMPEIANO, M.; TONONI, G. Fos-like immunoreactivity in the rat 
brain in spontaneous waking and sleep. Arch. Ital. Biol. v.131, p.327-330, 
1993. 
CIRELLI, C.; POMPEIANO, M.; TONONI, G. Sleep deprivation and c-fos 
expression in the rat brain. J. Sleep Res. v.4, p.92-106, 1995. 
CIRELLI, C. How sleep deprivation affects gene expression in the brain: a 
review of recent findings. J. Appl. Physiol.(1985). v.92, p.394-400, 2002. 
COLLE, M.; ROSENZWEIG, P.; BIANCHETTI, G.; FUSEAU, E.; RUFFIE, A.; 
RUEDAS, E.; MORSELLI, P.L. Nocturnal profile of growth hormone secretion 
during seeping induced by zolpidem: a double-blind study in young adults 
and children. Horm. Res. v.35, p.30-34, 1991. 
DANJOU, P.; PATY, I.; FRUNCILLO, R.; WORTHINGTON, P.; UNRUH, M.; 
CEVALLOS, W.; MARTIN, P. A comparison of the residual effects of zaleplon 
and zolpidem following administration 5 to 2 h before awakening. J Clin. 
Pharmacol. v.48, p.367-374, 1999. 
DAVIS, M. The role of amygdala in fear-potentiated startle: implications for 
animal models of anxiety. Trends Pharmacol. Sci. v.13, p.35-41, 1992. 
DAVIS, S.; BOZON, B.; LAROCHE, S. How necessary is the activation of the 
immediate early gene zif268 in synaptic plasticity and learning? Behav. Brain 
Res. v.142, p.17-30, 2003. 
DEL-BEL, E.A.; TITZE-DE-ALMEIDA, R.; SHIDA, H.; GARCIA-CAIRASCO, N.; 
CORRÊA, F.M.; GUIMARÃES, F.S. Induction of the c-fos proto-oncogene in 
the rat pineal gland during stress. Braz. J. Med. Biol. Res. v.26, p.975-981, 
1993. 
DEMENT, W.; KLEITMAN, N. Cyclic variations in EEG during sleep and their 
relation to eye movements, body motility, and dreaming. Electroencephalogr. 
Clin. Neurophysiol. v.9, p.673-690, 1957. 
DEPOORTERE, H.B.; ZIVKOVIC, B.; LLOYD, K.G.; SANGER, D.J.; 
PERRAULT, G.; LANGER, S. Z.; BARTHOLINI, G. Zolpidem, a novel 
nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral 
effects. J. Pharmacol. Exp. Ther. v.237, p.649-657, 1986. 
DEUTSCH, J.A.; ROERS J.B. Cholinergic excitability and memory: animal 
studies and their clinical implications. In: DAVIS K.L; BERGER, P.A. (Eds.). 
Brain Acetilcholine and Neuropsychiatric Disease. New York: Plenum, 1979. 
p.175-204. 
DI CHIARA, G.; IMPERATO, A. Drugs abused by humans preferentially 
increase synaptic dopamine concentrations in the mesolimbic system of 
freely moving rats. Proc. Natl. Acad. Sci. USA. v.85, p.5274-5278, 1988. 
Karina Agustini Zanin  Referências Bibliográficas 
 
216 
 
DIEKELMANN, S.; BORN, J. The memory function of sleep. Nat. Rev. 
Neurosci. v.11, p.114-126, 2010. 
DISMUKES, R.K.; RAKE, A.V. Involvement of biogenic amines on memory 
formation. Psycopharmacol. v.23, p.17-25, 1972. 
EDGAR, D.M.; SEIDEL, W.F.; GEE, K.W.; LAN, N.C.; FIELD, G.; XIA, H.; 
HAWKINSON, J.E.; WIELAND, S.; CARTER, R.B.; WOOD, P.L. CCd-3693: 
An orally bioavailable analog of the endogenous neuroactive steroid, 
pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J. 
Pharmacol. Exp. Ther. v.282, p.420-429, 1997. 
ERICKSON, C.K. Studies on the mechanism of avoidance facilitation by 
nicotine. Psycopharmacol. v.22, p.357-368, 1971. 
EVANGELISTA, A.M.; GATTONI, R.C.; IZQUIERDO, I. Effect of amphetamine, 
nicotine and hexamethonium on performance of a conditioned response 
during acquisition and retention trials. Pharmacology. v.3, p.91-96, 1970. 
EVANS, S.M.; FUNDERBURK, F.R.; GRIFFITHS, R.R. Zolpidem and triazolam 
in humans: behavioral and subjective effects and abuse liability. J. 
Pharmacol. Exp. Ther. v.255, p.1246-1255, 1990. 
EVERSON, C.A.; BERGMANN, B.M.; RECHTSCHAFFEN, A. Sleep deprivation 
in the rat. III. Total sleep deprivation. Sleep. v.12, p.13-21, 1989. 
EVERSON CA, SZABO A. Recurrent restriction of sleep and inadequate 
recuperation induce both adaptive changes and pathological outcomes. Am. 
J. Physiol. Regul. Integr. Comp. Physiol. v.297, p.R1430-R1440, 2009. 
FERGUSON, J.; DEMENT, W. The behavioral effects of amphetamine on REM 
deprived rats. J. Psychiatr. Res. v.7, p.111-118, 1969. 
FERNANDES-SANTOS, L.; PATTI, C.L.; ZANIN, K.A.; FERNANDES, H.A.; 
TUFIK, S.; ANDERSEN, M.L.; FRUSSA-FILHO, R. Sleep deprivation impairs 
emotional memory retrieval in mice: Influence of sex. Prog. 
Neuropsychopharmacol. Biol. Psychiatry. v.38, p.216-222, 2012. 
FERREIRA, M.B.C; Da SILVA, R.C.; MEDINA, J.H.; IZQUIERDO, I. Late post-
training memory processing by entorhinal cortex: involvement of NMDA and 
GABAergic receptors. Pharmacol. Biochem. Behav. v.41, p.767-771, 1992. 
FICCA, G.; SALZARULO, P. What in sleep is for memory. Sleep Med. v.5, 
p.225-230, 2004. 
FITZGERALD, A.C.; WRIGHT, B.T.; HELDT, S.A. The behavioral 
pharmacology of zolpidem: evidence for the functional significance of α1-
containing GABA(A) receptors. Psychopharmacology (Berl). v.231, p.1865-
1896, 2014. 
FRUSSA-FILHO, R.; GONÇALVES, M.T.; ANDERSEN, M.L.; ARAUJO, N.P.; 
CHINEN, C.C.; TUFIK, S. Paradoxical sleep deprivation potentiates 
amphetamine-induced behavioural sensitization by increasing its conditioned 
component. Brain Res. v.1003, p.188-193, 2004. 
Karina Agustini Zanin  Referências Bibliográficas 
 
217 
 
GAIS, S.; BORN, J. Low acetylcholine during slow-wave sleep is critical for 
declarative memory consolidation. Proc. Natl. Acad. Sci. USA. v.101, p.2140-
2144, 2004. 
GAO, B.; FRITSCHY, J.M.; BENKE, D.; MOHLER, H. Neuron-specific 
expression of GABAA-receptor subtypes: differential association of the alpha 
1- and alpha 3-subunits with serotonergic and GABAergic neurons. 
Neuroscience. v.54, p.881-892, 1993. 
GAO, B.; FRITSCHY, J.M. Selective allocation of GABAA receptors containing 
the alpha 1 subunit to neurochemically distinct subpopulations of rat 
hippocampal interneurons. Eur. J. Neurosci. v.6, p.837-853, 1994. 
GARCIA-GARCIA, F.; BELTRAN-PARRAZAL, L.; JIMENEZ-ANGUIANO, A.; 
VEGA-GONZALEZ, A.; DRUKER-COLIN, R. Manipulations during forced 
wakefulness have differential impact on sleep architecture, EEG power 
spectrum, and Fos induction. Brain Res. Bull. v.47, p.317-324, 1998. 
GARG, M. The effect of nicotine on two different types of learning. 
Psycopharmacol. v.15, p.408-414, 1969. 
GIVENS, B.S.; OLTON, D.S. Cholinergic and GABAergic modulation of medial 
septal area: effects on working memory. Behav. Neurosci. v.104, p.849-855, 
1990. 
GLICK, S.D.; ZIMMERBERG, B. Comparative learning impairment and amnesia 
by scopolamine, phencyclidine and ketamine. Psychonomic Science. v.25, 
p.165-166, 1971. 
GRACE, A.; HOMMER, D.; AND BUNNEY, C.B. Peripheral and striatal 
influences on nigral dopamine cells: Mediation by reticulate neurons. Brain 
Res. Bull., v.5 (Suppl. 2), p.105-109, 1980. 
GRASSI-ZUCCONI, G.; MENEGAZZI, M.; CARCERERI DE PRATI, A.; 
BASSETTI, A.; MONTAGNESE, P.; MANDILE, P.; COSI, C.; BENTIVOGLIO, 
M. C-fos mRNA is spontaneously induced in the rat brain during the activity 
period of the circadian cycle. Eur. J. Neurosci. v.5, p.1071-1078, 1993. 
GRASSI-ZUCCONI, G.; GIUDITTA, A.; MANDILE, P.; CHEN, S.; VESCIA, S.; 
BENTIVOGLIO, M. C-fos spontaneous expression during wakefulness is 
reversed during sleep in neuronal subsets of the rat cortex. J. Physiol. v.88, 
p.91-93, 1994a. 
GRASSI-ZUCCONI, G.; MENEGAZZI, M.; CARCERERI DE PRATI, A.; 
VESCIA, S.; RANUCCI, G.; BENTIVOGLIO, M. Different programs of gene 
expression are associated with different phases of the 24h and sleep-wake 
cycle. Chronobiologia. v.21, p.93-97, 1994b. 
GRIFFITHS, R.R.; SANNERUD, C.A.; ATOR, N.A.; BRADY, J.V. Zolpidem 
behavioral pharmacology in baboons: self-injection, discrimination, tolerance, 
and withdrawal. J. Pharmacol. Exp. Ther. v.260, p.1199-1208, 1992. 
GRIMM, R.; SCHICKNICK, H.; RIEDE, I.; GUNDELFINGER, E.D.; 
HERDEGEN, T.; ZUSCHRATTER, W.; TISCHMEYER, W. Suppression of c-
fos induction in rat brain impairs retention of a brightness discrimination 
reaction. Learn. Mem. v.3, p.402-413, 1997. 
Karina Agustini Zanin  Referências Bibliográficas 
 
218 
 
GRZANNA, R.; BROWN, R. Activation of Immediate Early Genes By Drugs of 
Abuse. NIDA Research Monograph 125. National Institutes of 
Health/National Institute on Drug Abuse, 1993. 
HADINGHAM, K.L.; GARRETT, E.M.; WAFFORD, K.A.; BAIN, C.; HEAVENS, 
R.P.; SIRINATHSINGHJI, D.J.; WHITING, P.J. Cloning of cDNAs encoding 
the human gamma-aminobutyric acid type A receptor alpha 6 subunit and 
characterization of the pharmacology of alpha 6-containing receptors. Mol. 
Pharmacol. v.49, p.253-259, 1996. 
HAJAK, G.; MÜLLER, W.E.; WITTCHEN, H.U.; PITTROW, D.; KIRCH, W. 
Abuse and dependence potential for the non-benzodiazepine hypnotics 
zolpidem and zopiclone: a review of case reports and epidemiological data. 
Addiction. v.98, p.1371-1378, 2003. 
HARRIS, J.A. Descending antinociceptive mechanisms in the brainstem: their 
role in the animal's defensive system. J. Physiol. Paris. v.90, p.15-25, 1996. 
HEIKKINEN, A.E.; MÖYKKYNEN, T.P.; KORPI, E.R. Long-lasting modulation of 
glutamatergic transmission in VTA dopamine neurons after a single dose of 
benzodiazepine agonists. Neuropsychopharmacology. v.34, p.290-298, 
2009. 
HERDEGEN, T.; LEAH, J.D. Inducible and constitutive transcription factors in 
the mammalian nervous system: control of gene expression by Jun, Fos and 
Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. v.28, p.370-490, 
1998. 
HERRERA, D.G.; ROBERTSON, H.A. Activation of c-fos in the brain. Prog. 
Neurobiol. v.50, p.83-107, 1996. 
HERZOG, C.D.; GANDHI, C.; BHATTACHARYA, P.; WALSH, T.J. Effects of 
intraseptal zolpidem and chlordiazapoxide on spatial working memory and 
high-affinity choline uptake in the hippocampus. Neurobiol. Learn. Mem. v.73, 
p.168-179, 2000. 
HESS, U.S.; LYNCH, G.; GALL, C.M. Changes in c-fos mRNA expression in rat 
brain during odor discrimination learning: differential involvement of 
hippocampal subfields CA1 and CA3. J. Neurosci. v.15, p.4786-4795, 1995a. 
HESS, U.S.; LYNCH, G.; GALL, C.M. Regional patterns of c-fos mRNA 
expression in rat hippocampus following exploration of a novel environment 
versus performance of a well-learned discrimination. J. Neurosci. v.15, 
p.7796-7809, 1995b. 
HIROI, N.; BROWN, J.R.; HAILE, C.N.; YE, H.; GREENBERG, M.E.; 
NESTLER, E.J. FosB mutant mice: loss of chronic cocaine induction of Fos-
related proteins and heightened sensitivity to cocaine's psychomotor and 
rewarding effects. Proc. Natl. Acad. Sci. USA. v.94, p.10397-10402, 1997. 
HIROI, N.; MAREK, G.J.; BROWN, J.R.; YE, H.; SAUDOU, F.; VAIDYA, V.A.; 
DUMAN, R.S.; GREENBERG, M.E.; NESTLER, E.J. Essential role of the 
fosB gene in molecular, cellular, and behavioral actions of chronic 
electroconvulsive seizures. J. Neurosci. v.18, 6952-6962, 1998. 
Karina Agustini Zanin  Referências Bibliográficas 
 
219 
 
HOPE, B.T.; NYE, H.E.; KELZ, M.B.; SELF, D.W.; IADAROLA, M.J.; 
NAKABEPPU, Y.; DUMAN, R.S.; NESTLER, E.J. Induction of a long-lasting 
AP-1 complex composed of altered Fos-like proteins in brain by chronic 
cocaine and other chronic treatments. Neuron. v.13, p.1235-1244, 1994. 
HOSHINO, K. Aspectos Filogenéticos do Sono. In: TUFIK, S. (Ed.) Medicina e 
Biologia do Sono. São Paulo: Manole, 2008. p.7-23. 
HUNT, S.P.; PINI, A.; EVAN, G. Induction of c-fos-like protein in spinal cord 
neurons following sensory stimulation. Nature. v.328, p.632-634, 1987. 
IDZIKOWSKI, C. Sleep and memory. Br. J. Psychol. v.75, p.439-449, 1984. 
IZQUIERDO, I.; MEDINA, J.H. GABA-A receptor modulation of memory: the 
role of endogenous benzodiazepines. Trends Pharmacol. Sci. v.12, p.260-
265, 1991. 
JERUSALINSKY, D.; KORNISIUK, E.; IZQUIERDO, I. Cholinergic 
neurotransmission and synaptic plasticity concerning memory processing. 
Neurochem Res. v.22, p.507-515, 1997. 
JOUVET, D.; VIMONT, P.; DELORME, F.; JOUVET, M. Study of selective 
deprivation of the paradoxal sleep phase in the cat. C R Seances Soc. Biol. 
Fil. v.158, p.756-759, 1964. 
KANDEL, E.R. Mecanismos celulares da aprendizagem e as bases biológicas 
da individualidade. In: KANDEL, E.R.; SCHWARTS, J.H.; JESSEL, T.M. 
(Eds.). Princípios da Neurociência. São Paulo: Manole, 2003. p.1247-1280. 
KATO, M.; PHILLIPS, B.G.; SIGURDSSON, G.; NARKIEWICZ, K.; PESEK, 
C.A.; SOMERS, V.K. Effects of sleep deprivation on neural circulatory 
control. Hypertension. v.35. p.1173-1175, 2000. 
KIM, Y.; LAPOSKY, A.D.; BERGMANN, B.M.; TUREK, F.W. Repeated sleep 
restriction in rats leads to homeostatic and allostatic responses during 
recovery sleep. Proc Natl Acad Sci USA. v.104, p.10697-10702, 2007. 
KIM, Y.; BOLORTUYA, Y.; CHEN, L.; BASHEER, R.; McCARLEY, R.W.; 
STRECKER, R.E. Decoupling of sleepiness from sleep time and intensity 
during chronic sleep restriction: evidence for a role of the adenosine system. 
Sleep. v.35, p.861-869, 2012. 
KLEYKAMP, B.A.; GRIFFITHS, R.R.; MCCANN, U.D.; SMITH, M.T.; MINTZER, 
M.Z. Acute effects of zolpidem extended-release on cognitive performance 
and sleep in healthy males after repeated nightly use. Exp. Clin. 
Psychopharmacol. v.20, p.28-39, 2012. 
LANGTRY, H.D.; BENFIELD, P. Zolpidem: A review of its phrmacodynamic and 
pharmacokinetic properties and therapeutic potential. Drugs. v.40, p.291-313, 
1990. 
LEEMBURG, S.; VYAZOVSKIY, V.V.; OLCESE, U.; BASSETTI, C.L.; TONONI, 
G.; CIRELLI, C. Sleep homeostasis in the rat is preserved during chronic 
sleep restriction. Proc. Natl. Acad. Sci. USA. v.107, p.15939-15944, 2010. 
Karina Agustini Zanin  Referências Bibliográficas 
 
220 
 
LEGER, D.; POURSAIN, B.; NEUBAUER, D.; UCHIYAMA, M. An international 
survey of sleeping problems in the general population. Curr. Med. Res. Opin. 
v.24, p.307-317, 2008. 
LISTER, R.G. The amnestic action of benzodiazepines in man. Neurosci. 
Biobehav. Rev. v.9, p.87-94, 1985. 
LLOYD, K.G.; ZIVKOVIC, B. Specificity within the GABA receptor 
supramolecular complex: a consideration of the new omega 1 receptor 
selective imidazopyridine hypnotic zolpidem. Pharmacol. Biochem. Behav. 
v.129, p.781-783, 1988. 
MARKOWITZ, J.S.; BREWERTON, T.D. Zolpidem-induced psychosis. Ann. 
Clin. Psychiatry. v.8, p.89-91, 1996. 
MAVIEL, T.; DURKIN, T.P.; MENZAGHI, F.; BONTEMPI, B. Sites of neocortical 
reorganization critical for remote spatial memory. Science. v.305, p.96-99, 
2004. 
McCOY, J.G.; CHRISTIE, M.A.; KIM, Y.; BRENNAN, R.; POETA, D.L.; 
McCARLEY, R.W.; STRECKER, R.E. Chronic sleep restriction impairs 
spatial memory in rats. Neuroreport. v.24, p.91-95, 2013. 
MEIER-EWERT, H.K.; RIDKER, P.M.; RIFAI, N.; REGAN, M.M.; PRICE, N.J.; 
DINGES, D.F.; MULLINGTON, J.M. Effect of sleep loss on C-reactive 
protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 
v.43, p.678-683, 2004. 
MISHKIN M; MALAMUT B; BACHEVALIER J. Memories and Habits: Two 
Neural Systems. In: LYNCH, G.; McGAUGH, J.L.; WEINBERGER, N.M., 
(Eds.). Neurobiololy of learning and memory. New York: Guilford Press, 
1984. p. 65-77. 
MORIN, C.M.; LEBLANC, M.; DALEY, M.; GREGOIRE, J.P.; MÉRETTE, C. 
Epidemiology of insomnia: prevalence, self-help treatments, consultations, 
and determinants of help-seeking behaviors. Sleep Med. v.7, p.123-130, 
2006. 
NAGAHARA, A.H.; HANDA, R.J. Fetal alcohol exposure alters the induction of 
immediate early gene mRNA in the rat prefrontal cortex after an alternation 
task. Alcohol Clin. Exp. Res. v.19, p.1389-1397, 1995. 
NATIONAL SLEEP FOUNDATION. Sleep in AmericaTM poll. Summary of 
findings. 2009. Disponível em: 
http://sleepfoundation.org/sites/default/files/2009%20SLEEP%20IN%20AME
RICA%20SOF%20EMBARGOED_0.PDF 
NESTLER, E.J.; BARROT, M.; SELF, D.W. DeltaFosB: a sustained molecular 
switch for addiction. Proc. Natl. Acad. Sci. USA. v.98, p.11042-11046, 2001. 
NESTLER, E.J. Molecular mechanisms of drug addiction. Neuropharmacology. 
v.47, p.24-32, 2004. 
NIKOLAEV, E.; KAMINSKA, B.; TISCHMEYER, W.; MATTHIES, H.; 
KACZMAREK, L. Induction of expression of genes encoding transcription 
factors in the rat brain elicited by behavioral training. Brain Res. Bull. v.28, 
p.479-484, 1992. 
Karina Agustini Zanin  Referências Bibliográficas 
 
221 
 
NOVAK, C.M.; NUNEZ, A.A. Daily rhythms in Fos activity in the rat ventrolateral 
preoptic area and midline thalamic nuclei. Am. J. Physiol. v.275, p.R1620-
R1626, 1998. 
NUTT, D. GABAA receptors: subtypes, regional distribution, and function. J. 
Clin. Sleep Med. v.2, p.S7-11, 2006. 
O’HARA, B.F.; YOUNG, K.A.; WATSON, F.L.; HELLER, H.C.; KILDUFF, T.S. 
Immediate early gene expression in brain during sleep deprivation: 
preliminary observations. Sleep. v.16, p.1-7, 1993. 
OHAYON, M.M. Epidemiology of insomnia: what we know and what we still 
need to learn. Sleep Med. Rev. v.6, p. 97-111, 2002. 
PALCHYKOVA, S.; WINSKY-SOMMERER, R.; MEERLO, P.; DÜRR, R.; 
TOBLER, I. Sleep deprivation impairs object recognition in mice. Neurobiol. 
Learn. Mem. v.85, p.263-271, 2006. 
PAPA, M.; PELLICANO, M.P.; CERBONE, A.; LAMBERTI-D’MELLO, C.; 
MENNA, T.; BUONO, C.; GIUDITTA, A.; WELZL, H.; SADILE, A.G. 
Immediate early genes and brain DNA remodeling in the Naples high- and 
low-excitability rat lines following exposure to a spatial novelty. Brain Res. 
Bull. v.37, p.111-118, 1995. 
PATTI, C.L.; ZANIN, K.A.; SANDAY, L.; KAMEDA, S.; FERNANDES-SANTOS, 
L.; FERNANDES, H.A.; ANDERSEN, M.L.; TUFIK, S.; FRUSSA-FILHO, R. 
Effects of sleep deprivation on memory in mice: role of state-dependent 
learning. Sleep. v.33, p.1669-1679, 2010. 
PERRAULT, G.; MOREL, E.; SANGER, D.J.; ZIVKOVIC, B. Differences in 
pharmacological profiles of a new generation of benzodiazepine and 
nonbenzodiazepine hypnotics. Eur. J. Pharmacol. v.187, p.487-494, 1990. 
POMPEIANO, M.; CIRELLI, C.; TONONI, G. Effects of sleep deprivation on 
Fos-like immunoreactivity in the rat brain. Arch. Ital. Biol. v.130, p.325-335, 
1992. 
POMPEIANO, M.; CIRELLI, C.; TONONI, G. Immediate-early genes in 
spontaneous wakefulness and sleep: Expression of c-fos and NGFI-A mRNA 
and protein. J. Sleep Res. v.3, p.80-96, 1994. 
POMPEIANO, M.; CIRELLI, C.; RONCA-TESTONI, S.; TONONI, G. NGFI-A 
expression in the rat brain after sleep deprivation. Mol. Brain Res. v.46, 
p.143-153, 1997. 
POWER, A. E. Slow-wave sleep, acetylcholine, and memory consolidation. 
Proc. Natl. Acad. Sci. USA. v.101, p.1795-1796, 2004. 
POYARES, D.; PINTO, L.R.Jr.; TAVARES, S.; BARROS-VIEIRA, S. Sleep 
promoters and insomnia. Rev. Bras. Psiquiatr. v.27, p.2-7, 2005. 
RADULOVIC, J.; KAMMERMEIER, J.; SPIESS, J. Relationship between Fos 
production and classical fear conditioning: effects of novelty, latent inhibition, 
and unconditioned stimulus preexposure. J. Neurosci. v.18, p.7452-7461, 
1998. 
Karina Agustini Zanin  Referências Bibliográficas 
 
222 
 
RANDT, C.T.; QUARTERMAN, D.; GOLDSTEIN, M.; ANAGNOSTE, B. 
Norepinephrine biosyntesis inhibition: effects on memory in mice. Science. 
v.172, p.498-499, 1971. 
RECHTSCHAFFEN, A. Current perspectives on the function of sleep. Perspect. 
Biol. Med. v.41, p.359-390, 1998. 
REVEL, F.G.; GOTTOWIK, J.; GATTI, S.; WETTSTEIN, J.G.; MOREAU, J.L. 
Rodent models of insomnia: a review of experimental procedures that induce 
sleep disturbances. Neurosci. Biobehav. Rev. v.33, p.874-899, 2009. 
ROEHRS, T.; ROTH, T. Sleep disorders: an overview. Clin. Cornerstone. v.6, 
p.6-16, 2004. 
ROSS, R.S.; EICHENBAUM, H. Dynamics of hippocampal and cortical 
activation during consolidation of a nonspatial memory. J. Neurosci. v.26; 
p.4852-4859, 2006. 
ROTH, T.; DRAKE, C. Evolution of insomnia: current status and future direction. 
Sleep Med. v.5, p.23-30, 2004. 
SALVÀ, P.; COSTA, J. Clinical pharmacokinetics and pharmacodynamics of 
zolpidem. Therapeutic implications. Clin. Pharmacokinet. v.29, p.142-153, 
1995. 
SANGER, D.J.; JOLY, D.; ZIVKOVIC, B. effects of zolpidem, a new 
imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. 
Comparison with triazolam and CL 218,872. Psychopharmacology. v.90, 
p.207-210, 1986. 
SARTER, M.; MARKOWITSCH, H.J. The amygdala’s role in human menrmonic 
processing. Cortex. 21:7-24, 1985. 
SCHULTZ, W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 
v.80, p.1-27, 1998. 
SHERIN, J.E.; SHIROMANI, P.J.; MCCARLEY, R.W.; SAPER, C.B. Activation 
of ventrolateral preoptic neurons during sleep. Science. v.271, p.216-219, 
1996. 
SILVA, R.H.; CHEHIN, A.B.; KAMEDA, S.R.; TAKATSU-COLEMAN, A.L.; 
ABÍLIO, V.C.; TUFIK, S.; FRUSSA-FILHO, R. Effects of pre- or post-training 
paradoxical sleep deprivation on two animal models of learning and memory 
in mice. Neurobiol. Learn. Mem. v.82, p.90-98, 2004. 
SIVERTSEN, B.; KROKSTAD, S.; OVERLAND, S.; MYKLETUN, A. The 
epidemiology of insomnia: associations with physical and mental health. The 
HUNT-2 study. J. Psychosom. Res. v.67, p.109-116, 2009. 
SMITH, C. Paradoxical sleep deprivation and sleep recording following training 
in a brightness discrimination avoidance task in Sprague-Dawley rats: 
paradoxical effects. Neurobiol. Learn. Mem. v.66, p.283-294, 1996. 
SMITH, C.T; CONWAY, J.M.; ROSE, G.M. Brief paradoxical sleep deprivation 
impairs reference, but not working, memory in the radial arm maze task. 
Neurobiol. Learn. Mem. v.69, p.211-217, 1998. 
Karina Agustini Zanin  Referências Bibliográficas 
 
223 
 
SOLDATOS, C.R.; ALLAERT, F.A.; OHTA, T.; DIKEOS, D.G. How do 
individuals sleep around the world? Results from a single-day survey in ten 
countries. Sleep Med. v.6, p.5-13, 2005. 
SPIEGEL, K.; LEPROULT, R.; L’HERMITE-BALERIAUX, M.; COPINSCHI, G.; 
PENEV, P.D.; VAN CAUTER, E. Leptin levels are dependent on sleep 
duration: relationships with sympathovagal balance, carbohydrate regulation, 
cortisol, and thyrotropin. J. Clin. Endocrinol. Metab. v.8, p.5762-5771, 2004. 
SPIEGEL, K.; LEPROULT, R.; VAN CAUTER, E. Impact of sleep debt on 
metabolic and endocrine function. Lancet. v.354, p.1435-1439, 1999. 
STACKMAN, R.W.; WALSH, T.J. Chlordiazepoxide-induced working memory 
impairments: site specificity and reversal by flumazenil. Behav. Neural 
Biology. v.61, p.181-185, 1992. 
STACKMAN, R.W.; WALSH, T.J. Anatomical specificity and time-dependence 
of chlordiazepoxide-induced spatial memory impairments. Behav. Neurosci. 
v.109, p.436-445, 1995a. 
STACKMAN, R.W.; WALSH, T.J. Distinct profile of working memory errors 
following acute or chronic disruption of the cholinergic septohippocampal 
pathway. Neurobiol. Learn. Mem. v.64, p.226-236, 1995b. 
STECKLER, T.; SAHGAL, A. The role of serotoninergic-cholinergic interactions 
of na anticholinesterase drug and maze learning in two strains of rats. 
Psycopharmacol. v.5, p.47-54, 1995. 
STEPHENS, D.N. A glutamatergic hypothesis of drug dependence: 
extrapolations from benzodiazepine receptor ligands. Behav. Pharmacol. v.6, 
p.425-446, 1995. 
STOOPS, W.W.; RUSH, C.R. Differential effects in humans after repeated 
administrations of zolpidem and triazolam. Am. J. Drug Alcohol Abuse. v. 29, 
p. 281-299, 2003. 
STRATON, L.D.; PETRINOVICH, L.F. Post-trial injections of an 
anticholinesterase drug and maze learning in two strains of rats. 
Psycopharmacol. v.5, p.47-54, 1963. 
SVITEK, J.; HEBERLEIN, A.; BLEICH, S.; WILTFANG, J.; KORNHUBER, J.; 
HILLEMACHER, T. Extensive craving in high dose zolpidem dependency. 
Prog. Neuropsychopharmacol. Biol. Psychiatry. v.32, p.591-592, 2008. 
TANG, A.H.; SMITH, M.W.; CARTER, D.B.; IM, W.B.; VON VOIGTLANDER, 
P.F. U-90042, A sedative/hypnotic compound that interacts differentially with 
the GABA-A receptor subtypes. J. Pharmacol. Exp. Ther. v.275, p.761-767, 
1995. 
TAN, K.R.; BROWN, M.; LABOUÈBE, G.; YVON, C.; CRETON, C.; FRITSCHY, 
J.M.; RUDOLPH, U.; LÜSCHER, C. Neural bases for addictive properties of 
benzodiazepines. Nature. v.463, p.769-774, 2010. 
TAN, K.R.; RUDOLPH, U.; LÜSCHER, C. Hooked on benzodiazepines: GABAA 
receptor subtypes and addiction. Trends Neurosci. v.34, p.188-197, 2011. 
Karina Agustini Zanin  Referências Bibliográficas 
 
224 
 
THOMPSON, A.M.; GOSNELL, B.A.; WAGNER, J.J. Enhancement of long-term 
potentiation in rat hippocampus following cocaine exposure. 
Neuropharmacology. v.42, p.1039-42, 2002. 
TIMO-LARIA, C.; NEGRÃO, C.N.; SCHIMIDEK, R.W.; HOSHINO, K.; 
MENEZES, C.E.; ROCHA, L.T.I. Phases and states of sleep in the rat. 
Physiol. Behav. v.5, p.1057-1062, 1970. 
TISCHMEYER, W.; KACZMAREK, L.; STRAUSS, M.; JORK, R.; MATTHIES, H. 
Accumulation of c-fos mRNA in rat hippocampus during acquisition of a 
brightness discrimination. Behav. Neural. Biol. v.54, p.165-171, 1990. 
TITZE-DE-ALMEIDA, R.; DE OLIVEIRA, C.L.; SHIDA, H.W.; GUIMARÃES, 
F.S.; DEL BEL, E.A. Midazolam and the N-methyl-D-aspartate (NMDA) 
receptor antagonist 2-amino-7-phosphonoheptanoic acid (AP-7) attenuate 
stress-induced expression of c-fos mRNA in the dentate gyrus. Cell. Mol. 
Neurobiol. v.14, p.373-380, 1994. 
TOBLER, I.; BORBÉLY, A.A. The effect of 3-h and 6-h sleep deprivation on 
sleep and EEG spectra of the rat. Behav. Brain Res. v.36, p.73-78, 1990. 
TOCHIKUBO, O.; IKEDA, A.; MIYAJIMA, E.; ISHII, M. Effects of insufficient 
sleep on blood pressure monitored by a new multibiomedical recorder. 
Hypertension. v.27, p.1318-1324, 1996. 
TRONCONE, L.R.; FERREIRA, T.M.; BRAZ, S.; SILVEIRA-FILHO, N.G.; 
TUFIK, S. Reversal of the increase in apomorphine-induced stereotypy and 
aggression in REM sleep deprived rats by dopamine agonist pretreatments. 
Psychopharmacol. v.94, p.79-83, 1988. 
TUFIK, S.; LINDSEY, C.J.; CARLINI, E.A. Does REM sleep deprivation induce 
a supersensitivity of dopaminergic receptors in the rat brain? Pharmacology. 
v.16, p.98-105, 1978. 
TUFIK, S. Increased responsiveness to apomorphine after REM sleep 
deprivation:supersensitivity of dopamine receptors or increase in dopamine 
turnover? J. Pharm. Pharmacol. v.33, p.732-738, 1981a. 
TUFIK, S. Changes of response to dopaminergic drugs in rats submitted to 
REM-sleep deprivation. Psychopharmacol. v.72, p.257-260, 1981b. 
VAN DONGEN, H.P.; MAISLIN, G.; MULLINGTON, J.M.; DINGES, D.F. The 
cumulative cost of additional wakefulness: dose-response effects on 
neurobehavioral functions and sleep physiology from chronic sleep restriction 
and total sleep deprivation. Sleep. v.26, p.117-126, 2003. 
VANN, S.D.; BROWN, M.W.; ERICHSEN, J.T.; AGGLETON, J.P. Fos imaging 
reveals differential patterns of hippocampal and parahippocampal subfield 
activation in rats in response to different spatial memory tests. J. Neurosci. 
v.20, p.2711-2718, 2000. 
WAFFORD, K.A.; THOMPSON, S.A.; THOMAS, D.; SIKELA, J.; WILCOX, A.S.; 
WHITING, P.J. Functional characterization of human gamma-aminobutyric 
acidA receptors containing the alpha 4 subunit. Mol. Pharmacol. v.50, p.670-
678, 1996. 
Karina Agustini Zanin  Referências Bibliográficas 
 
225 
 
WAN, H.; AGGLETON, J.P.; BROWN, M.W. Different contributions of the 
hippocampus and perirhinal cortex to recognition memory. J. Neurosci. v.19, 
p.1142-1148, 1999. 
WARE, J.C.; WALSH, J.K.; SCHARF, M.B.; ROEHRS, T.; ROTH, T.; VOGEL, 
G.W. Minimal rebound insomnia after treatment with 10 mg zolpidem. Clin. 
Neuropharmacol. v.20, p.116-125, 1997. 
WEISSMAN, A. Drugs and retrograde amnesia. Int. Rev. Neurobiol. v.10, 
p.167-168, 1967. 
WIENER, N.I.; MESSER, J. Scopolamine-induced impairment of long-term 
retention in rats. Behav. Biol. v.9, p.227-234, 1973. 
WISDEN, W.; HERB, A.; WIELAND, H.;KEINANEN, K.; LUDDENS, H.; 
SEEBURG, P.H. Cloning, pharmacological characteristics and expression 
pattern of the rat GABAA receptor alpha 4 subunit. FEBS Lett. v.289, p.227-
230, 1991. 
WISE, R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. v.6, p.243-251, 
1996. 
WITTER, M.P.; GROENEWEGEN, H.J.; LOPES DA SILVA, F.H.; LOHMAN, 
A.H.M. Functional organization of the extrinsic and intrinsic circuitry of the 
para hippocampal region. Prog Neurobiol. v.33, p.161-253, 1989. 
YANG, S.R.; SUN, H.; HUANG, Z.L.; YAO, M.H.; QU, W.M. Repeated sleep 
restriction in adolescent rats altered sleep patterns and impaired spatial 
learning/memory ability. Sleep. v.35, p.849-859, 2012. 
YOUNGBLOOD, B.D.; ZHOU, J.; SMAGIN, G.N.; RYAN, D.H.; HARRIS, R.B. 
Sleep deprivation by the "flower pot" technique and spatial reference 
memory. Physiol. Behav. v.61, p.249-256, 1997. 
YOUNGBLOOD, B.D.; SMAGIN, G.N.; ELKINS, P.D.; RYAN, D.H.; HARRIS, 
R.B. The effects of paradoxical sleep deprivation and valine on spatial 
learning and brain 5-HT metabolism. Physiol. Behav. v.67, p.643-649, 1999. 
ZANIN, K.A.; PATTI, C.L.; TUFIK, S.; POYARES, D.; FRUSSA-FILHO, R. 
Zolpidem impairs non-associative memory in mice. Sleep Sci. v.3, p.81-87, 
2011. 
ZANIN, K.A.; PATTI, C.L.; SANDAY, L.; FERNANDES-SANTOS, L.; OLIVEIRA, 
L.C.; POYARES, D.; TUFIK, S.; FRUSSA-FILHO, R. Effects of zolpidem on 
sedation, anxiety, and memory in the plus-maze discriminative avoidance 
task. Psychopharmacology (Berl). v.226, p.459-474, 2013. 
ZHU, X.O.; BROWN, M.W.; MCCABE, B.J.; AGGLETON, J.P. Effects of the 
novelty or familiarity of visual stimuli on the expression of the immediate early 
gene c-fos in rat brain. Neuroscience. v.69, p.821-829, 1995. 
ZHU, X.O.; MCCABE, B.J.; AGGLETON, J.P.; BROWN, M.W. Differential 
activation of the rat hippocampus and perirhinal cortex by novel visual stimuli 
and a novel environment. Neurosci. Lett. v.229, p.141-143, 1997. 
ZIELINSKI, M.R.; DAVIS, J.M.; FADEL, J.R.; YOUNGSTEDT, S.D. Influence of 
chronic moderate sleep restriction and exercise training on anxiety, spatial 
Karina Agustini Zanin  Referências Bibliográficas 
 
226 
 
memory, and associated neurobiological measures in mice. Behav. Brain 
Res. v.250, p.74-80, 2013. 
ZISAPEL, N. Sleep and sleep disturbances: biological basis and clinical  
implications. Cell Mol. Life Sci. v.64, p.1174-1186, 2007. 
ZIVKOVIC, B.; PERRAULT, G.; MOREL, E.; SANGER, D.J. Comparative 
pharmacology of zolpidem and other hypnotics and sleep inducers. In: 
SAUVANET, J.P.; LANGER, S.Z.; MORSELLI, P.L. (Eds.). Imidazopyridines 
in sleep disorders: A novel experimental and therapeutic approach. New 
York: Raven Press, 1988. p.97-109. 
ZOLA-MORGAN, S.; SQUIRE, L.R.; AMARAL, D.G.; SUZUKI, W. Lesions of 
perihinal and parahippocampal cortex that spare the amygdada and 
hippocampal formation produce severe memory impairment. J. Neurosci. v.9, 
p.4355-4370, 1989. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anexos 
 
Karina Agustini Zanin  Anexos 
227 
 
6.1 Anexo 1: Comitê de ética 
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6.2 Anexo 2: Comprovante de submissão - Manuscrito 2 
